10-Q

0001413329-16-000082.txt : 20160426 0001413329-16-000082.hdr.sgml : 20160426 20160426102231 ACCESSION NUMBER: 0001413329-16-000082 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160426 DATE AS OF CHANGE: 20160426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Philip Morris International Inc. CENTRAL INDEX KEY: 0001413329 STANDARD INDUSTRIAL CLASSIFICATION: CIGARETTES [2111] IRS NUMBER: 133435103 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33708 FILM NUMBER: 161590766 BUSINESS ADDRESS: STREET 1: 120 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (917) 663-2000 MAIL ADDRESS: STREET 1: 120 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 10-Q 1 pm-033116x10qxdoc.htm 10-Q 10-Q

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


(X)	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016


( )	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-33708



Philip Morris International Inc.

(Exact name of registrant as specified in its charter)



Virginia	13-3435103
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)



120 Park Avenue New York, New York	10017
(Address of principal executive offices)	(Zip Code)



Registrant’s telephone number, including area code	(917) 663-2000

Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company ¨

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

At April 22, 2016, there were 1,551,264,326 shares outstanding of the registrant’s common stock, no par value per share.

-1-

Table of Contents

PHILIP MORRIS INTERNATIONAL INC.

TABLE OF CONTENTS



		Page No.

PART I -	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)

	Condensed Consolidated Balance Sheets at
	March 31, 2016 and December 31, 2015	3 – 4

	Condensed Consolidated Statements of Earnings for the
	Three Months Ended March 31, 2016 and 2015	5

	Condensed Consolidated Statements of Comprehensive Earnings for the
	Three Months Ended March 31, 2016 and 2015	6

	Condensed Consolidated Statements of Stockholders’ (Deficit) Equity for the
	Three Months Ended March 31, 2016 and 2015	7

	Condensed Consolidated Statements of Cash Flows for the
	Three Months Ended March 31, 2016 and 2015	8 – 9

	Notes to Condensed Consolidated Financial Statements	10 – 33

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	34 – 67

Item 4.	Controls and Procedures	68

PART II -	OTHER INFORMATION

Item 1.	Legal Proceedings	69

Item 1A.	Risk Factors	69

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	70

Item 6.	Exhibits	71

Signature		72

In this report, “PMI,” “we,” “us” and “our” refer to Philip Morris International Inc. and its subsidiaries.

- 2-

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in millions of dollars)

(Unaudited)



	March 31, 2016		December 31, 2015
ASSETS
Cash and cash equivalents	$	2,944	$	3,417
Receivables (less allowances of $58 in 2016 and $58 in 2015)	2,989		2,778
Inventories:
Leaf tobacco	3,034		2,640
Other raw materials	1,615		1,613
Finished product	4,050		4,220
	8,699		8,473
Deferred income taxes	485		488
Other current assets	811		648
Total current assets	15,928		15,804
Property, plant and equipment, at cost	12,202		11,767
Less: accumulated depreciation	6,337		6,046
	5,865		5,721
Goodwill (Note 5)	7,683		7,415
Other intangible assets, net (Note 5)	2,664		2,623
Investments in unconsolidated subsidiaries (Note 15)	942		890
Other assets	1,539		1,503
TOTAL ASSETS	$	34,621	$	33,956

See notes to condensed consolidated financial statements.

Continued

- 3-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Continued)

(in millions of dollars, except share data)

(Unaudited)



	March 31, 2016			December 31, 2015
LIABILITIES
Short-term borrowings (Note 11)	$	673		$	825
Current portion of long-term debt (Note 11)	2,437			2,405
Accounts payable	1,496			1,289
Accrued liabilities:
Marketing and selling	536			640
Taxes, except income taxes	4,569			5,121
Employment costs	735			903
Dividends payable	1,591			1,589
Other	1,387			1,438
Income taxes	576			970
Deferred income taxes	91			206
Total current liabilities	14,091			15,386
Long-term debt (Note 11)	26,683			25,250
Deferred income taxes	1,378			1,543
Employment costs	2,602			2,566
Other liabilities	761			687
Total liabilities	45,515			45,432
Contingencies (Note 9)
STOCKHOLDERS’ (DEFICIT) EQUITY
Common stock, no par value (2,109,316,331 shares issued in 2016 and 2015)	—			—
Additional paid-in capital	1,874			1,929
Earnings reinvested in the business	29,785			29,842
Accumulated other comprehensive losses	(8,914		)	(9,402		)
	22,745			22,369
Less: cost of repurchased stock (558,058,798 and 559,972,262 shares in 2016 and 2015, respectively)	35,498			35,613
Total PMI stockholders’ deficit	(12,753		)	(13,244		)
Noncontrolling interests	1,859			1,768
Total stockholders’ deficit	(10,894		)	(11,476		)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY	$	34,621		$	33,956

See notes to condensed consolidated financial statements.

- 4-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Earnings

(in millions of dollars, except per share data)

(Unaudited)



	For the Three Months Ended March 31,
	2016			2015
Net revenues	$	16,788		$	17,352
Cost of sales	2,096			2,229
Excise taxes on products	10,705			10,736
Gross profit	3,987			4,387
Marketing, administration and research costs	1,496			1,494
Amortization of intangibles	18			22
Operating income	2,473			2,871
Interest expense, net	247			275
Earnings before income taxes	2,226			2,596
Provision for income taxes	630			785
Equity (income)/loss in unconsolidated subsidiaries, net	(9		)	(23		)
Net earnings	1,605			1,834
Net earnings attributable to noncontrolling interests	75			39
Net earnings attributable to PMI	$	1,530		$	1,795
Per share data (Note 7):
Basic earnings per share	$	0.98		$	1.16
Diluted earnings per share	$	0.98		$	1.16
Dividends declared	$	1.02		$	1.00

See notes to condensed consolidated financial statements.

- 5-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Earnings

(in millions of dollars)

(Unaudited)



	For the Three Months Ended March 31,
	2016			2015
Net earnings	$	1,605		$	1,834
Other comprehensive earnings (losses), net of income taxes:
Change in currency translation adjustments:
Unrealized gains (losses), net of income taxes of $162 in 2016 and ($434) in 2015	538			(1,343		)
Change in net loss and prior service cost:
Net losses and prior service costs, net of income taxes of $3 in 2016 and $- in 2015	(10		)	—
Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($8) in 2016 and ($12) in 2015	55			56
Change in fair value of derivatives accounted for as hedges:
Gains (losses) recognized, net of income taxes of $17 in 2016 and ($2) in 2015	(62		)	25
(Gains) losses transferred to earnings, net of income taxes of ($1) in 2016 and $3 in 2015	(7		)	(27		)
Total other comprehensive earnings (losses)	514			(1,289		)
Total comprehensive earnings	2,119			545
Less comprehensive earnings attributable to:
Noncontrolling interests	101			14
Comprehensive earnings attributable to PMI	$	2,018		$	531

See notes to condensed consolidated financial statements

- 6-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ (Deficit) Equity

For the Three Months Ended March 31, 2016 and 2015

(in millions of dollars, except per share amounts)

(Unaudited)



	PMI Stockholders’ (Deficit) Equity
	Common Stock		Additional Paid-in Capital			Earnings Reinvested in the Business			Accumulated Other Comprehensive Losses			Cost of Repurchased Stock			Noncontrolling Interests			Total
Balances, January 1, 2015	$	—	$	710		$	29,249		$	(6,826	)	$	(35,762	)	$	1,426		$	(11,203	)
Net earnings						1,795									39			1,834
Other comprehensive earnings (losses), net of income taxes									(1,264		)				(25		)	(1,289		)
Issuance of stock awards			(97		)							134						37
Dividends declared ($1.00 per share)						(1,555		)										(1,555		)
Payments to noncontrolling interests															(70		)	(70		)
Balances, March 31, 2015	$	—	$	613		$	29,489		$	(8,090	)	$	(35,628	)	$	1,370		$	(12,246	)
Balances, January 1, 2016	$	—	$	1,929		$	29,842		$	(9,402	)	$	(35,613	)	$	1,768		$	(11,476	)
Net earnings						1,530									75			1,605
Other comprehensive earnings (losses), net of income taxes									488						26			514
Issuance of stock awards			(56		)							115						59
Dividends declared ($1.02 per share)						(1,587		)										(1,587		)
Payments to noncontrolling interests															(12		)	(12		)
Other			1												2			3
Balances, March 31, 2016	$	—	$	1,874		$	29,785		$	(8,914	)	$	(35,498	)	$	1,859		$	(10,894	)

See notes to condensed consolidated financial statements.

- 7-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in millions of dollars)

(Unaudited)



	For the Three Months Ended March 31,
	2016			2015
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

Net earnings	$	1,605		$	1,834

Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	175			192
Deferred income tax provision	10			132
Asset impairment and exit costs, net of cash paid	(14		)	(160		)
Cash effects of changes:
Receivables, net	(175		)	54
Inventories	49			393
Accounts payable	223			44
Income taxes	(485		)	(535		)
Accrued liabilities and other current assets	(922		)	(2,327		)
Pension plan contributions	(52		)	(9		)
Other	48			7
Net cash provided by (used in) operating activities	462			(375		)

CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

Capital expenditures	(226		)	(203		)
Investments in unconsolidated subsidiaries	(7		)	(8		)
Other	(186		)	279
Net cash provided by (used in) investing activities	(419		)	68

See notes to condensed consolidated financial statements.

Continued

- 8-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(in millions of dollars)

(Unaudited)



	For the Three Months Ended March 31,
	2016			2015
CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

Short-term borrowing activity by original maturity:
Net (repayments) issuances - maturities of 90 days or less	$	(136	)	$	2,237
Issuances - maturities longer than 90 days	—			13
Long-term debt proceeds	1,978			302
Long-term debt repaid	(827		)	(399		)
Repurchases of common stock	—			(48		)
Dividends paid	(1,585		)	(1,555		)
Sale (purchase) of subsidiary shares to (from) noncontrolling interests	6			—
Other	(29		)	(25		)
Net cash provided by (used in) financing activities	(593		)	525
Effect of exchange rate changes on cash and cash equivalents	77			(376		)

Cash and cash equivalents:
Decrease	(473		)	(158		)
Balance at beginning of period	3,417			1,682
Balance at end of period	$	2,944		$	1,524

See notes to condensed consolidated financial statements.

- 9-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1. Background and Basis of Presentation:

Background

Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Throughout these financial statements, the term “PMI” refers to Philip Morris International Inc. and its subsidiaries.

Basis of Presentation

The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.

Certain prior years' amounts have been reclassified to conform with the current year's presentation, as reflected in Note 8. Segment Reporting. The changes did not have an impact on PMI's consolidated financial position, results of operations or cash flows in any of the periods presented.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2015.

Note 2. Asset Impairment and Exit Costs:

During the three months ended March 31, 2016 and 2015, PMI did not incur asset impairment and exit costs.

Movement in Exit Cost Liabilities

The movement in exit cost liabilities for the three months ended March 31, 2016 was as follows:



(in millions)
Liability balance, January 1, 2016	$	54
Charges, net	—
Cash spent	(14		)
Currency/other	2
Liability balance, March 31, 2016	$	42

Cash payments related to exit costs at PMI were $14 million and $160 million for the three months ended March 31, 2016 and 2015, respectively. Future cash payments for exit costs incurred to date are expected to be approximately $42 million, and will be substantially paid by the end of 2017.

Note 3. Stock Plans:

In May 2012, PMI’s shareholders approved the Philip Morris International Inc. 2012 Performance Incentive Plan (the “2012 Plan”). Under the 2012 Plan, PMI may grant to eligible employees restricted stock, restricted stock units and deferred stock units (collectively referred to as restricted share units), performance-based cash incentive awards and performance-based equity awards. Up to 30 million shares of PMI’s common stock may be issued under the 2012 Plan. At March 31, 2016, shares available for grant under the 2012 Plan were 21,608,980.

In 2008, PMI adopted the Philip Morris International Inc. 2008 Stock Compensation Plan for Non-Employee Directors (the “Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million

- 10-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

shares of PMI common stock may be awarded under the Non-Employee Directors Plan. At March 31, 2016, shares available for grant under the plan were 691,432.

Restricted share unit (RSU) awards

During the three months ended March 31, 2016, PMI granted 1.2 million shares of RSU awards to eligible employees at a weighted-average grant date fair value of $89.02 per share. During the three months ended March 31, 2015, PMI granted 1.5 million shares of RSU awards to eligible employees at a grant date fair value of $82.28 per share. PMI recorded compensation expense related to RSU awards of $41 million and $58 million during the three months ended March 31, 2016 and 2015, respectively. As of March 31, 2016, PMI had $198 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three or more years after the date of the award, subject to earlier vesting on death, disability or normal retirement, or separation from employment by mutual agreement after reaching age 58.

During the three months ended March 31, 2016, 2.1 million shares of PMI RSU awards vested. The grant date fair value of all the vested shares was approximately $190 million. The total fair value of RSU awards that vested during the three months ended March 31, 2016 was approximately $196 million.

Performance share unit (PSU) awards

During the three months ended March 31, 2016, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a three-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group, PMI’s currency neutral compound annual adjusted operating companies income growth rate, excluding acquisitions, and PMI’s performance against specific measures of PMI’s innovation. The aggregate of the weighted performance factors for the three metrics determines the percentage of PSUs that will vest at the end of the three-year performance cycle. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. The minimum percentage of PSUs that can vest is zero, with a maximum percentage of 200. Participants are entitled to dividend equivalents for any vested PSUs, at the end of the performance cycle.

During the three months ended March 31, 2016, PMI granted 0.4 million shares of PSU awards to eligible employees. The grant date fair value of the PSU market based awards subject to the TSR performance factor is $104.60 per share, which was determined by using the Monte Carlo simulation model. The grant date fair value of the PSU awards subject to the other performance factors is $89.02 per share, which was determined by using the average of the high and low market price of PMI’s stock at the date of grant. PMI recorded compensation expense related to PSU awards of $12 million during the three months ended March 31, 2016. As of March 31, 2016, PMI had $29 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

Note 4. Benefit Plans:

Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to substantially all U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans.

- 11-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Pension Plans

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:



	U.S. Plans						Non-U.S. Plans
	For the Three Months Ended March 31,						For the Three Months Ended March 31,
(in millions)	2016			2015			2016			2015
Service cost	$	1		$	1		$	50		$	51
Interest cost	4			5			31			36
Expected return on plan assets	(3		)	(4		)	(81		)	(83		)
Amortization:
Net loss	1			3			44			46
Prior service cost	1			—			1			1
Net periodic pension cost	$	4		$	5		$	45		$	51

Employer Contributions

PMI makes, and plans to make, contributions, to the extent that they are tax deductible and to meet specific funding requirements of its funded U.S. and non-U.S. plans. Employer contributions of $52 million were made to the pension plans during the three months ended March 31, 2016. Currently, PMI anticipates making additional contributions during the remainder of 2016 of approximately $59 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest rates.

Note 5. Goodwill and Other Intangible Assets, net:

Goodwill and other intangible assets, net, by segment were as follows:



	Goodwill				Other Intangible Assets, net
(in millions)	March 31, 2016		December 31, 2015		March 31, 2016		December 31, 2015
European Union	$	1,349	$	1,310	$	514	$	516
Eastern Europe, Middle East & Africa	381		374		202		201
Asia	3,705		3,581		1,118		1,087
Latin America & Canada	2,248		2,150		830		819
Total	$	7,683	$	7,415	$	2,664	$	2,623

Goodwill primarily reflects PMI’s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from December 31, 2015, were as follows:



(in millions)	European Union		Eastern Europe, Middle East & Africa		Asia		Latin America & Canada		Total
Balances, December 31, 2015	$	1,310	$	374	$	3,581	$	2,150	$	7,415
Changes due to:
Currency	39		7		124		98		268
Balances, March 31, 2016	$	1,349	$	381	$	3,705	$	2,248	$	7,683

- 12-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Additional details of other intangible assets were as follows:



	March 31, 2016				December 31, 2015
(in millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Non-amortizable intangible assets	$	1,559			$	1,527
Amortizable intangible assets	1,650		$	545	1,609		$	513
Total other intangible assets	$	3,209	$	545	$	3,136	$	513

Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2016, were as follows:



(dollars in millions)	Gross Carrying Amount		Initial Estimated Useful Lives	Weighted-Average Remaining Useful Life
Trademarks	$	1,409	2 - 40 years	21 years
Distribution networks	153		5 - 30 years	11 years
Other (including farmer contracts and intellectual property rights)	88		4 - 17 years	10 years
	$	1,650

Pre-tax amortization expense for intangible assets during the three months ended March 31, 2016 and 2015 was $18 million and $22 million, respectively. Amortization expense for each of the next five years is estimated to be $73 million or less, assuming no additional transactions occur that require the amortization of intangible assets.

The increase in the gross carrying amount of other intangible assets from December 31, 2015, was due to currency movements.

During the first quarter of 2016, PMI completed its annual review of goodwill for potential impairment using the market valuation approach. No impairment charge was required as a result of this review.

Note 6. Financial Instruments:

Overview

PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. PMI reports its net transaction gains or losses in marketing, administration and research costs on the condensed consolidated statements of earnings.

PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Russian ruble, Swiss franc and Turkish lira. At March 31, 2016, PMI had contracts with aggregate notional amounts of $25.3

- 13-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

billion of which $3.7 billion related to cash flow hedges, $7.2 billion related to hedges of net investments in foreign operations and $14.4 billion related to other derivatives that primarily offset currency exposures on intercompany financing.

The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2016 and December 31, 2015, were as follows:



	Asset Derivatives					Liability Derivatives
		Fair Value					Fair Value
(in millions)	Balance Sheet Classification	At March 31, 2016		At December 31, 2015		Balance Sheet Classification	At March 31, 2016		At December 31, 2015
Foreign exchange contracts designated as hedging instruments	Other current assets	$	199	$	301	Other accrued liabilities	$	33	$	26
	Other assets	149		181		Other liabilities	228		117
Foreign exchange contracts not designated as hedging instruments	Other current assets	100		7		Other accrued liabilities	30		29
	Other assets	63		85		Other liabilities	8		—
Total derivatives		$	511	$	574		$	299	$	172

For the three months ended March 31, 2016 and 2015, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:



(pre-tax, millions)	For the Three Months Ended March 31,
	Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives					Statement of Earnings Classification of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings
	2016			2015			2016			2015
Derivatives in Cash Flow Hedging Relationship
Foreign exchange contracts	$	(79	)	$	27
						Net revenues	$	5		$	30
						Cost of sales	14			—
						Marketing, administration and research costs	4			7
						Interest expense, net	(17		)	(7		)
Derivatives in Net Investment Hedging Relationship
Foreign exchange contracts	(197		)	286
Total	$	(276	)	$	313		$	6		$	30

- 14-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Cash Flow Hedges

PMI has entered into foreign exchange contracts to hedge foreign currency exchange risk related to certain forecasted transactions. The effective portion of gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. During the three months ended March 31, 2016 and 2015, ineffectiveness related to cash flow hedges was not material. As of March 31, 2016, PMI has hedged forecasted transactions for periods not exceeding the next twenty-one months with the exception of one foreign exchange contract that expires in May 2024. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statement of cash flows.

Hedges of Net Investments in Foreign Operations

PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges of its foreign operations. For the three months ended March 31, 2016 and 2015, these hedges of net investments resulted in gains (losses), net of income taxes, of $(267) million and $835 million, respectively. These gains/(losses) were reported as a component of accumulated other comprehensive losses within currency translation adjustments. For the three months ended March 31, 2016 and 2015, ineffectiveness related to net investment hedges was not material. Other investing cash flows on PMI’s condensed consolidated statements of cash flows include the premiums paid for, and settlements of, net investment hedges.

Other Derivatives

PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. For the three months ended March 31, 2016 and 2015, the gains (losses) from contracts for which PMI did not apply hedge accounting were $91 million and $(751) million, respectively. The gains/(losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.

For the three months ended March 31, 2016 and 2015, the net impact of these contracts on the condensed consolidated statements of earnings was not material.

Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses

Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:



(in millions)	For the Three Months Ended March 31,
	2016			2015
Gain as of January 1,	$	59		$	123
Derivative gains transferred to earnings	(7		)	(27		)
Change in fair value	(62		)	25
Gain/(loss) as of March 31,	$	(10	)	$	121

At March 31, 2016, PMI expects $8 million of derivative losses that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next twelve months. These losses are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.

Contingent Features

PMI’s derivative instruments do not contain contingent features.

Credit Exposure and Credit Risk

- 15-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

its exposure to credit risk through the use of credit approvals and credit limits, and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.

Fair Value

See Note 12. Fair Value Measurements and Note 14. Balance Sheet Offsetting for additional discussion of derivative financial instruments.

Note 7. Earnings Per Share:

Basic and diluted earnings per share (“EPS”) were calculated using the following:



(in millions)	For the Three Months Ended March 31,
	2016		2015
Net earnings attributable to PMI	$	1,530	$	1,795
Less distributed and undistributed earnings attributable to share-based payment awards	5		7
Net earnings for basic and diluted EPS	$	1,525	$	1,788
Weighted-average shares for basic and diluted EPS	1,550		1,548

Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.

For the 2016 and 2015 computations, there were no antidilutive stock awards.

Note 8. Segment Reporting:

PMI’s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Reportable segments for PMI are organized and managed by geographic region. PMI’s reportable segments are European Union; Eastern Europe, Middle East & Africa; Asia; and Latin America & Canada. PMI records net revenues and operating companies income to its segments based upon the geographic area in which the customer resides.

PMI’s management evaluates segment performance and allocates resources based on operating companies income, which PMI defines as operating income, excluding general corporate expenses and amortization of intangibles, plus equity (income)/loss in unconsolidated subsidiaries, net. Interest expense, net, and provision for income taxes are centrally managed and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by management.

In the fourth quarter of 2015, to further align with the Member State composition of the European Union, PMI transferred the management of its operations in Bulgaria, Croatia, Romania and Slovenia from its Eastern Europe, Middle East & Africa segment to its European Union segment, resulting in the reclassification of prior year amounts between the two segments.

- 16-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Segment data were as follows:



(in millions)	For the Three Months Ended March 31,
	2016			2015
Net revenues:
European Union	$	6,143		$	6,222
Eastern Europe, Middle East & Africa	3,997			4,147
Asia	4,689			4,764
Latin America & Canada	1,959			2,219
Net revenues	$	16,788		$	17,352
Earnings before income taxes:
Operating companies income:
European Union	$	906		$	927
Eastern Europe, Middle East & Africa	633			866
Asia	778			934
Latin America & Canada	229			230
Amortization of intangibles	(18		)	(22		)
General corporate expenses	(46		)	(41		)
Less:
Equity (income)/loss in unconsolidated subsidiaries, net	(9		)	(23		)
Operating income	2,473			2,871
Interest expense, net	(247		)	(275		)
Earnings before income taxes	$	2,226		$	2,596

Note 9. Contingencies:

Tobacco-Related Litigation

Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.

It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.

Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.

We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated

- 17-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.

It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.

To date, no tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.

The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 22, 2016, April 30, 2015 and May 1, 2014:



Type of Case	Number of Cases Pending as of April 22, 2016	Number of Cases Pending as of April 30, 2015	Number of Cases Pending as of May 1, 2014
Individual Smoking and Health Cases	66	61	65
Smoking and Health Class Actions	11	11	11
Health Care Cost Recovery Actions	16	16	15
Lights Class Actions	—	—	1
Individual Lights Cases	3	2	2
Public Civil Actions	3	2	2

Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 444 Smoking and Health, Lights, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Twelve cases have had decisions in favor of plaintiffs. Nine of these cases have subsequently reached final resolution in our favor and three remain on appeal.

- 18-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

The table below lists the verdict and significant post-trial developments in the three pending cases where a verdict was returned in favor of the plaintiff:



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
February 2004	Brazil/The Smoker Health Defense Association	Class Action	The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.	Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Cecilia Létourneau	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36.3 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)

- 19-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.2 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion, into a trust within 60 days.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $178 million). A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)

- 20-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Pending claims related to tobacco products generally fall within the following categories:

Smoking and Health Litigation: These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.

As of April 22, 2016, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:


•	66 cases brought by individual plaintiffs in Argentina (31), Brazil (20), Canada (2), Chile (8), Costa Rica (2), Italy (1), the Philippines (1) and Scotland (1), compared with 61 such cases on April 30, 2015, and 65 cases on May 1, 2014; and


•	11 cases brought on behalf of classes of individual plaintiffs in Brazil (2) and Canada (9), compared with 11 such cases on April 30, 2015 and 11 such cases on May 1, 2014.

In the first class action pending in Brazil, The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of São Paulo, Brazil, filed July 25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.

In the second class action pending in Brazil, Public Prosecutor of São Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of São Paulo, Brazil, filed August 6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of São Paulo, is seeking (i) damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii) damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii) reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities, and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of São Paulo only. In December 2008, the Seventh Civil Court of São Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the ADESF case discussed above and should be transferred to the Nineteenth Lower Civil Court in São Paulo where the ADESF case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the São Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of São Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the São Paulo Court of Appeals rejected plaintiff’s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.

- 21-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million), in the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.7 million) beginning in December 2015 through March 2017. See the Blais description for further detail concerning the security order. The Court of Appeal has scheduled a hearing for the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than three years after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

- 22-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

226 million (approximately $178 million) to cover both the Létourneau and Blais cases. Such security may take the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.7 million) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $598 million) in seven equal consecutive quarterly installments of approximately CAD 108 million (approximately $85 million) beginning in December 2015 through June 2017. In March 2016, our subsidiary made its second quarterly installment of security for approximately CAD 37.6 million (approximately $29.7 million) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal has scheduled a hearing for the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the third class action pending in Canada, Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada, filed June 12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of Adams, below).

In the fourth class action pending in Canada, Adams v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Saskatchewan, Canada, filed July 10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.

In the fifth class action pending in Canada, Semple v. Canadian Tobacco Manufacturers' Council, et al., The Supreme Court (trial court), Nova Scotia, Canada, filed June 18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).

In the sixth class action pending in Canada, Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada, filed June 15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).

In the seventh class action pending in Canada, McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking,

- 23-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed.

In the eighth class action pending in Canada, Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, the plaintiff filed an amended statement of claim.

In the ninth class action pending in Canada, Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.

Health Care Cost Recovery Litigation: These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.

As of April 22, 2016, there were 16 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (10), Korea (1) and Nigeria (5), compared with 16 such cases on April 30, 2015 and 15 such cases on May 1, 2014.

In the first health care cost recovery case pending in Canada, Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.” The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.

In the second health care cost recovery case filed in Canada, Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada, filed March 13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.

In the third health care cost recovery case filed in Canada, Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada, filed September 29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants are scheduled to file their defenses in April 2016.

- 24-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants are scheduled to file their defenses in May 2016.

In the fifth health care cost recovery case filed in Canada, Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in December 2014 and July 2015. Pre-trial discovery is ongoing.

In the sixth health care cost recovery case filed in Canada, Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in March 2016.

In the seventh health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in September 2014. Discovery is scheduled to begin in 2017.

In the eighth health care cost recovery case filed in Canada, The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.

In the ninth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada, filed September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.

In the tenth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in July 2015. Discovery is scheduled to begin in 2017.

In the first health care cost recovery case in Nigeria, The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria, filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.

- 25-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

In the second health care cost recovery case in Nigeria, The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria, filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.

In the third health care cost recovery case in Nigeria, The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria, filed October 17, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.

In the fourth health care cost recovery case in Nigeria, The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria, filed May 25, 2007, we and other members of the industry are defendants. Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.

In the fifth health care cost recovery case in Nigeria, The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.

In the health care cost recovery case in Korea, the National Health Insurance Service v. KT&G, et. al., filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that Lights cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately $53.7 million allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.

Lights Cases: These cases, brought by individual plaintiffs, allege that the use of the term “lights” constitutes fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.

As of April 22, 2016, there were 3 lights cases brought by individual plaintiffs pending against our subsidiaries or indemnitees in Chile (2) and Italy (1), compared with 2 such cases on April 30, 2015, and 2 such cases on May 1, 2014.

Public Civil Actions: Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.

As of April 22, 2016, there were 3 public civil actions pending against our subsidiaries in Argentina (1), Romania (1) and Venezuela (1), compared with 2 such cases on April 30, 2015, and 2 such cases on May 1, 2014.

In the public civil action in Argentina, Asociación Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina, filed February 26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to

- 26-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

the Federal Court on Administrative Matters after the Civil Court granted the plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.

In a newly filed action in Romania, Foundation for the Defense of Citizens against Abuses of the State (FACIAS) v. the State of Romania, Philip Morris România (PMR) and Philip Morris Trading SLR (PMTR), et al., Administrative and Fiscal Litigation Section of the Bucharest Tribunal, filed November 20, 2015, our subsidiaries, several other members of the industry, and the State of Romania through various of its institutions are defendants. The plaintiff, a non-governmental organization, asks the court to compel the government to enact legislation as directed by the 2014 EU Tobacco Product Directive and to establish a fund for the treatment of smoking-related diseases and promotion of tobacco control efforts. The plaintiff also seeks an order directing that 1% of the excise taxes collected from tobacco manufacturers, “as well as an amount representing 1% of the turnover” of tobacco manufacturers and distributors, be used to finance the fund. It is unclear whether the “1% of turnover” is sought from the tobacco company defendants or the government. Our subsidiaries answered the complaint in December 2015. In January 2016, the Tribunal ruled that it lacked jurisdiction. The case was transferred to the Bucharest Court of Appeals, which has jurisdiction to hear administrative cases involving the central government. In March 2016, the Bucharest Court of Appeal announced its dismissal of plaintiff’s claims as inadmissible. A written ruling is expected in the second quarter 2016. The plaintiff may appeal.

In the public civil action in Venezuela, Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.

Other Litigation

The Department of Special Investigations of the government of Thailand has been conducting an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees in the Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under declared import prices of cigarettes to avoid full payment of taxes and duties in connection with 272 import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB 80.8 billion (approximately $2.30 billion). The first hearing, held in April 2016, focused on preliminary procedural matters. The case is now in the pre-trial evidentiary phase. PM Thailand contends that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies.

We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.

Note 10. Income Taxes:

Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.

PMI’s effective tax rates for the three months ended March 31, 2016 and 2015 were 28.3% and 30.2%, respectively. PMI estimates that its full-year 2016 effective tax rate will be approximately 28%. The effective tax rate for the three months ended March 31, 2015, was unfavorably impacted by changes to repatriation assertions on certain foreign subsidiary historical earnings ($58 million).

- 27-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Excluding the effect of the 2015 repatriation assertion changes, the change in the effective tax rate for the three months ended March 31, 2016, as compared to the three months ended March 31, 2015, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences.

The effective tax rates are based on PMI’s full-year earnings mix projections by taxing jurisdiction and cash repatriation plans. Changes in earnings mix by taxing jurisdiction or in cash repatriation plans could have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2012 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.

It is reasonably possible that within the next twelve months certain tax examinations will close, which could result in a change in unrecognized tax benefits, along with related interest and penalties. An estimate of any possible change cannot be made at this time.

Note 11. Indebtedness:

Short-term Borrowings:

At March 31, 2016 and December 31, 2015, PMI’s short-term borrowings, consisting of bank loans to certain PMI subsidiaries, had a carrying value of $673 million and $825 million, respectively. The fair value of PMI’s short-term borrowings, based on current market interest rates, approximates carrying value.

Long-term Debt:

At March 31, 2016 and December 31, 2015, PMI’s long-term debt consisted of the following:



(in millions)	March 31, 2016		December 31, 2015
U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.612%), due through 2044	$	20,079	$	18,091
Foreign currency obligations:
Euro notes, 1.750% to 3.125% (average interest rate 2.433%), due through 2033	6,844		7,423
Swiss franc notes, 0.750% to 2.000% (average interest rate 1.217%), due through 2024	1,737		1,690
Other (average interest rate 3.126%), due through 2024	460		451
	29,120		27,655
Less current portion of long-term debt	2,437		2,405
	$	26,683	$	25,250

Other foreign currency debt above includes mortgage debt in Switzerland, capital lease obligations and a bank loan in the Philippines.

- 28-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

PMI's debt issuances in the first three months of 2016 were as follows:



(in millions)
Type		Face Value	Interest Rate		Issuance	Maturity

U.S. dollar notes	^(a)	$500	1.375	%	February 2016	February 2019
U.S. dollar notes	^(a)	$750	1.875	%	February 2016	February 2021
U.S. dollar notes	^(a)	$750	2.750	%	February 2016	February 2026

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2016.

The net proceeds from the sale of the securities listed in the table above will be used for general corporate purposes.

Credit Facilities:

On January 27, 2016, PMI entered into an agreement to amend and extend its existing $2.0 billion 364-day revolving credit facility from February 9, 2016 to February 7, 2017. On January 27, 2016, PMI also entered into an agreement to extend the term of its existing $2.5 billion multi-year revolving credit facility from February 28, 2020 to February 28, 2021.

At March 31, 2016, PMI's total committed credit facilities were as follows:

(in billions)



Type	Committed Credit Facilities
364-day revolving credit, expiring February 7, 2017	$	2.0
Multi-year revolving credit, expiring February 28, 2021	2.5
Multi-year revolving credit, expiring October 1, 2020	3.5
Total facilities	$	8.0

At March 31, 2016, there were no borrowings under these committed credit facilities, and the entire committed amounts were available for borrowing.

Note 12. Fair Value Measurements:

The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:


Level 1 -	Quoted prices in active markets for identical assets or liabilities;


Level 2 -	Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and


Level 3 -	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

- 29-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period.

Derivative Financial Instruments

PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. PMI’s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 6. Financial Instruments for an additional discussion of derivative financial instruments.

Debt

The fair value of PMI’s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI’s debt, excluding short-term borrowings and $14 million of capital lease obligations, was $29,106 million at March 31, 2016. The fair value of PMI’s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, has been classified within Level 1 and Level 2 in the table shown below.

The aggregate fair values of PMI’s derivative financial instruments and debt as of March 31, 2016, were as follows:



(in millions)	Fair Value at March 31, 2016		Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Foreign exchange contracts	$	511	$	—	$	511	$	—
Total assets	$	511	$	—	$	511	$	—
Liabilities:
Debt	$	31,912	$	31,432	$	480	$	—
Foreign exchange contracts	299		—		299		—
Total liabilities	$	32,211	$	31,432	$	779	$	—

Note 13. Accumulated Other Comprehensive Losses:

PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:



(in millions)	At March 31, 2016			At December 31, 2015			At March 31, 2015
Currency translation adjustments	$	(5,617	)	$	(6,129	)	$	(5,247	)
Pension and other benefits	(3,287		)	(3,332		)	(2,964		)
Derivatives accounted for as hedges	(10		)	59			121
Total accumulated other comprehensive losses	$	(8,914	)	$	(9,402	)	$	(8,090	)

Reclassifications from Other Comprehensive Earnings

The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the three months ended March 31, 2016 and 2015. For additional information, see Note 4. Benefit Plans and Note 6. Financial Instruments for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.

Note 14. Balance Sheet Offsetting:

Derivative Financial Instruments

PMI uses foreign exchange contracts and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the condensed consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. See Note 6. Financial Instruments for disclosures related to PMI's derivative financial instruments.

The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:



(in millions)	Gross Amounts Recognized		Gross Amount Offset in the Condensed Consolidated Balance Sheet		Net Amounts Presented in the Condensed Consolidated Balance Sheet		Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet
							Financial Instruments			Cash Collateral Received/Pledged
													Net Amount

At March 31, 2016
Assets
Foreign exchange contracts	$	511	$	—	$	511	$	(209	)	$	(273	)	$	29
Liabilities
Foreign exchange contracts	$	299	$	—	$	299	$	(209	)	$	(63	)	$	27
At December 31, 2015
Assets
Foreign exchange contracts	$	574	$	—	$	574	$	(131	)	$	(432	)	$	11
Liabilities
Foreign exchange contracts	$	172	$	—	$	172	$	(131	)	$	(30	)	$	11

- 30-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 15. Investments in Unconsolidated Subsidiaries:

At March 31, 2016 and December 31, 2015, PMI had total investments in unconsolidated subsidiaries of $942 million and $890 million, respectively, which were accounted for under the equity method of accounting. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses and movements in currency translation adjustments. The carrying value of our equity method investments at March 31, 2016 and December 31, 2015 exceeded our share of the unconsolidated subsidiaries' book value by $824 million and $806 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets, excluding $765 million and $744 million attributable to goodwill as of March 31, 2016 and December 31, 2015, respectively, is being amortized on a straight-line basis over the underlying assets' estimated useful lives of 3 to 20 years. At March 31, 2016, PMI received no dividends from unconsolidated subsidiaries. At December 31, 2015, PMI received year-to-date dividends from unconsolidated subsidiaries of $127 million.

PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”), formerly Arab Investors-TA (FZC). As a result of this transaction, PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Société Nationale des Tabacs et Allumettes SpA. STAEM manufactures and distributes under license some of PMI’s brands. The initial investment in EITA was recorded at cost and is included in investments in unconsolidated subsidiaries on the condensed consolidated balance sheets.

PMI acquired in 2013 from Megapolis Investment BV a 20% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis ("Megapolis"), PMI's distributor in Russia, for a purchase price of $760 million. An additional payment of up to $100 million, which is contingent on Megapolis's operational performance over the four fiscal years following the closing of the transaction, will also be made by PMI if the performance criteria are satisfied. PMI has also agreed to provide Megapolis Investment BV with a $100 million interest-bearing loan. PMI and Megapolis Investment BV have agreed to set off any future contingent payments owed by PMI against the future repayments due under the loan agreement. Any loan repayments in excess of the contingent consideration earned by the performance of Megapolis are due to be repaid, in cash, to PMI on March 31, 2017. At December 31, 2013, PMI had recorded a $100 million asset related to the loan receivable and a discounted liability of $86 million related to the contingent consideration. The initial investment in Megapolis was recorded at cost and is included in investments in unconsolidated subsidiaries on the condensed consolidated balance sheets.

PMI’s earnings activity from unconsolidated subsidiaries was as follows:



	For the Three Months Ended March 31,
(in millions)	2016		2015
Net revenues	$	777	$	896

PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:



(in millions)	At March 31, 2016		At December 31, 2015

Receivables	$	319	$	64
Notes receivable	$	102	$	100
Other liabilities	$	100	$	100

The activity primarily related to agreements with PMI’s unconsolidated subsidiaries within the Eastern Europe, Middle East & Africa segment. These agreements, which are in the ordinary course of business, are primarily for distribution, contract manufacturing and licenses. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.

- 31-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 16. Acquisitions and Other Business Arrangements:

As announced in June 2015, PMI’s subsidiary PT HM Sampoerna Tbk. (“Sampoerna”), of which PMI held a 98.18% interest, was required to comply with the January 30, 2014, Indonesian Stock Exchange (“IDX”) regulation requiring all listed public companies to have at least a 7.5% public shareholding by January 30, 2016. In order to comply with this requirement, Sampoerna conducted a rights issue (the “Rights Issue”). The exercise price for the rights was set at Rp. 77,000 per share, a 1.349% premium to the closing price on the IDX as of September 30, 2015. In connection with the Rights Issue, PT Philip Morris Indonesia (“PMID”), a fully consolidated subsidiary of PMI, sold 264,209,711 of the rights to third-party investors. Delivery of the rights sold took place on October 26, 2015. The total net proceeds from the Rights Issue were $1.5 billion at prevailing exchange rates on the closing date. The sale of the rights resulted in an increase to PMI's additional paid-in capital of $1.1 billion during the fourth quarter of 2015.

In June 2014, PMI acquired 100% of Nicocigs Limited, a leading U.K.-based e-vapor company, for the final purchase price of $103 million, net of cash acquired, with additional contingent payments of up to $77 million, primarily relating to performance targets over a three-year period. As of March 31, 2016, PMI does not anticipate that the performance targets will be met.

In September 2013, Grupo Carso, S.A.B. de C.V. ("Grupo Carso") sold to PMI its remaining 20% interest in PMI's Mexican tobacco business for $703 million. As a result, PMI now owns 100% of its Mexican tobacco business. A former director of PMI, whose term expired at the Annual Meeting of Shareholders in May 2015, had an affiliation with Grupo Carso. The final purchase price was subject to an adjustment based on the actual performance of the Mexican tobacco business over the three-year period ending two fiscal years after the closing of the purchase. In May 2015, PMI received a payment of $113 million from Grupo Carso as the final purchase price adjustment. This resulted in a total net purchase price of $590 million. In addition, PMI agreed to pay a dividend of approximately $38 million to Grupo Carso related to the earnings of the Mexican tobacco business for the nine months ended September 30, 2013. In March 2014, the dividend was declared and paid. The purchase of the remaining 20% interest resulted in a net decrease to PMI's additional paid-in capital of $559 million.

The effects of these acquisitions were not material to PMI's condensed consolidated financial position, results of operations or operating cash flows in any of the periods presented.

Note 17. Sale of Accounts Receivable:

To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of March 31, 2016 and March 31, 2015. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions.

Cumulative trade receivables sold for the three months ended March 31, 2016 and March 31, 2015, were $1.9 billion and $0.3 billion, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2016 and March 31, 2015, were $589 million, and $108 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the consolidated statements of earnings. For the three months ended March 31, 2016 and 2015, the loss on sale of trade receivables was not material.

- 32-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 18. New Accounting Standards:

On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position or results of operations.

On January 5, 2016, the FASB issued Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01 will require equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changes certain disclosure requirements and other aspects of current U.S. GAAP. ASU 2016-01 is effective for interim and annual reporting periods beginning on or after January 1, 2018. PMI is currently assessing the impact that the adoption of ASU 2016-01 will have on its financial position or results of operations.

On November 20, 2015, the FASB issued Accounting Standard Update ASU 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”). ASU 2015-17 requires that all deferred tax assets and liabilities, along with any related valuation allowance, be classified as noncurrent on the balance sheet. ASU 2015-17 is effective for interim and annual reporting periods beginning on or after January 1, 2017 with early adoption permitted. Entities can apply the final standard either prospectively, for all deferred tax assets and liabilities, or retrospectively with disclosures providing qualitative information about the effects of the accounting change on prior periods. The adoption of ASU 2015-17 will not have a material impact on PMI’s consolidated results of operations, financial position or cash flows.

On May 28, 2014, the FASB issued Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services.

Entities can apply the final standard using one of the following two methods:


1.	retrospectively to each prior period presented; or


2.	retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.

ASU 2014-09 is effective for interim and annual reporting periods beginning on or after January 1, 2017. In July 2015, the FASB approved a proposal which allows for a deferral of the implementation until January 1, 2018, and permits early application, but not before the original effective date of January 1, 2017. PMI is currently assessing the impact that the adoption of ASU 2014-09 will have on its financial position or results of operations.

- 33-

Table of Contents

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Description of Our Company

We are a holding company whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside the United States of America. We manage our business in four segments:


•	European Union;


•	Eastern Europe, Middle East & Africa (“EEMA”);


•	Asia; and


•	Latin America & Canada.

Our products are sold in more than 180 markets, and in many of these markets they hold the number one or number two market share position. We have a wide range of premium, mid-price and low-price brands. Our portfolio comprises both international and local brands. We are engaged in the development and commercialization of Reduced Risk Products ("RRPs"). RRPs is the term we use to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes.

We use the term net revenues to refer to our operating revenues from the sale of our products, net of sales and promotion incentives. Our net revenues and operating income are affected by various factors, including the volume of products we sell, the price of our products, changes in currency exchange rates and the mix of products we sell. Mix is a term used to refer to the proportionate value of premium-price brands to mid-price or low-price brands in any given market (product mix). Mix can also refer to the proportion of shipment volume in more profitable markets versus shipment volume in less profitable markets (geographic mix). We often collect excise taxes from our customers and then remit them to governments, and, in those circumstances, we include the excise taxes in our net revenues and in excise taxes on products. Our cost of sales consists principally of tobacco leaf, non-tobacco raw materials, labor and manufacturing costs.

Our marketing, administration and research costs include the costs of marketing and selling our products, other costs generally not related to the manufacture of our products (including general corporate expenses), and costs incurred to develop new products. The most significant components of our marketing, administration and research costs are marketing and sales expenses and general and administrative expenses.

Philip Morris International Inc. is a legal entity separate and distinct from our direct and indirect subsidiaries. Accordingly, our right, and thus the right of our creditors and stockholders, to participate in any distribution of the assets or earnings of any subsidiary is subject to the prior rights of creditors of such subsidiary, except to the extent that claims of our company itself as a creditor may be recognized. As a holding company, our principal sources of funds, including funds to make payment on our debt securities, are from the receipt of dividends and repayment of debt from our subsidiaries. Our principal wholly owned and majority-owned subsidiaries currently are not limited by long-term debt or other agreements in their ability to pay cash dividends or to make other distributions with respect to their common stock.

Certain prior years' amounts have been reclassified to conform with the current year's presentation. In the fourth quarter of 2015, to further align with the Member State composition of the European Union, PMI transferred the management of its operations in Bulgaria, Croatia, Romania and Slovenia from its EEMA segment to its European Union segment, resulting in the reclassification of prior year amounts between the two segments. The changes did not have an impact on our consolidated financial position, results of operations or cash flows in any of the periods presented.

- 34-

Table of Contents

Executive Summary

The following executive summary provides significant highlights from the "Discussion and Analysis" that follows.

Consolidated Operating Results for the Three Months Ended March 31, 2016 – The changes in our reported diluted earnings per share ("diluted EPS") for the three months ended March 31, 2016, from the comparable 2015 amounts, were as follows:



	Diluted EPS			% Growth
For the three months ended March 31, 2015	$	1.16
2015 Asset impairment and exit costs	—
2015 Tax items	—
Subtotal of 2015 items	—
2016 Asset impairment and exit costs	—
2016 Tax items	—
Subtotal of 2016 items	—
Currency	(0.19		)
Interest	0.01
Change in tax rate	0.03
Impact of shares outstanding and share-based payments	(0.01		)
Operations	(0.02		)
For the three months ended March 31, 2016	$	0.98		(15.5	)%

Currency – The unfavorable currency impact during the reporting period results from the strengthening of the U.S. dollar, especially against the Argentine peso, Australian dollar, Canadian dollar, Egyptian pound, Euro, Indonesian rupiah, Japanese yen, Kazakh tenge, Mexican peso, Russian ruble and Turkish lira. This unfavorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Income Taxes – Our effective income tax rate for the three months ended March 31, 2016 decreased by 1.9 percentage points to 28.3%. The change in the tax rate increased our diluted EPS by $0.03 per share in 2016. The effective tax rate during the first quarter of 2015 was unfavorably impacted by changes to repatriation assertions on certain foreign subsidiary historical earnings ($58 million). Excluding the effect of the 2015 repatriation assertion changes, the change in the effective tax rate for the three months ended March 31, 2016, as compared to the three months ended March 31, 2015, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences. We estimate that our full-year 2016 effective tax rate will be approximately 28%.

Operations – The decrease in diluted EPS of $0.02 from our operations in the table above was due primarily to the following segments:


•	Asia: Unfavorable volume/mix and higher marketing, administration and research costs, partially offset by lower manufacturing costs and higher pricing; and


•	EEMA: Unfavorable volume/mix and higher marketing, administration and research costs, partially offset by higher pricing;

partially offset by


•	Latin America & Canada: Higher pricing and favorable volume/mix, partially offset by higher manufacturing costs; and


•	European Union: Higher pricing and lower manufacturing costs, partially offset by higher marketing, administration and research costs and unfavorable volume/mix.

For further details, see the “Consolidated Operating Results” and “Operating Results by Business Segment” sections of the following “Discussion and Analysis.”

2016 Forecasted Results - On April 19, 2016, we increased our 2016 full-year reported diluted EPS forecast to be in a range of $4.40 to $4.50, at prevailing exchange rates at that time, versus $4.42 in 2015. Excluding an unfavorable currency impact, at then-

- 35-

Table of Contents

prevailing rates, of approximately $0.45 per share for the full-year 2016, the reported diluted earnings per share range represents an increase of approximately 10% to 12% versus adjusted diluted earnings per share of $4.42 in 2015. This forecast does not include any share repurchases in 2016. We estimate 2016 international cigarette volume, excluding the People's Republic of China and the U.S., to decline by approximately 2.0% to 2.5%, in line with the estimated decline of 2.4% in 2015.

We calculated 2015 adjusted diluted EPS as reported diluted EPS of $4.42, plus the $0.03 per share charge related to asset impairment and exit costs, less the $0.03 per share benefit related to discrete tax items.

Adjusted diluted EPS is not a measure under accounting principles generally accepted in the United States of America ("U.S. GAAP"). We define adjusted diluted EPS as reported diluted EPS adjusted for asset impairment and exit costs, discrete tax items and unusual items. We believe it is appropriate to disclose this measure as it represents core earnings, improves comparability and helps investors analyze business performance and trends. Adjusted diluted EPS should be considered neither in isolation nor as a substitute for reported diluted EPS prepared in accordance with U.S. GAAP.

This 2016 guidance excludes the impact of any future acquisitions, unanticipated asset impairment and exit cost charges, future changes in currency exchange rates and any unusual events. The factors described in the "Cautionary Factors That May Affect Future Results" section of the following "Discussion and Analysis" represent continuing risks to this forecast.

- 36-

Table of Contents

Discussion and Analysis

Consolidated Operating Results

See pages 64-68 for a discussion of our "Cautionary Factors That May Affect Future Results." Our cigarette volume, net revenues, excise taxes on products and operating companies income by segment were as follows:



	For the Three Months Ended March 31,
(in millions)	2016			2015
Cigarette volume:
European Union	45,993			44,810
Eastern Europe, Middle East & Africa	63,126			62,632
Asia	65,222			70,125
Latin America & Canada	21,700			21,190
Total cigarette volume	196,041			198,757
Net revenues:
European Union	$	6,143		$	6,222
Eastern Europe, Middle East & Africa	3,997			4,147
Asia	4,689			4,764
Latin America & Canada	1,959			2,219
Net revenues	$	16,788		$	17,352
Excise taxes on products:
European Union	$	4,280		$	4,271
Eastern Europe, Middle East & Africa	2,395			2,363
Asia	2,721			2,609
Latin America & Canada	1,309			1,493
Excise taxes on products	$	10,705		$	10,736
Operating income:
Operating companies income:
European Union	$	906		$	927
Eastern Europe, Middle East & Africa	633			866
Asia	778			934
Latin America & Canada	229			230
Amortization of intangibles	(18		)	(22		)
General corporate expenses	(46		)	(41		)
Less:
Equity (income)/loss in unconsolidated subsidiaries, net	(9		)	(23		)
Operating income	$	2,473		$	2,871

As discussed in Note 8. Segment Reporting to our condensed consolidated financial statements, we evaluate segment performance and allocate resources based on operating companies income, which we define as operating income, excluding general corporate expenses and amortization of intangibles, plus equity (income)/loss in unconsolidated subsidiaries, net. We believe it is appropriate to disclose this measure to help investors analyze the business performance and trends of our various business segments.

References to total international cigarette market, defined as worldwide cigarette volume excluding the United States, total cigarette market, total market and market shares throughout this "Discussion and Analysis" reflect our best estimates of tax-paid volumes based on a number of internal and external sources.

- 37-

Table of Contents

Consolidated Operating Results for the Three Months Ended March 31, 2016

The following discussion compares our consolidated operating results for the three months ended March 31, 2016, with the three months ended March 31, 2015.

Our cigarette shipment volume decreased by 1.4%, or by 1.7% excluding favorable net estimated inventory movements, reflecting declines in:


•	Asia, principally Indonesia, Pakistan and the Philippines, partly offset by Korea;

partially offset by growth in:

•European Union, driven notably by France, Italy, Poland and Spain, partly offset by the United Kingdom;


•	EEMA, driven by Egypt and Tunisia in North Africa, Turkey and Ukraine, partly offset by Algeria and Russia; and


•	Latin America & Canada, driven mainly by Mexico, partly offset by Argentina.

The decrease was further offset by the favorable estimated impact of the leap year.

Our cigarette shipment volume by brand is shown in the table below:



PMI Cigarette Shipment Volume by Brand (Million Units)
	First-Quarter
	2016	2015	Change
Marlboro	67,985	67,247	1.1	%
L&M	23,690	22,678	4.5	%
Parliament	10,137	9,570	5.9	%
Bond Street	9,721	9,180	5.9	%
Chesterfield	10,176	9,540	6.7	%
Philip Morris	9,209	7,762	18.6	%
Lark	6,501	6,444	0.9	%
Others	58,622	66,336	(11.6	)%
Total PMI	196,041	198,757	(1.4	)%

Cigarette shipment volume of Marlboro increased, reflecting growth in: the European Union, notably Germany, Italy and Spain, partly offset by the United Kingdom; Asia, driven by Korea and the Philippines, partly offset by Indonesia and Vietnam; and Latin America & Canada, driven by Mexico, partly offset by Argentina. The growth was partly offset by declines in EEMA, mainly due to North Africa, partly offset by Saudi Arabia and Turkey.

Cigarette shipment volume of L&M increased, driven by: the European Union, notably Poland and Portugal, partly offset by Germany; and EEMA, notably Egypt and Ukraine, partly offset by Russia and Saudi Arabia. The growth was partly offset by Asia, mainly Thailand.

Cigarette shipment volume of Parliament increased, driven mainly by Korea and Turkey. Cigarette shipment volume of Bond Street increased, driven mainly by Ukraine, partly offset by Russia. Cigarette shipment volume of Chesterfield increased, mainly driven by the morphing of Red & White in the Czech Republic, and Italy, partly offset by Russia. Cigarette shipment volume of Philip Morris increased, mainly driven by Italy, benefiting from the morphing of Diana, partly offset by Argentina. Cigarette shipment volume of Lark increased, principally driven by Turkey, partly offset by Japan.

Our cigarette market share increased in a number of key markets, including Australia, Belgium, Canada, Egypt, France, Germany, Kuwait, the Netherlands, Mexico, the Philippines, Poland, Saudi Arabia, Spain, Switzerland, Turkey and the United Kingdom.

Our other tobacco products ("OTP") primarily include tobacco for roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos. Total shipment volume of OTP, in cigarette equivalent units, increased by 2.8%.

Total shipment volume for cigarettes and OTP, in cigarette equivalent units, decreased by 1.2%, excluding acquisitions.

- 38-

Table of Contents

Our net revenues and excise taxes on products were as follows:



	For the Three Months Ended March 31,
(in millions)	2016		2015		Variance			%
Net revenues	$	16,788	$	17,352	$	(564	)	(3.3	)%
Excise taxes on products	10,705		10,736		(31		)	(0.3	)%
Net revenues, excluding excise taxes on products	$	6,083	$	6,616	$	(533	)	(8.1	)%

Net revenues, which include excise taxes billed to customers, decreased by $564 million. Excluding excise taxes, net revenues decreased by $533 million due to:


•	unfavorable currency ($691 million) and


•	unfavorable volume/mix ($114 million), partly offset by


•	price increases ($272 million).

The unfavorable currency was due primarily to the Argentine peso, Australian dollar, Brazilian real, Canadian dollar, Egyptian pound, Euro, Indonesian rupiah, Japanese yen, Kazakh tenge, Mexican peso, Russian ruble and Turkish lira.

Net revenues include $427 million in 2016 and $443 million in 2015 related to sales of OTP. These net revenue amounts include excise taxes billed to customers. Excluding excise taxes, net revenues for OTP were $153 million in 2016 and $164 million in 2015.

Excise taxes on products decreased by $31 million (0.3)%, due to:


•	favorable currency ($1.5 billion), partly offset by


•	higher excise taxes resulting from changes in retail prices and tax rates ($990 million) and


•	higher excise taxes resulting from volume/mix ($503 million).

Governments have consistently increased excise taxes in most of the markets in which we operate. As discussed in Business Environment, we expect excise taxes to continue to increase.

Our cost of sales; marketing, administration and research costs; and operating income were as follows:



	For the Three Months Ended March 31,
(in millions)	2016		2015		Variance			%
Cost of sales	$	2,096	$	2,229	$	(133	)	(6.0	)%
Marketing, administration and research costs	1,496		1,494		2			0.1	%
Operating income	2,473		2,871		(398		)	(13.9	)%

Cost of sales decreased by $133 million (6.0%), due to:


•	favorable currency ($178 million) and


•	lower manufacturing costs ($24 million), partly offset by


•	higher cost of sales resulting from volume/mix ($69 million).

Marketing, administration and research costs were essentially flat as:


•	higher expenses ($135 million, primarily higher marketing and selling expenses) were offset by


•	favorable currency ($133 million).

- 39-

Table of Contents

Operating income decreased by $398 million (13.9%), due primarily to:


•	unfavorable currency ($378 million),


•	unfavorable volume/mix ($183 million) and


•	higher marketing, administration and research costs ($135 million), partly offset by


•	price increases ($272 million) and


•	lower manufacturing costs ($24 million).

Our effective tax rate decreased by 1.9 percentage points to 28.3%. We estimate that our full-year 2016 effective tax rate will be approximately 28%. The effective tax rate for the three months ended March 31, 2015, was unfavorably impacted by changes to repatriation assertions on certain foreign subsidiary historical earnings ($58 million). The effective tax rate is based on our full-year earnings mix by taxing jurisdiction and cash repatriation plans. Changes in earnings mix by taxing jurisdiction or in our cash repatriation plans could have an impact on the effective tax rate, which we monitor each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

We are regularly examined by tax authorities around the world, and we are currently under examination in a number of jurisdictions. It is reasonably possible that within the next twelve months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.

Net earnings attributable to PMI of $1.5 billion decreased by $265 million (14.8%). This decrease was due primarily to lower operating income as discussed above, partially offset by a lower effective tax rate. Diluted and basic EPS of $0.98 decreased by 15.5%. Excluding an unfavorable currency impact of $0.19, diluted EPS increased by 0.9%.

Operating Results by Business Segment

Business Environment

Taxes, Legislation, Regulation and Other Matters Regarding the Manufacture, Marketing, Sale and Use of Tobacco Products

The tobacco industry and our business face a number of challenges that may adversely affect our business, volume, results of operations, cash flows and financial position. These challenges, which are discussed below and in “Cautionary Factors That May Affect Future Results,” include:


•	fiscal challenges, such as excise tax increases and discriminatory tax structures;

•

actual and proposed extreme regulatory requirements, including regulation of the packaging, marketing and sale of tobacco products, as well as the products themselves, that may reduce our competitiveness, eliminate our ability to communicate with adult smokers, ban certain of our products, limit our ability to differentiate our products from those of our competitors, and interfere with our intellectual property rights;


•	illicit trade in cigarettes and other tobacco products, including counterfeit, contraband and so-called “illicit whites”;


•	intense competition, including from non-tax paid volume by certain local manufacturers;


•	pending and threatened litigation as discussed in Note 9. Contingencies; and


•	governmental investigations.

FCTC: The World Health Organization's (“WHO”) Framework Convention on Tobacco Control (“FCTC”), an international public health treaty with the objective of reducing tobacco use, drives much of the regulation that shapes the business environment in which we operate. The treaty, to which 179 countries and the European Union are Parties, requires Parties to have in place various tobacco control measures and recommends others.

We support many of the regulatory policies required by the FCTC, including measures that strictly prohibit the sale of tobacco products to minors, limit public smoking, require health warnings on tobacco packaging, and regulate product content to prevent increased adverse health effects of smoking. We advocate measures that establish a regulatory framework for Reduced-Risk

- 40-

Table of Contents

Products. We also support the use of tax and price policies to achieve public health objectives, as long as such policies are not discriminatory or excessive, and do not result in increased illicit trade.

However, the FCTC governing body, the Conference of the Parties (“CoP”), has adopted non-binding guidelines and policy recommendations related to certain articles of the FCTC, some of which we strongly oppose, including extreme measures such as point-of-sale display bans, plain packaging, bans on all forms of communications with adult smokers, ingredient restrictions or bans based on the concepts of palatability or attractiveness and excessive taxation. Among other things, these measures would limit our ability to differentiate our products and disrupt competition, are not based on sound evidence of a public health benefit, are likely to lead to adverse consequences, such as increased illicit trade and, in some cases, result in the expropriation of our trademarks and violate international treaties.

It is not possible to predict whether or to what extent measures recommended in the FCTC guidelines will be implemented. In some instances where these extreme measures have been adopted by national governments, we have commenced legal proceedings challenging them.

Excise, Sales and Other Taxes: Excessive and disruptive tax increases and discriminatory tax structures are expected to continue to have an adverse impact on our profitability, due to lower consumption and consumer down-trading from premium to non-premium, discount, other low-price or low-taxed tobacco products, such as fine cut tobacco and illicit products. In addition, in certain jurisdictions, our products are subject to tax structures that discriminate against premium-price products and manufactured cigarettes. We believe that such tax structures undermine public health by encouraging consumers to turn to the illicit trade for cheaper tobacco products and ultimately undercut government revenue objectives, disrupt the competitive environment, and encourage criminal activity. Other jurisdictions have imposed, or are seeking to impose, levies or other taxes on tobacco companies. We oppose such extreme and discriminatory tax measures.

EU Tobacco Products Directive: In April 2014, the EU adopted the text of a significantly revised EU Tobacco Products Directive that, among other things, provides for:

•

health warnings covering 65% of the front and back panels of packs with specific health warning dimensions that will in effect prohibit various pack formats, such as certain packs for slim cigarettes, even though the agreed text does not ban slim cigarettes. Member States would also have the option to further standardize tobacco packaging, including, under certain conditions, by introducing plain packaging;


•	a ban on packs of fewer than 20 cigarettes;


•	a ban on characterizing flavors in some tobacco products, with a transition period for menthol expiring in May 2020;


•	security features and tracking and tracing measures, which we support, but also tracking at pack level down to retail as from May 2019, which we believe will most likely not provide any incremental benefit in the fight against illicit trade, but have the potential to increase operational expenses if excessive implementing regulation is enacted; and


•	a framework for the regulation of novel tobacco products and e-cigarettes (except for those found to be medicines or medical devices), including requirements for health warnings and information leaflets, prohibiting product packaging text related to reduced risk, and introducing notification requirements in advance of commercialization.

The revised Directive entered into force in May 2014. Member States are required to implement the Directive by May 2016.

In June 2014, two of our subsidiaries filed papers in the English High Court seeking judicial review of whether the Directive complies with existing EU Treaties. In November 2014, the English High Court referred the case to the Court of Justice of the European Union (“CJEU”) and requested that the CJEU issue a judgment by May 2016. In July 2014, the government of Poland filed a complaint with the CJEU challenging the validity of various provisions in the Directive that ban menthol cigarettes. The CJEU conducted hearings in both proceedings in September and October 2015. In December 2015, the Advocate General of the CJEU issued opinions in both proceedings advising that the Directive complies with EU law. These opinions are not binding on the CJEU, which is expected to issue its judgment on May 4, 2016. It is not possible to predict the outcome of these legal proceedings.

Plain Packaging: Plain packaging regulation bans the use of branding, logos and colors on packaging of tobacco products other than the brand name and variant, which may be printed only in specified locations and in a uniform font. Similarly, the brand name and variant may be printed on individual cigarettes only in specified locations and in a uniform font or not at all.

To date, only Australia has implemented plain packaging.

- 41-

Table of Contents

France, Ireland and the U.K. have adopted plain packaging legislation, with implementation scheduled to begin no later than May 2016 and full compliance at retail required as of November 2016 in France and as of May 2017 in Ireland and the U.K. In Ireland, implementation is subject to a Ministerial Commencement Order, which has yet to be issued.

In May 2015, three of our subsidiaries filed papers in the English High Court seeking judicial review of the U.K.’s plain packaging legislation. The English High Court held a hearing in December 2015 and is expected to issue a judgment in May 2016. It is not possible to predict the outcome of this legal proceeding.

In other countries, including Hungary, New Zealand and Norway, proposals to implement plain packaging are in various stages of the legislative process. Additionally, several countries, including Canada, Finland and Singapore, are considering plain packaging, but no legislative proposals have been published. It is not possible to predict whether any of these countries will implement plain packaging.

Australia’s plain packaging legislation triggered three legal challenges. First, major tobacco manufacturers, including our Australian subsidiary, challenged the legislation’s constitutionality in the High Court of Australia. Although the High Court found the legislation constitutional, a majority of the Justices concluded that plain packaging deprives tobacco manufacturers of their property, raising serious questions about the legality of similar proposals in other jurisdictions. Second, our Hong Kong subsidiary initiated arbitration proceedings against the Australian government pursuant to the Hong Kong-Australia Bilateral Investment Treaty and sought substantial compensation for the deprivation of its investments in Australia. In December 2015, the tribunal hearing the case declined jurisdiction to hear the merits of our subsidiary's claim. The tribunal's decision, which is final, did not address the legality or effectiveness of Australia's plain packaging legislation. Third, several countries have initiated World Trade Organization (“WTO”) dispute settlement proceedings against Australia. It is not possible to predict the outcome of these legal proceedings.

We oppose plain packaging because it expropriates our valuable intellectual property by taking away our trademarks and moves the industry much closer to a commodity business where there is no distinction among brands, and, therefore, the ability to compete for adult smoker market share is greatly reduced. Several studies, including industry-commissioned studies as well as data released by Australian state governments, show that there is no sound basis to conclude that the implementation of plain packaging in Australia has had any impact on smoking prevalence among adults or youth. Data from Australia also appear to confirm that, since the implementation of plain packaging, down-trading to lower price and lower margin brands has accelerated and illicit trade has increased.

In the event any particular jurisdiction adopts plain packaging regulation, we will consider all available options to ensure the protection of our intellectual property and adult smoker access to product information, especially with respect to RRPs.

Restrictions and Bans on the Use of Ingredients: Currently, the WHO and others in the public health community recommend restrictions or total bans on the use of some or all ingredients in tobacco products, including menthol. Some regulators have considered and rejected such proposals, while others have proposed and, in a few cases, adopted restrictions or bans. In particular, as mentioned above, the European Union has banned characterizing flavors in tobacco products, subject to an exemption until May 2020 for menthol. Other countries may follow the EU’s approach. For instance, Turkey has banned menthol as of May 2020. More sweeping ingredient bans have been adopted by Canada and Brazil.

While the Canadian ingredient ban exempts menthol on the national level, some Canadian provinces have adopted or are in the process of adopting menthol bans.

The Brazil ingredients ban, which, as originally drafted, would prohibit the use of virtually all ingredients with flavoring or aromatic properties, is not in force due to a legal challenge by a tobacco industry union, of which our Brazilian subsidiary is a member. It is not possible to predict the outcome of this legal proceeding.

Broad restrictions and ingredient bans would require us to reformulate our American Blend tobacco products and could reduce our ability to differentiate these products in the market in the long term. Menthol bans would eliminate the entire category of mentholated tobacco products. We oppose broad bans or sweeping restrictions on the use of ingredients, as they are often based on the subjective and scientifically unsupported notion that ingredients make tobacco products more “attractive” or “palatable” and therefore could encourage tobacco consumption, and also because prohibiting entire categories of cigarettes, such as menthol, is likely to lead to a massive increase in illicit trade.

Many countries have enacted or proposed legislation or regulations that require cigarette manufacturers to disclose to governments and to the public the ingredients used in the manufacture of tobacco products and, in certain cases, to provide toxicological

- 42-

Table of Contents

information about those ingredients. We have made, and will continue to make, full disclosures where adequate assurances of trade secret protection are provided.

Bans on Display of Tobacco Products at Retail: In a few of our markets, governments have banned or propose to ban the display of tobacco products at the point of retail sale. Other countries have rejected display ban proposals. We oppose display bans because they restrict competition by favoring established brands and encourage illicit trade, while not reducing smoking or otherwise benefiting public health. In some markets, our subsidiaries and, in some cases, individual retailers have commenced legal proceedings to overturn display bans.

Health Warning Requirements: In most countries, governments require large and often graphic health warnings covering at least 30% of the front and back of cigarette packs (the size mandated by the FCTC). A growing number of countries require warnings covering 50% of the front and back of the pack, and a small number of countries require larger warnings, such as Australia (75% front and 90% back), Mexico (30% front and 100% back), Uruguay (80% front and back) and Canada (75% front and back).

In Thailand, litigation challenging excessively large health warnings is pending. It is not possible to predict the outcome of this proceeding.

We support health warning requirements designed to inform consumers of the risks of smoking. Where health warnings are not required, we place them on packaging voluntarily in the official language or languages of the country. We defer to governments on the content of warnings except for content that vilifies tobacco companies or does not fairly represent the actual effects of smoking. However, we oppose excessively large health warnings. The data show that disproportionately increasing the size of health warnings does not effectively reduce tobacco consumption. Yet, such health warnings impede our ability to compete in the market by leaving insufficient space for our distinctive trademarks and pack designs.

Other Packaging Restrictions: Some governments have passed, or are seeking to pass, restrictions on packaging and labeling, including standardizing the shape, format and layout of packaging, as well as imposing broad restrictions on how the space left for branding and product descriptions can be used. Examples include prohibitions on: (1) the use of colors that are alleged to suggest that one brand is less harmful than others, (2) specific descriptive phrases deemed to be misleading, including, for example, “premium,” “full flavor,” “international,” “gold,” “silver,” and “menthol” and (3) in one country, all but one variant per brand. We oppose broad packaging restrictions because they unnecessarily limit brand and product differentiation, are anticompetitive, prevent us from providing adult smokers with information about our products, unduly restrict our intellectual property rights, and violate international trade agreements. In some instances, we have commenced litigation challenging such regulations. It is not possible to predict the outcome of these proceedings.

Bans and Restrictions on Advertising, Marketing, Promotions and Sponsorships: For many years, the FCTC has called for, and countries have imposed, partial or total bans on tobacco advertising, marketing, promotions and sponsorships, including bans and restrictions on advertising on radio and television, in print and on the Internet. The FCTC also requires disclosure of expenditures on advertising, promotion and sponsorship where such activities are not prohibited. The FCTC guidelines recommend that governments adopt extreme and sweeping prohibitions, including all forms of communication to adult smokers. Where restrictions on advertising prevent us from communicating directly and effectively with adult smokers, they impede our ability to compete in the market. For this reason and because we believe that the available evidence does not show that marketing restrictions effectively reduce smoking, we oppose complete bans on advertising and communication that do not allow manufacturers to communicate directly and effectively with adult smokers.

Restrictions on Product Design: Anti-tobacco organizations and some regulators are calling for the further standardization of tobacco products by requiring, for example, that cigarettes have a certain minimum diameter, which amounts to a ban on slim cigarettes, or requiring the use of standardized filter and cigarette paper designs. We oppose such restrictions because they limit our ability to differentiate our products and because we believe that there is no correlation, let alone a causal link, between product design variations and smoking rates, nor is there any scientific evidence that these restrictions would improve public health.

Reduced cigarette ignition propensity (“RCIP”) standards recommended by the FCTC guidelines, have been adopted in several of our markets (e.g., Australia, Canada, South Africa, South Korea, and the EU), and are being considered in several others. While the available evidence (namely, from two provinces in Canada, the State of New York and Sweden) so far suggests that the implementation of RCIP standards did not result in the predicted reduction of smoking-related fires, RCIP standards do increase production costs.

Restrictions on Public Smoking: The pace and scope of public smoking restrictions have increased significantly in most of our markets. Many countries around the world have adopted, or are likely to adopt, regulations that restrict or ban smoking in public and/or work places, restaurants, bars and nightclubs. Some public health groups have called for, and some countries, regional

- 43-

Table of Contents

governments and municipalities have adopted or proposed, bans on smoking in outdoor places, as well as bans on smoking in cars (typically, when minors are present) and private homes. The FCTC requires Parties to adopt restrictions on public smoking, and the guidelines call for broad bans in all indoor public places but limit their recommendations on private-place smoking, such as in cars and homes, to increased education on the risk of exposure to environmental tobacco smoke.

While we believe outright bans are appropriate in many public places, such as schools, playgrounds, youth facilities, and many indoor public places, governments can and should seek a balance between the desire to protect non-smokers from environmental tobacco smoke and allowing adults who choose to smoke to do so. Owners of restaurants, bars, cafes, and other entertainment establishments should have the flexibility to permit, restrict, or prohibit smoking, and workplaces should be permitted to provide designated smoking rooms for adult smokers. Finally, we oppose bans on smoking outdoors (beyond places and facilities for children) and in private places.

Restrictions on the Sale of Innovative Tobacco Products: Some governments have passed, or are seeking to pass, regulations that ban the sale of e-cigarettes or “emerging” tobacco products, including novel tobacco or nicotine products, such as smokeless tobacco - where no combustion takes place and no smoke is produced - dissolvable tobacco products or nicotine, and nicotine delivery systems (e.g., e-vapor products). These regulations might foreclose adult smoker access even to products that might be shown to present significantly less risk of harm than existing products. We oppose such blanket bans of products that may have the potential to reduce the harm of smoking. By contrast, we support regulation that sets strict standards and propels innovation to benefit adult smokers and public health.

Other Regulatory Issues: Some regulators are considering, or in some cases have adopted, regulatory measures designed to reduce the supply of tobacco products. These include regulations intended to reduce the number of retailers selling tobacco by, for example, reducing the overall number of tobacco retail licenses available or banning the sale of tobacco within arbitrary distances of certain public facilities. We oppose such measures because they stimulate illicit trade and could arbitrarily deprive business owners and their employees of their livelihood with no indication that such restrictions would improve public health.

Regulators in some countries have also called for the exclusion of tobacco from certain basic provisions of trade and investment agreements. The Trans-Pacific Partnership Agreement (“TPP”) includes a provision that denies “investors,” as defined in the TPP, access to the Investor State Dispute Settlement Mechanism to challenge “tobacco control measures.” None of the 12 parties to this agreement has yet ratified it. If this carve-out enters into force, we believe it would constitute unfair discrimination against a legal industry, be at odds with fundamental principles of international investment protection, and constitute a dangerous precedent for many other sectors.

In a limited number of markets, most notably Argentina and Japan, we are dependent on governmental approvals that may limit our pricing flexibility.

Illicit Trade: The illicit tobacco trade creates a cheap and unregulated supply of tobacco products, undermines efforts to reduce smoking, especially among youth, damages legitimate businesses, stimulates organized crime, increases corruption and reduces government tax revenue. Illicit trade may account for as much as 10% of global cigarette consumption; this includes counterfeit, contraband and the growing problem of “illicit whites,” which are cigarettes legally produced in one jurisdiction for the sole purpose of being exported and illegally sold in another jurisdiction where they have no legitimate market. We estimate that illicit trade in the European Union accounted for more than 10% of total cigarette consumption in 2015.

A number of jurisdictions are considering regulatory measures and government action to prevent illicit trade. In November 2012, the FCTC adopted the Protocol to Eliminate Illicit Trade in Tobacco Products (the “Protocol”), which includes supply chain control measures, such as licensing of manufacturers and distributors, enforcement in free trade zones, controls on duty free and Internet sales and the implementation of tracking and tracing technologies. To date, 54 countries have signed the Protocol and 15 countries have ratified it. The Protocol will come into force once the fortieth country ratifies it, after which countries must implement its measures via national legislation. It is not possible to predict whether other countries will sign or ratify the Protocol.

Additionally, we and our subsidiaries have entered into cooperation agreements with governments and authorities to support their anti-illicit trade efforts. For example, in 2004, we entered into a 12-year cooperation agreement with the EU and its member states that provides for cooperation with European law enforcement agencies on anti-contraband and on anti-counterfeit efforts. Under the terms of this agreement we make financial contributions of approximately $75 million per year (recorded as an expense in cost of sales when product is shipped) to support these efforts. We are also required to pay the excise taxes, VAT and customs duties on qualifying seizures of up to 450 million genuine PMI products in the EU in a given year, and five times the applicable taxes and duties if seizures exceed this threshold in a given year. To date, our payments for product seizures have been immaterial. The agreement is due to expire in July 2016. It is not possible to predict whether the EU will seek a renewal of the agreement.

- 44-

Table of Contents

In 2009, our Colombian subsidiaries entered into an Investment and Cooperation Agreement with the national and regional governments of Colombia to promote investment in, and cooperation on, anti-contraband and anti-counterfeit efforts. The agreement provides $200 million in funding over a 20-year period to address issues such as combating the illegal cigarette trade and increasing the quality and quantity of locally grown tobacco.

Reduced-Risk Products: We use the term RRP to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes. Our RRPs are in various stages of development and commercialization, and we are conducting extensive and rigorous scientific studies to determine whether we can support claims for such products of reduced exposure to harmful and potentially harmful constituents in smoke and, ultimately, claims of reduced disease risk when compared to smoking cigarettes. Before making any such claims, we will rigorously evaluate the full set of data from the relevant scientific studies to determine whether they substantiate reduced exposure or risk. Any such claims may also be subject to government review and authorization, as is the case in the United States today. We draw upon a team of world-class scientists and engineers from a broad spectrum of scientific disciplines, and our efforts are guided by the following three key objectives:


•	to develop RRPs that provide adult smokers the taste, sensory experience, nicotine delivery profile and ritual characteristics that are similar to those currently provided by cigarettes;


•	to substantiate the reduction of risk for the individual adult smoker and the reduction of harm to the population as a whole, based on robust scientific evidence derived from well-established assessment processes; and


•	to advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs, including the communication to adult smokers of scientifically substantiated reduced exposure or reduced risk claims.

Our product development is based on the elimination of combustion via tobacco heating and other innovative systems for aerosol generation, which we believe is the most promising path to reduce risk.

Our approach to individual risk assessment is to use cessation as the benchmark, because the short-term and long-term effects of smoking cessation on risk reduction are well known.

Four RRP platforms are in various stages of development and commercialization readiness:

•

Platform 1, as discussed below, uses a precisely controlled heating device that we are commercializing under the iQOS brand name, into which a specially designed tobacco product under the Marlboro, Parliament and HeatSticks brand names is inserted and heated to generate an aerosol. Six short-term clinical studies have been completed. The study results show a substantial reduction in relevant biomarkers of exposure to harmful or potentially harmful constituents (“HPHCs”) in adult consumers who switched to iQOS compared to adult consumers who continued to smoke cigarettes over a five-day period. The conduct phase of two three-month clinical reduced-exposure studies conducted in Japan and the United States of America has also been completed. The final study report for Japan has been issued, and the report for the U.S. study is expected shortly. In these studies, we observed reduction in all 15 biomarkers of exposure to corresponding HPHCs measured in those who switched to iQOS compared to those who either continued to smoke cigarettes or quit smoking for the duration of the study. The reductions measured in those who switched to iQOS approached those that were observed in study participants who quit smoking for the duration of the study. We also initiated a 6+6 month exposure response study in December 2014, and expect the results regarding the first six-month term in the first quarter of 2017.


•	Platform 2 uses a pressed carbon heat source to generate an aerosol by heating tobacco. Clinical testing of Platform 2 started in the second quarter of 2015.

•

Platform 3 is based on technology we acquired from Professor Jed Rose of Duke University and his co-inventors in May 2011. This product creates an aerosol of nicotine salt formed by the chemical reaction of nicotine with a weak organic acid and replicates the feel and ritual of smoking. We are exploring two routes for this platform, one with electronics and one without. We have begun pre-clinical and clinical testing of this product.

•

Platform 4 covers e-vapor products, which are battery-powered devices that produce an aerosol by vaporizing a liquid nicotine solution. Our e-vapor products comprise devices using current generation technology, and we are working on developing the next generation of e-vapor technologies to address the challenges presented by the e-vapor products currently on the market, ranging from consumer satisfaction to manufacturing processes and product consistency.

- 45-

Table of Contents

We are also developing other potential product platforms.

We are proceeding with the commercialization of RRPs. In January 2014, we announced an investment of up to €500 million over three years in our first manufacturing facility in the European Union and an associated pilot plant near Bologna, Italy, to produce our RRPs. The factory is designed to produce up to 30 billion units and started commercial production in the first quarter of 2016. It will initially manufacture Platform 1 tobacco sticks (HeatSticks).

In the United States of America, an established regulatory framework for assessing “Modified Risk Tobacco Products” exists under the jurisdiction of the Food and Drug Administration (“FDA”). We expect that future FDA actions are likely to influence the regulatory approach of other interested governments. Our assessment approach and the studies conducted to date reflect the rigorous evidentiary package contemplated in the FDA’s Draft Guidance for Modified Risk Tobacco Product Applications (2012). We have shared our approach and studies with the FDA’s Center for Tobacco Products. In parallel, we are engaging with regulators in several EU member states, as well as in a number of other countries. We plan to submit a Modified Risk Tobacco Product application for Platform 1 late in 2016.

As we work to develop evidence to substantiate the risk reduction potential of our products, we will review our ability to make claims of reduced exposure or risk based on applicable laws and regulations and, as we are already doing, engage with regulators and share the evidence with them. We are also engaging with the scientific community, sharing our assessment approach and the results we have generated. There can be no assurance that we will succeed in our efforts or that regulators will permit the marketing of our RRPs with substantiated claims of reduced exposure or risk as compared with smoking cigarettes.

In 2014, we introduced the iQOS system in pilot city launches in Nagoya, Japan, and in Milan, Italy. We commenced national expansion in Japan in September 2015. We launched iQOS in Switzerland in August 2015 and started pilot city launches in Moscow, Lisbon and Bucharest in November 2015. We also started our gradual expansion in Italy, beginning with Rome and Turin in December 2015. We started a pilot city launch in Kiev in February 2016. To date, the product has not been marketed with claims of reduced risk.

In December 2013, we established a strategic framework with Altria Group, Inc. (“Altria”) under which Altria will make available its e-vapor products exclusively to us for commercialization outside the United States of America, and we will make available two of our RRPs exclusively to Altria for commercialization in the United States of America. In March 2015, we launched Solaris, a Platform 4 e-vapor product licensed from Altria, in Spain. In December 2015, we introduced Solaris in Israel.

In July 2015, we extended the strategic framework with Altria to include a Joint Research, Development and Technology Sharing Agreement. The additional agreement provides the framework under which PMI and Altria will collaborate to develop the next generation of e-vapor products for commercialization in the United States of America by Altria and in markets outside the United States of America by PMI. The collaboration between PMI and Altria in this endeavor is enabled by exclusive technology cross licenses and technical information sharing. The agreements also provide for cooperation on the scientific assessment of, and for the sharing of improvements to, the existing generation of licensed products.

In June 2014, we acquired 100% of Nicocigs Limited, a leading U.K.-based e-vapor company whose principal brand is Nicolites. This acquisition provided PMI with immediate access to, and a significant presence in, the U.K. e-vapor market.

Other Legislation, Regulation or Governmental Action: In Argentina, the National Commission for the Defense of Competition issued a resolution in May 2010 in which it found that our affiliate's establishment in 1997 of a system of exclusive zonified distributors (“EZDs”) in Buenos Aires city and region was anticompetitive, despite having issued two prior decisions (in 1997 and 2000) in which it had found the establishment of the EZD system was not anticompetitive. In February 2016, the Commission closed the investigation without finding any fault on the part of our affiliate. This decision has been appealed.

In Germany, in October 2013, the Administrative District Office Munich, acting under the policy supervision of the Bavarian Ministry of Health and Environment, sent our German affiliate an order alleging that certain components of its Marlboro advertising campaign do not comply with the applicable tobacco advertising law, and requiring our affiliate to stop this particular campaign throughout Germany. Our affiliate filed a challenge in the Munich Administrative Court, which was granted in part and denied in part. At an appeals hearing in April 2014, before the Bavarian Higher Administrative Court, the parties agreed that our affiliate could continue the campaign with certain limitations on image visuals and text slogans for the duration of the court proceedings. In April 2015, the Administrative District Office Munich issued a revised order, which again required our affiliate to stop using core elements of this particular campaign within one to three months from the effective date of the order. Our affiliate again challenged the order in the Munich Administrative Court, and, in September 2015, the first instance court nullified the order. The decision was not appealed and is now final.

- 46-

Table of Contents

It is not possible to predict what, if any, additional legislation, regulation or other governmental action will be enacted or implemented relating to the manufacturing, advertising, sale or use of tobacco products, or the tobacco industry generally. It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that might materially affect our business, volume, results of operations, cash flows and financial position.

Governmental Investigations

From time to time, we are subject to governmental investigations on a range of matters. The Department of Special Investigations (“DSI”) of the government of Thailand has been conducting an investigation into alleged underpayment by Philip Morris (Thailand) Limited (“PM Thailand”) of customs duties and excise taxes of approximately $1.8 billion, relating to imports from Indonesia covering the period 2000-2003. PM Thailand has been cooperating with the Thai authorities and believes that its declared import prices are in compliance with the Customs Valuation Agreement of the WTO and Thai law.

Additionally, in November 2010, a WTO panel issued its decision in a dispute relating to facts that arose from August 2006 between the Philippines and Thailand concerning a series of Thai customs and tax measures affecting cigarettes imported by PM Thailand into Thailand from the Philippines (see Note 9. Contingencies for additional information). The WTO panel decision, which was upheld by the WTO Appellate Body, concluded that Thailand had no basis to find that PM Thailand's declared customs values and taxes paid were too low, as alleged by the DSI in 2009. The decision also created obligations for Thailand to revise its laws, regulations, or practices affecting the customs valuation and tax treatment of future cigarette imports. Thailand agreed in September 2011 to fully comply with the decision by October 2012. The Philippines contends that to date Thailand has not fully complied and is pursuing bilateral discussions with Thailand to address the outstanding issues. The Philippines has repeatedly expressed concerns with ongoing investigations by Thailand of PM Thailand, including those that led to the criminal charges described in Note 9. Contingencies, noting that these investigations appear to be based on grounds not supported by WTO customs valuation rules and inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies.

Acquisitions and Other Business Arrangements

In July 2015, we dissolved our exclusive joint venture agreement with Swedish Match AB ("SWMA") to commercialize Swedish snus and other smoke-free tobacco products worldwide, outside of Scandinavia and the United States. The dissolution, mutually agreed with SWMA, means that both companies will now focus on independent strategies for the commercialization of these products, and the trademarks and intellectual property licensed to the joint venture by the companies will revert to their original owners. The dissolution of this agreement was not material to our consolidated financial position, results of operations or cash flows in any of the periods presented.

On January 30, 2014, the Indonesian Stock Exchange (“IDX”) adopted a regulation requiring all listed public companies to have at least a 7.5% public shareholding by January 30, 2016. In order to comply with this requirement, our subsidiary PT HM Sampoerna Tbk. (“Sampoerna”), of which we held a 98.18% interest, conducted a rights issue. The exercise price for the rights was set at Rp. 77,000 per share, a 1.349% premium to the closing price on the IDX as of September 30, 2015. In connection with the rights issue, PT Philip Morris Indonesia (“PMID”), a fully consolidated subsidiary of PMI, sold 264,209,711 of the rights to third-party investors. Delivery of the rights sold took place on October 26, 2015. The total net proceeds from the rights issue were $1.5 billion at prevailing exchange rates on the closing date. The sale of the rights resulted in an increase to our additional paid-in capital of $1.1 billion.

In September 2013, Grupo Carso, S.A.B. de C.V. ("Grupo Carso") sold to us its remaining 20% interest in our Mexican tobacco business for $703 million. As a result, we now own 100% of the Mexican tobacco business. A former director of PMI, whose term expired at the Annual Meeting of Shareholders in May 2015, had an affiliation with Grupo Carso. The final purchase price was subject to an adjustment based on the actual performance of the Mexican tobacco business over the three-year period ending two fiscal years after the closing of the purchase. In May 2015, we received a payment of $113 million from Grupo Carso as the final purchase price adjustment. This resulted in a total net purchase price of $590 million. In addition, we agreed to pay a dividend of approximately $38 million to Grupo Carso related to the earnings of the Mexican tobacco business for the nine months ended September 30, 2013. In March 2014, the dividend was declared and paid. The purchase of the remaining 20% interest resulted in a net decrease to our additional paid-in capital of $559 million.

Asset Impairment and Exit Costs

In November 2015, we commenced the implementation of a restructuring program within our European Union segment. The program is expected to be completed by the end of 2017. In total, we expect to incur a total pre-tax charge of approximately $93 million for the program. During 2015, we recorded pre-tax exit costs of $68 million related to employee separation costs. In addition, as part of the total program, up to $25 million of pre-tax implementation costs, primarily related to costs for the project

- 47-

Table of Contents

team and notice period payments, will be reflected in cost of sales and marketing, administration and research costs in our condensed consolidated statement of earnings.

Trade Policy

We are subject to various trade restrictions imposed by the United States of America and countries in which we do business (“Trade Sanctions”), including the trade and economic sanctions administered by the U.S. Department of the Treasury's Office of Foreign Assets Control and the U.S. Department of State. It is our policy to comply fully with these Trade Sanctions.

Tobacco products are agricultural products under U.S. law and are not technological or strategic in nature. From time to time we make sales in countries subject to Trade Sanctions, either where they do not apply to our business or pursuant to either exemptions or licenses granted under the applicable Trade Sanctions.

A subsidiary sells products to distributors that in turn sell those products to duty free customers that supply U.N. peacekeeping forces around the world, including those in the Republic of the Sudan. We do not believe that these exempt sales of our products for ultimate resale in the Republic of the Sudan, which are de minimis in volume and value, present a material risk to our shareholders, our reputation or the value of our shares. We have no employees, operations or assets in the Republic of the Sudan.

To our knowledge, none of our commercial arrangements results in the governments of any country identified by the U.S. government as a state sponsor of terrorism, nor entities controlled by those governments, receiving cash or acting as intermediaries in violation of U.S. laws.

We do not sell products in Cuba, Iran, North Korea and Syria.

Certain states within the U.S. have enacted legislation permitting state pension funds to divest or abstain from future investment in stocks of companies that do business with certain countries that are sanctioned by the U.S. We do not believe such legislation has had a material effect on the price of our shares.

Operating Results – Three Months Ended March 31, 2016

The following discussion compares operating results within each of our reportable segments for the three months ended March 31, 2016, with the three months ended March 31, 2015.

European Union:



European Union	For the Three Months Ended March 31,
(in millions)	2016		2015		Variance			%
Net revenues	$	6,143	$	6,222	$	(79	)	(1.3	)%
Excise taxes on products	4,280		4,271		9			0.2	%
Net revenues, excluding excise taxes on products	1,863		1,951		(88		)	(4.5	)%
Operating companies income	906		927		(21		)	(2.3	)%

For the three months ended March 31, 2016, net revenues, which include excise taxes billed to customers, decreased by $79 million. Excluding excise taxes, net revenues decreased by $88 million due to:


•	unfavorable currency ($155 million) and


•	unfavorable volume/mix ($6 million), partly offset by


•	price increases ($73 million).

The net revenues of the European Union segment include $335 million in 2016 and $352 million in 2015 related to sales of OTP. Excluding excise taxes, OTP net revenues for the European Union segment were $119 million in 2016 and $124 million in 2015.

Operating companies income decreased by $21 million during the three months ended March 31, 2016. This decrease was due primarily to:


•	unfavorable currency ($54 million),

- 48-

Table of Contents


•	higher marketing, administration and research costs ($42 million, reflecting the timing of the marketing support behind our cigarette brand portfolio, notably Marlboro in Germany; investments behind the commercialization of RRPs; and the implementation of the EU Tobacco Products Directive) and


•	unfavorable volume/mix ($12 million), partially offset by


•	price increases ($73 million) and


•	lower manufacturing costs ($16 million).

European Union - Industry Volume

The estimated total cigarette market in the European Union of 114.9 billion units increased by 0.6%, primarily reflecting improved macroeconomics, a lower prevalence of illicit trade and e-vapor products and, in certain geographies, the estimated favorable impact of immigration. The net impact of inventory movements in the quarter was immaterial.

The estimated total OTP market in the European Union of 38.4 billion cigarette equivalent units increased by 1.4%, reflecting a larger total fine cut market, up by 1.2% to 33.5 billion cigarette equivalent units.

European Union - PMI Shipment Volume and Market Share

Cigarette shipment volume and market share performance by brand are shown in the tables below:



European Union Cigarette Shipment Volume by Brand (Million Units)
	First-Quarter
	2016	2015	Change
Marlboro	22,700	21,904	3.6	%
L&M	8,188	7,833	4.5	%
Chesterfield	7,148	6,506	9.9	%
Philip Morris	4,054	2,424	67.2	%
Others	3,903	6,143	(36.5	)%
Total EU	45,993	44,810	2.6	%



European Union Cigarette Market Shares by Brand
	First-Quarter
					Change
	2016		2015		p.p.
Marlboro	19.1	%	18.7	%	0.4
L&M	7.0	%	6.8	%	0.2
Chesterfield	6.0	%	5.8	%	0.2
Philip Morris	3.3	%	3.1	%	0.2
Others	3.3	%	3.7	%	(0.4	)
Total EU	38.7	%	38.1	%	0.6

Our cigarette shipment volume of 46.0 billion units increased by 2.6%, driven notably by France, Italy, Poland and Spain, partly offset by the United Kingdom, or by 2.1% excluding estimated favorable distributor inventory movements, mainly in Spain. Our cigarette market share increased by 0.6 points to 38.7%, with gains notably in France, Germany, Poland and Spain, partly offset by Italy and Portugal.

Our shipments of OTP of 5.6 billion cigarette equivalent units increased by 0.4%. Our total OTP market share decreased by 0.2 points to 14.1%.

- 49-

Table of Contents

European Union - Key Market Commentaries

In France, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	France Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	10.7		10.6		1.0	%

PMI Shipments (million units)	4,778		4,578		4.4	%

PMI Cigarette Market Share
Marlboro	26.1	%	25.4	%	0.7
Philip Morris	10.1	%	9.6	%	0.5
Chesterfield	3.1	%	3.3	%	(0.2	)
Others	2.8	%	2.9	%	(0.1	)
Total	42.1	%	41.2	%	0.9

The estimated total cigarette market increased by 1.0%. Excluding the favorable net impact of estimated trade inventory movements, the total market increased by 0.5%, partly reflecting a lower prevalence of illicit trade and e-vapor products. The increase in our cigarette shipment volume mainly reflected the higher total cigarette market and market share growth, driven by Marlboro, benefiting from the positive performance of Marlboro 25s, launched in March 2015, as well as the launch of Philip Morris 25s and 100s in January 2016. The estimated total industry fine cut category of 3.5 billion cigarette equivalent units increased by 5.4%. Our market share of the category increased by 0.3 points to 25.4%.

In Germany, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Germany Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	17.8		18.2		(1.7	)%

PMI Shipments (million units)	6,767		6,745		0.3	%

PMI Cigarette Market Share
Marlboro	22.9	%	21.8	%	1.1
L&M	11.8	%	12.1	%	(0.3	)
Chesterfield	1.6	%	1.7	%	(0.1	)
Others	1.6	%	1.5	%	0.1
Total	37.9	%	37.1	%	0.8

The estimated total cigarette market decreased by 1.7%. Excluding the unfavorable net impact of estimated trade inventory movements, the total market was essentially flat, principally reflecting a lower prevalence of illicit trade. The increase in our cigarette shipment volume mainly reflected higher market share, driven by Marlboro, principally reflecting the positive impact of the new Architecture 2.0 and marketing support, partly offset by L&M resulting from its moving off the round €5.00/pack price point in mid-2015. The estimated total industry fine cut category of 9.5 billion cigarette equivalent units decreased by 0.1%. Our market share of the category increased by 0.2 points to 12.7%.

- 50-

Table of Contents

In Italy, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Italy Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	17.1		16.5		3.9	%

PMI Shipments (million units)	9,846		9,650		2.0	%

PMI Cigarette Market Share
Marlboro	24.4	%	24.8	%	(0.4	)
Chesterfield	11.6	%	10.5	%	1.1
Philip Morris	9.0	%	9.6	%	(0.6	)
Others	8.5	%	9.2	%	(0.7	)
Total	53.5	%	54.1	%	(0.6	)

The estimated total cigarette industry increased by 3.9%. Excluding the unfavorable net impact of estimated trade inventory movements, the total market increased by 4.6%, partly reflecting a lower prevalence of illicit trade and e-vapor products, as well as the estimated favorable impact of immigration. Although our cigarette shipments increased by 2.0%, market share decreased, due notably to Marlboro, largely reflecting its price increase in the first quarter of 2015 to €5.20 per pack from its round retail price point of €5.00 per pack, and low-price Philip Morris, impacted by the growth of the super-low price segment, partly offset by super-low price Chesterfield. The estimated total industry fine cut category of 1.5 billion cigarette equivalent units increased by 5.2%. Our market share of the category decreased by 1.9 points to 39.6%.

In Poland, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Poland Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	10.1		9.8		3.1	%

PMI Shipments (million units)	4,145		3,757		10.4	%

PMI Cigarette Market Share
Marlboro	11.2	%	10.6	%	0.6
L&M	18.5	%	17.6	%	0.9
Chesterfield	8.6	%	8.0	%	0.6
Others	2.9	%	2.3	%	0.6
Total	41.2	%	38.5	%	2.7

The estimated total cigarette market increased by 3.1%, or by 5.6% excluding the unfavorable net impact of estimated trade inventory movements, driven primarily by a lower prevalence of e-vapor products and non-duty paid products. The increase in our cigarette shipment volume reflected the higher total market and higher market share, driven by Marlboro, reflecting the positive impact of the new Architecture 2.0, L&M, reflecting the positive impact of brand support, and Chesterfield, benefiting from its 100s and super-slims variants. The estimated total industry fine cut category of 1.1 billion cigarette equivalent units increased by 3.8%. Our market share of the category decreased by 8.2 points to 25.4%, mainly due to increased price competition at the bottom of the market.

- 51-

Table of Contents

In Spain, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Spain Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	10.3		10.5		(1.3	)%

PMI Shipments (million units)	4,022		3,567		12.7	%

PMI Cigarette Market Share
Marlboro	17.7	%	16.1	%	1.6
Chesterfield	9.0	%	9.4	%	(0.4	)
L&M	5.6	%	6.0	%	(0.4	)
Others	1.9	%	1.2	%	0.7
Total	34.2	%	32.7	%	1.5

The estimated total cigarette market decreased by 1.3%, mainly due to unfavorable estimated trade inventory movements. Excluding these inventory movements, the estimated total cigarette market declined by 0.5%. Excluding the net impact of favorable inventory movements, our cigarette shipment volume increased by 3.1%, driven by higher market share reflecting the strong performance of Marlboro, benefiting from a round price point in the vending channel, the new Architecture 2.0, and an improving economy. The estimated total industry fine cut category of 2.1 billion cigarette equivalent units decreased by 3.9%. Our market share of the fine cut category decreased by 1.3 points to 13.1%.

Eastern Europe, Middle East & Africa:



Eastern Europe, Middle East & Africa	For the Three Months Ended March 31,
(in millions)	2016		2015		Variance			%
Net revenues	$	3,997	$	4,147	$	(150	)	(3.6	)%
Excise taxes on products	2,395		2,363		32			1.4	%
Net revenues, excluding excise taxes on products	1,602		1,784		(182		)	(10.2	)%
Operating companies income	633		866		(233		)	(26.9	)%

For the three months ended March 31, 2016, net revenues, which include excise taxes billed to customers, decreased by $150 million. Excluding excise taxes, net revenues decreased by $182 million due to:


•	unfavorable currency ($203 million) and


•	unfavorable volume/mix ($90 million), partly offset by


•	price increases ($111 million).

Operating companies income decreased by $233 million during the three months ended March 31, 2016. This decrease was due primarily to:


•	unfavorable currency ($177 million),


•	unfavorable volume/mix ($106 million) and


•	higher marketing, administration and research costs ($58 million, reflecting the timing of marketing and sales investments, including those behind the commercialization of iQOS), partly offset by


•	price increases ($111 million).

- 52-

Table of Contents

Eastern Europe, Middle East & Africa - PMI Cigarette Shipment Volume

Despite a difficult comparison with the first quarter of 2015 in which our cigarette shipment volume grew by 4.2%, excluding acquisitions, our cigarette shipment volume of 63.1 billion units in the quarter increased by 0.8%, or by 0.4% excluding the favorable net impact of estimated inventory movements, mainly reflecting growth in Egypt and Tunisia in North Africa, Turkey and Ukraine, partly offset by Algeria and Russia.

Our cigarette shipment volume of premium brands decreased by 2.7%, mainly due to: Marlboro, down by 8.7% to 17.5 billion units, mainly due to North Africa, partly offset by Saudi Arabia and Turkey, partly offset by Parliament, up by 0.7% to 7.3 billion units, primarily driven by Turkey. Our cigarette shipment volume of L&M increased by 8.6% to 12.9 billion units, mainly driven by North Africa, principally Egypt, and Ukraine, partly offset by Russia and Saudi Arabia.

Eastern Europe, Middle East & Africa - Key Market Commentaries

In North Africa (defined as Algeria, Egypt, Libya, Morocco and Tunisia), estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	North Africa Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	34.0		32.4		5.1	%

PMI Shipments (million units)	10,230		9,202		11.2	%

PMI Cigarette Market Share
Marlboro	7.4	%	14.8	%	(7.4	)
L&M	14.3	%	10.8	%	3.5
Others	3.0	%	2.0	%	1.0
Total	24.7	%	27.6	%	(2.9	)

The estimated total market increased by 5.1%, principally due to Egypt. Excluding net favorable distributor inventory movements, mainly in Morocco and Tunisia, our cigarette shipment volume decreased by 5.7%. Our market share decreased, mainly due to Marlboro in Algeria, Egypt and Libya, partly offset by L&M in Egypt and Next in "Others" in Morocco.

- 53-

Table of Contents

In Russia, estimated industry size, our cigarette shipment volume and February quarter-to-date market share performance, as measured by Nielsen, are shown in the table below.



	Russia Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	57.8		61.5		(6.0	)%

PMI Shipments (million units)	17,809		19,008		(6.3	)%

PMI Cigarette Market Share
Marlboro	1.4	%	1.4	%	—
Parliament	3.9	%	4.0	%	(0.1	)
Bond Street	8.4	%	8.0	%	0.4
Others	14.1	%	14.6	%	(0.5	)
Total	27.8	%	28.0	%	(0.2	)

The estimated total cigarette market decreased by 6.0%, mainly due to the impact of excise tax-driven retail price increases. Excluding the unfavorable net impact of estimated distributor inventory movements, our cigarette shipment volume declined by 4.8%, mainly reflecting the lower total market, and lower market share due to a decline of mid-price L&M and Chesterfield, partly offset by super-low Next/Dubliss in "Others."

In Turkey, estimated industry size, our cigarette shipment volume and February quarter-to-date market share performance, as measured by Nielsen, are shown in the table below.



	Turkey Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	22.3		20.0		11.7	%

PMI Shipments (million units)	10,345		9,271		11.6	%

PMI Cigarette Market Share
Marlboro	10.0	%	8.9	%	1.1
Parliament	11.5	%	11.5	%	—
Lark	7.8	%	7.3	%	0.5
Others	14.6	%	15.6	%	(1.0	)
Total	43.9	%	43.3	%	0.6

The estimated total cigarette market increased by 11.7%, mainly due to a lower prevalence of illicit trade, as well as the estimated favorable impact of immigration. The increase in our cigarette shipment volume was mainly driven by a higher total market and market share, led by Marlboro, partly offset by L&M and Chesterfield in "Others" reflecting the impact of competitive price repositioning.

In Ukraine, estimated industry size, our cigarette shipment volume and February quarter-to-date market share performance, as measured by Nielsen, are shown in the table below.

- 54-

Table of Contents



	Ukraine Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	17.3		14.8		17.3	%

PMI Shipments (million units)	5,647		4,608		22.5	%

PMI Cigarette Market Share
Marlboro	3.2	%	4.7	%	(1.5	)
Parliament	2.7	%	3.1	%	(0.4	)
Bond Street	10.2	%	8.0	%	2.2
Others	13.5	%	16.2	%	(2.7	)
Total	29.6	%	32.0	%	(2.4	)

The estimated total market increased by 17.3%, or by 12.5% excluding the favorable net impact of estimated trade inventory movements, mainly driven by a lower prevalence of illicit trade. The increase in our cigarette shipment volume reflected the higher total cigarette market. The decrease in our market share, as measured by Nielsen, was primarily due to Marlboro, reflecting the impact of widened price gaps, and Chesterfield and President in "Others," mainly resulting from competitive price pressure in the low price segment, partially offset by low price Bond Street, and L&M in "Others."

Asia:



Asia	For the Three Months Ended March 31,
(in millions)	2016		2015		Variance			%
Net revenues	$	4,689	$	4,764	$	(75	)	(1.6	)%
Excise taxes on products	2,721		2,609		112			4.3	%
Net revenues, excluding excise taxes on products	1,968		2,155		(187		)	(8.7	)%
Operating companies income	778		934		(156		)	(16.7	)%

For the three months ended March 31, 2016, net revenues, which include excise taxes billed to customers, decreased by $75 million. Excluding excise taxes, net revenues decreased by $187 million due to:


•	unfavorable currency ($150 million) and


•	unfavorable volume/mix ($46 million), partly offset by


•	price increases ($9 million).

Operating companies income decreased by $156 million during the three months ended March 31, 2016. This decrease was due primarily to:


•	unfavorable volume/mix ($88 million),


•	unfavorable currency ($63 million) and


•	higher marketing, administration and research costs ($27 million, mainly in Indonesia, notably related to cigarette brand support, and Japan, primarily related to the commercialization of iQOS), partly offset by


•	lower manufacturing costs ($14 million) and


•	price increases ($9 million).

- 55-

Table of Contents

Asia - PMI Cigarette Shipment Volume

Our cigarette shipment volume of 65.2 billion units decreased by 7.0%, mainly due to Indonesia, Pakistan and the Philippines, partly offset by Korea. Net inventory movements in the quarter were immaterial.

Cigarette shipment volume of Marlboro of 18.9 billion units increased by 5.1%, predominantly driven by Korea and the Philippines, partly offset by Indonesia and Vietnam. Cigarette shipment volume of Parliament of 2.4 billion units increased by 28.5%, driven by Korea. Cigarette shipment volume of Lark of 4.3 billion units decreased by 5.6%, mainly due to Japan.

Asia - Key Market Commentaries

In Indonesia, estimated industry size, our cigarette shipment volume, market share and segmentation performance are shown in the table below.



	Indonesia Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	73.7		78.3		(5.9	)%

PMI Shipments (million units)	25,142		27,684		(9.2	)%

PMI Cigarette Market Share
Sampoerna A	14.6	%	14.9	%	(0.3	)
Dji Sam Soe	6.8	%	7.0	%	(0.2	)
U Mild	4.3	%	5.0	%	(0.7	)
Others	8.4	%	8.5	%	(0.1	)
Total	34.1	%	35.4	%	(1.3	)



	Indonesia Segmentation Data
	First-Quarter
					Change
	2016		2015		p.p.
Segment % of Total Market
Hand-Rolled Kretek (SKT)	18.3	%	19.2	%	(0.9	)
Machine-Made Kretek (SKM)	75.6	%	74.6	%	1.0
Whites (SPM)	6.1	%	6.2	%	(0.1	)
Total	100.0	%	100.0	%	—

PMI % Share of Segment
Hand-Rolled Kretek (SKT)	39.8	%	37.7	%	2.1
Machine-Made Kretek (SKM)	28.9	%	30.9	%	(2.0	)
Whites (SPM)	81.4	%	81.2	%	0.2

The estimated total cigarette market decreased by 5.9%, mainly due to a soft economy and the impact of price increases, as well as an unfavorable comparison with the first quarter of 2015 in which the estimated total cigarette market increased by 6.0%. The decrease in our cigarette shipments was principally due to the lower estimated total cigarette market and lower market share, mainly reflecting the soft performance of our SKM portfolio due to competitors' discounted product offerings, partly offset by share gains in the SKT segment.

- 56-

Table of Contents

In Japan, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Japan Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	43.5		42.5		2.3	%

PMI Shipments (million units)	11,551		11,846		(2.5	)%

PMI Cigarette Market Share
Marlboro	10.6	%	11.5	%	(0.9	)
Parliament	2.4	%	2.3	%	0.1
Lark	9.3	%	9.9	%	(0.6	)
Others	1.7	%	1.9	%	(0.2	)
Total	24.0	%	25.6	%	(1.6	)

The estimated total cigarette market increased by 2.3%, driven by estimated retail trade inventory movements and adult smoker purchases ahead of the April 2016 price increase of certain brands of our key competitor. Excluding these favorable inventory movements, the estimated total cigarette market was essentially flat, reflecting a favorable comparison with the first quarter of 2015. The decrease in our cigarette shipments in the quarter was due to lower cigarette market share. This decline in our cigarette market share reflected the unfavorable impact of the inventory movements mentioned above, as well as competitors' differentiated menthol taste product offerings.

Following the September 2015 roll-out of iQOS into a geographic expansion area representing approximately 60% of the adult smoker population at year-end 2015, Marlboro HeatSticks offtake share reached 1.8% in the first quarter of 2016, which equates to a first-quarter estimated national market share of approximately 0.8%. Offtake share represents select C-Store sales volume for HeatSticks as a percentage of the total estimated retail sales volume for cigarettes and HeatSticks. This iQOS volume is not included in the PMI cigarette market share or shipment data shown in the table above.

In Korea, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Korea Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	17.0		12.1		40.9	%

PMI Shipments (million units)	3,543		2,458		44.2	%

PMI Cigarette Market Share
Marlboro	9.4	%	9.5	%	(0.1	)
Parliament	7.5	%	6.9	%	0.6
Virginia S.	3.4	%	3.9	%	(0.5	)
Others	0.6	%	0.6	%	—
Total	20.9	%	20.9	%	—

The estimated total cigarette market increased by 40.9%, mainly driven by a favorable comparison with the first quarter of 2015 that was negatively impacted by the disruptive excise tax increase of 120% and related price increases, as well as the reversal of estimated trade inventory built up in the fourth quarter of 2014 in anticipation of the tax increase. Excluding the impact of these

- 57-

Table of Contents

estimated inventory movements, the total cigarette market increased by approximately 14.4%. The increase in our cigarette shipment volume mainly reflected these same dynamics.

In the Philippines, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Philippines Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	19.7		22.0		(10.8	)%

PMI Shipments (million units)	14,474		15,904		(9.0	)%

PMI Cigarette Market Share
Marlboro	27.5	%	18.7	%	8.8
Fortune	25.0	%	27.8	%	(2.8	)
Jackpot	9.0	%	14.2	%	(5.2	)
Others	12.1	%	11.5	%	0.6
Total	73.6	%	72.2	%	1.4

The estimated total cigarette market decreased by 10.8%, mainly due to the impact of price increases, notably in the fourth quarter of 2015 ahead of the January 2016 excise tax increase. The decline in our cigarette shipment volume reflected the impact of these price increases, particularly on our low and super-low price brands, Fortune and Jackpot. The increase in our cigarette market share in the quarter was driven by Marlboro, benefiting from its narrowed price gap with lower-priced brands.

Latin America & Canada:



Latin America & Canada	For the Three Months Ended March 31,
(in millions)	2016		2015		Variance			%
Net revenues	$	1,959	$	2,219	$	(260	)	(11.7	)%
Excise taxes on products	1,309		1,493		(184		)	(12.3	)%
Net revenues, excluding excise taxes on products	650		726		(76		)	(10.5	)%
Operating companies income	229		230		(1		)	(0.4	)%

For the three months ended March 31, 2016, net revenues, which include excise taxes billed to customers, decreased by $260 million. Excluding excise taxes, net revenues decreased by $76 million due to:


•	unfavorable currency ($183 million), partly offset by


•	price increases ($79 million) and


•	favorable volume/mix ($28 million).

Operating companies income was essentially flat during the three months ended March 31, 2016 as:


•	unfavorable currency ($89 million) and


•	higher manufacturing costs ($13 million), were offset by


•	price increases ($79 million) and


•	favorable volume/mix ($23 million).

- 58-

Table of Contents

Latin America & Canada - PMI Cigarette Shipment Volume and Market Share

Our cigarette shipment volume of 21.7 billion units increased by 2.4%, mainly driven by Mexico, partly offset by Argentina.

Shipment volume of Marlboro of 8.9 billion units increased by 8.5% and its Regional market share increased by 1.2 points to an estimated 15.9%, primarily driven by Brazil, up by 0.4 points to 10.0%, Colombia, up by 0.4 points to 9.2%, and Mexico, up by 3.2 points to 48.6%, partly offset by Argentina, down by 0.6 points to 24.1%. Shipment volume of Philip Morris of 4.6 billion units decreased by 3.8%, mainly due to Argentina.

Latin America & Canada - Key Market Commentaries

In Argentina, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Argentina Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	9.7		10.3		(5.5	)%

PMI Shipments (million units)	7,526		8,123		(7.4	)%

PMI Cigarette Market Share
Marlboro	24.1	%	24.7	%	(0.6	)
Parliament	2.0	%	2.2	%	(0.2	)
Philip Morris	44.8	%	44.7	%	0.1
Others	6.5	%	7.3	%	(0.8	)
Total	77.4	%	78.9	%	(1.5	)

The estimated total cigarette market decreased by 5.5%, or by 4.3% excluding the unfavorable net impact of trade inventory movements, mainly due to a soft economic environment and the impact of price increases. The decrease in our shipment volume reflected the impact of the same dynamics as for the total market. Our lower cigarette market share primarily reflected the growth in competitors' super-low priced products that was fueled by in-switching from illicit trade. Our share of the growing capsule segment, up by 2.2 points to represent 18.0% of the total market, increased by 1.3 points to 73.7%.

In Canada, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Canada Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	5.5		5.5		(0.4	)%

PMI Shipments (million units)	2,184		2,053		6.4	%

PMI Cigarette Market Share
Belmont	3.8	%	3.1	%	0.7
Canadian Classics	10.9	%	10.5	%	0.4
Next	11.8	%	10.5	%	1.3
Others	13.4	%	13.3	%	0.1
Total	39.9	%	37.4	%	2.5

- 59-

Table of Contents

The estimated total cigarette market decreased by 0.4%, or increased by 6.0% excluding the unfavorable impact of estimated competitors' trade inventory movements, mainly driven by improved consumer spending. The increase in our cigarette shipment volume was principally driven by higher cigarette market share, largely benefiting from the aforementioned inventory movements.

In Mexico, estimated industry size, our cigarette shipment volume and market share performance are shown in the table below.



	Mexico Key Market Data
	First-Quarter
					Change
	2016		2015		% / p.p.
Total Cigarette Market (billion units)	8.7		7.5		15.2	%

PMI Shipments (million units)	5,982		4,995		19.7	%

PMI Cigarette Market Share
Marlboro	48.6	%	45.4	%	3.2
Delicados	10.1	%	10.9	%	(0.8	)
Benson & Hedges	4.3	%	4.6	%	(0.3	)
Others	6.0	%	5.4	%	0.6
Total	69.0	%	66.3	%	2.7

The estimated total cigarette market increased by 15.2%, or by 3.2% excluding the favorable net impact of estimated trade inventory movements related to the timing of price increases, primarily reflecting improved market conditions and a lower prevalence of illicit trade. The increase in our cigarette shipment volume and market share benefited from the same dynamics as for the total cigarette market.

Financial Review

Net Cash Provided by (Used in) Operating Activities

During the first quarter of 2016, net cash provided by operating activities was $462 million, compared with net cash used of $375 million during the first quarter of 2015. The change was due primarily to favorable currency movements of $751 million, lower cash payments related to asset impairment and exit costs, and lower working capital requirements, partially offset by higher pension plan contributions.

Excluding currency, the favorable movements in working capital were due primarily to the following:


•	less cash used for accrued liabilities and other current assets, primarily due to the timing of payments for excise taxes; mostly offset by


•	less cash provided by inventories, primarily due to stock movements related to tax-driven price increases.

Net Cash Provided by (Used in) Investing Activities

During the first quarter of 2016, net cash used in investing activities was $419 million, compared with net cash provided of $68 million during first quarter of 2015. This change was due principally to cash collateral movements, primarily from derivatives designated as net investment hedges.

Our capital expenditures were $226 million and $203 million during the three months ended March 31, 2016 and 2015, respectively. The 2016 expenditures were primarily related to investments in RRPs, productivity-enhancing programs, and equipment for new products.

Net Cash Provided by (Used in) Financing Activities

During the first quarter of 2016, net cash used in financing activities was $593 million, compared with net cash provided of $525 million during the first quarter of 2015. The change was due primarily to lower cash proceeds from short-term borrowing activity (primarily movement of commercial paper), partially offset by higher proceeds from long-term debt (primarily the $2.0 billion proceeds in the first three months of 2016 from our U.S. dollar debt issuances.)

- 60-

Table of Contents

Dividends paid in the first quarter of 2016 and 2015 were $1,585 million and $1,555 million, respectively. The increase primarily reflects a higher dividend rate in 2016.

Debt and Liquidity

We define cash and cash equivalents as short-term, highly liquid investments, readily convertible to known amounts of cash that mature within a maximum of three months and have an insignificant risk of change in value due to interest rate or credit risk changes. As a policy, we do not hold any investments in structured or equity-linked products. Our cash and cash equivalents are predominantly held in short-term bank deposits with institutions that have investment-grade long-term credit rating.

Credit Ratings – The cost and terms of our financing arrangements as well as our access to commercial paper markets may be affected by applicable credit ratings. On March 21, 2016, Standard & Poor's affirmed our long-term credit rating at "A" and short-term at "A-1," but revised our outlook to "Negative" from "Stable." On July 10, 2015, Fitch affirmed our long-term credit rating at "A" and short-term at "F1," but revised our outlook to "Negative" from "Stable." We do not expect the Standard & Poor's and Fitch negative outlooks to impact our borrowing costs. On August 19, 2015, Moody's affirmed our long-term credit rating at "A2" and short-term at "P-1," as well as our "Stable" outlook. At March 31, 2016, our credit ratings and outlook by major credit rating agencies were as follows:



	Short-term	Long-term	Outlook
Moody’s	P-1	A2	Stable
Standard & Poor’s	A-1	A	Negative
Fitch	F1	A	Negative

Credit Facilities – On January 27, 2016, we entered into an agreement to amend and extend our existing $2.0 billion 364-day revolving credit facility from February 9, 2016 to February 7, 2017. On January 27, 2016, we also entered into an agreement to extend the term of our existing $2.5 billion multi-year revolving credit facility from February 28, 2020 to February 28, 2021.

At March 31, 2016, our committed credit facilities and commercial paper outstanding were as follows:



(in billions)
Type	Committed Credit Facilities		Commercial Paper
364-day revolving credit, expiring February 7, 2017	$	2.0
Multi-year revolving credit, expiring February 28, 2021	2.5
Multi-year revolving credit, expiring October 1, 2020	3.5
Total facilities	$	8.0
Commercial paper outstanding			$	—

At March 31, 2016, there were no borrowings under the committed credit facilities, and the entire committed amounts were available for borrowing.

All banks participating in our committed credit facilities have an investment-grade long-term credit rating from the credit rating agencies. We continuously monitor the credit quality of our banking group, and at this time we are not aware of any potential non-performing credit provider.

Each of these facilities requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“consolidated EBITDA”) to consolidated interest expense of not less than 3.5 to 1.0 on a rolling four-quarter basis. At March 31, 2016, our ratio calculated in accordance with the agreements was 10.2 to 1.0. These facilities do not include any credit rating triggers, material adverse change clauses or any provisions that could require us to post collateral. We expect to continue to meet our covenants. The terms “consolidated EBITDA” and “consolidated interest expense,” both of which include certain adjustments, are defined in the facility agreements previously filed with the U.S. Securities and Exchange Commission.

In addition to the committed credit facilities discussed above, certain of our subsidiaries maintain short-term credit arrangements to meet their respective working capital needs. These credit arrangements, which amounted to approximately $2.6 billion at

- 61-

Table of Contents

March 31, 2016 and $2.9 billion at December 31, 2015, are for the sole use of our subsidiaries. Borrowings under these arrangements amounted to $673 million at March 31, 2016, and $825 million at December 31, 2015.

Commercial Paper Program – We have commercial paper programs in place in the U.S. and in Europe. Our commercial paper programs in place in the U.S. and in Europe currently have an aggregate issuance capacity of $8.0 billion.

At March 31, 2016 and December 31, 2015, we had no commercial paper outstanding.

We expect that the existence of the commercial paper program and the committed credit facilities, coupled with our operating cash flows, will enable us to meet our liquidity requirements.

Sale of Accounts Receivable – To mitigate credit risk and enhance cash and liquidity management we sell trade receivables to unaffiliated financial institutions. These arrangements allow us to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. We sell trade receivables under two types of arrangements, servicing and nonservicing.

PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2016, and March 31, 2015 were $589 million and $108 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows.

For further details, see Note 17. Sale of Accounts Receivable to our condensed consolidated financial statements.

Debt – Our total debt was $29.8 billion at March 31, 2016 and $28.5 billion at December 31, 2015.

On February 21, 2014, we filed a shelf registration statement with the U.S. Securities and Exchange Commission, under which we may from time to time sell debt securities and/or warrants to purchase debt securities over a three-year period.

Our debt issuances in the first three months of 2016 were as follows:



(in millions)
Type		Face Value	Interest Rate		Issuance	Maturity

U.S. dollar notes	^(a)	$500	1.375	%	February 2016	February 2019
U.S. dollar notes	^(a)	$750	1.875	%	February 2016	February 2021
U.S. dollar notes	^(a)	$750	2.750	%	February 2016	February 2026

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2016.

The net proceeds from the sale of the securities listed in the table above will be used for general corporate purposes.

Guarantees – At March 31, 2016, we were contingently liable for $0.7 billion of guarantees of our own performance, which were primarily related to excise taxes on the shipment of our products. There is no liability in the condensed consolidated financial statements associated with these guarantees. At March 31, 2016, our third-party guarantees were insignificant.

Equity and Dividends

In May 2012, our stockholders approved the Philip Morris International Inc. 2012 Performance Incentive Plan (the “2012 Plan”). Under the 2012 Plan, we may grant to eligible employees restricted stock, restricted stock units and deferred stock units (collectively referred to as restricted share units), performance-based cash incentive awards and performance-based equity awards. Up to 30 million shares of our common stock may be issued under the 2012 Plan. At March 31, 2016, shares available for grant under the 2012 Plan were 21,608,980.

- 62-

Table of Contents

As discussed in Note 3. Stock Plans to our condensed consolidated financial statements, during the three months ended March 31, 2016, we granted 1.2 million shares of restricted share units ("RSU") awards to eligible employees at a weighted-average grant date fair value of $89.02 per share. During the same period, we also granted 0.4 million shares of performance share units ("PSU") awards to certain executives.

On August 1, 2012, we began repurchasing shares under a three-year $18.0 billion share repurchase program that was authorized by our Board of Directors in June 2012. From August 1, 2012 through December 31, 2014, we repurchased 144.6 million shares of our common stock at a cost of $12.7 billion under this repurchase program. Our authorized three-year share repurchase program of $18 billion expired in August 2015. During 2015, we did not repurchase any shares under this program. On February 4, 2016, we announced that we do not plan any share repurchases in 2016.

Dividends paid in the first three months of 2016 were $1.6 billion. During the third quarter of 2015, our Board of Directors approved a 2.0% increase in the quarterly dividend to $1.02 per common share. As a result, the present annualized dividend rate is $4.08 per common share.

Market Risk

Counterparty Risk - We predominantly work with financial institutions with strong short- and long-term credit ratings as assigned by Standard & Poor’s and Moody’s. These banks are also part of a defined group of relationship banks. Non-investment grade institutions are only used in certain emerging markets to the extent required by local business needs. We have a conservative approach when it comes to choosing financial counterparties and financial instruments. As such we do not invest or hold investments in any structured or equity-linked products. The majority of our cash and cash equivalents is currently invested in bank deposits maturing within less than 30 days.

We continuously monitor and assess the credit worthiness of all our counterparties.

Derivative Financial Instruments - We operate in markets outside of the United States of America, with manufacturing and sales facilities in various locations throughout the world. Consequently, we use certain financial instruments to manage our foreign currency and interest rate exposure. We use derivative financial instruments principally to reduce our exposure to market risks resulting from fluctuations in foreign exchange rates by creating offsetting exposures. We are not a party to leveraged derivatives and, by policy, do not use derivative financial instruments for speculative purposes.

See Note 6. Financial Instruments, Note 12. Fair Value Measurements, and Note 14. Balance Sheet Offsetting to our condensed consolidated financial statements for further details on our derivative financial instruments and the related collateral arrangements.

Contingencies

See Note 9. Contingencies to our condensed consolidated financial statements for a discussion of contingencies.

Cautionary Factors That May Affect Future Results

Forward-Looking and Cautionary Statements

We may from time to time make written or oral forward-looking statements, including statements contained in filings with the SEC, in reports to stockholders and in press releases and investor webcasts. You can identify these forward-looking statements by use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts.

We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements and whether to invest in or remain invested in our securities. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by us; any such statement is

- 63-

Table of Contents

qualified by reference to the following cautionary statements. We elaborate on these and other risks we face throughout this document, particularly in the “Business Environment” section. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider the following to be a complete discussion of all potential risks or uncertainties. We do not undertake to update any forward-looking statement that we may make from time to time, except in the normal course of our public disclosure obligations.

Risks Related to Our Business and Industry

Consumption of tax-paid cigarettes continues to decline in many of our markets.

This decline is due to multiple factors, including increased taxes and pricing, governmental actions, the diminishing social acceptance of smoking, continuing economic and geopolitical uncertainty, and the continuing prevalence of illicit products. These factors and their potential consequences are discussed more fully below and in the "Business Environment" section.

Cigarettes are subject to substantial taxes. Significant increases in cigarette-related taxes have been proposed or enacted and are likely to continue to be proposed or enacted in numerous jurisdictions. These tax increases may disproportionately affect our profitability and make us less competitive versus certain of our competitors.

Tax regimes, including excise taxes, sales taxes and import duties, can disproportionately affect the retail price of cigarettes versus other tobacco products, or disproportionately affect the relative retail price of our cigarette brands versus cigarette brands manufactured by certain of our competitors. Because our portfolio is weighted toward the premium-price cigarette category, tax regimes based on sales price can place us at a competitive disadvantage in certain markets. As a result, our volume and profitability may be adversely affected in these markets.

Increases in cigarette taxes are expected to continue to have an adverse impact on our sales of cigarettes, due to resulting lower consumption levels, a shift in sales from manufactured cigarettes to other tobacco products and from the premium-price to the mid-price or low-price cigarette categories, where we may be under-represented, from local sales to legal cross-border purchases of lower price products, or to illicit products such as contraband, counterfeit and "illicit whites."

Our business faces significant governmental action aimed at increasing regulatory requirements with the goal of reducing or preventing the use of tobacco products.

Governmental actions, combined with the diminishing social acceptance of smoking and private actions to restrict smoking, have resulted in reduced industry volume in many of our markets, and we expect that such factors will continue to reduce consumption levels and will increase down-trading and the risk of counterfeiting, contraband, "illicit whites" and legal cross-border purchases. Significant regulatory developments will take place over the next few years in most of our markets, driven principally by the FCTC. The FCTC is the first international public health treaty on tobacco, and its objective is to establish a global agenda for tobacco regulation. The FCTC has led to increased efforts by tobacco control advocates and public health organizations to reduce the palatability and attractiveness of tobacco products to adult smokers. Regulatory initiatives that have been proposed, introduced or enacted include:


•	restrictions on or licensing of outlets permitted to sell cigarettes;


•	the levying of substantial and increasing tax and duty charges;


•	restrictions or bans on advertising, marketing and sponsorship;


•	the display of larger health warnings, graphic health warnings and other labeling requirements;


•	restrictions on packaging design, including the use of colors, and plain packaging;


•	restrictions on packaging and cigarette formats and dimensions;


•	restrictions or bans on the display of tobacco product packaging at the point of sale and restrictions or bans on cigarette vending machines;


•	requirements regarding testing, disclosure and performance standards for tar, nicotine, carbon monoxide and other smoke constituents;


•	disclosure, restrictions, or bans of tobacco product ingredients;


•	increased restrictions on smoking in public and work places and, in some instances, in private places and outdoors;


•	restrictions on the sale of potentially reduced-risk tobacco products and other nicotine-containing products;

- 64-

Table of Contents


•	elimination of duty free sales and duty free allowances for travelers; and


•	encouraging litigation against tobacco companies.

Our operating income could be significantly affected by regulatory initiatives resulting in a significant decrease in demand for our brands, in particular requirements that lead to a commoditization of tobacco products, as well as any significant increase in the cost of complying with new regulatory requirements.

Litigation related to tobacco use and exposure to environmental tobacco smoke could substantially reduce our profitability and could severely impair our liquidity.

There is litigation related to tobacco products pending in certain jurisdictions. Damages claimed in some tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. We anticipate that new cases will continue to be filed. The FCTC encourages litigation against tobacco product manufacturers. It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Please see Note 9. Contingencies to our condensed consolidated financial statements for a discussion of pending litigation.

We face intense competition, and our failure to compete effectively could have a material adverse effect on our profitability and results of operations.

We compete primarily on the basis of product quality, brand recognition, brand loyalty, taste, innovation, packaging, service, marketing, advertising and price. We are subject to highly competitive conditions in all aspects of our business. The competitive environment and our competitive position can be significantly influenced by weak economic conditions, erosion of consumer confidence, competitors' introduction of lower-price products or innovative products, higher tobacco product taxes, higher absolute prices and larger gaps between retail price categories, and product regulation that diminishes the ability to differentiate tobacco products. Competitors include three large international tobacco companies and several regional and local tobacco companies and, in some instances, state-owned tobacco enterprises, principally in Algeria, the People's Republic of China, Egypt, Taiwan, Thailand and Vietnam. Industry consolidation and privatizations of state-owned enterprises have led to an overall increase in competitive pressures. Some competitors have different profit and volume objectives and some international competitors are susceptible to changes in different currency exchange rates.

Because we have operations in numerous countries, our results may be influenced by economic, regulatory and political developments, natural disasters or conflicts.

Some of the countries in which we operate face the threat of civil unrest and can be subject to regime changes. In others, nationalization, terrorism, conflict and the threat of war may have a significant impact on the business environment. Economic, political, regulatory or other developments or natural disasters could disrupt our supply chain, manufacturing capabilities or distribution capabilities. In addition, such developments could lead to loss of property or equipment that are critical to our business in certain markets and difficulty in staffing and managing our operations, which could reduce our volumes, revenues and net earnings.

There is an increasing number of conflicts, including in the Middle East and Ukraine. Political uncertainty, including potential effects from economic sanctions by the U.S. or other governments, could lead to significant disruptions to our business.

In certain markets, we are dependent on governmental approvals of various actions such as price changes, and failure to obtain such approvals could impair growth in our profitability.

In addition, despite our high ethical standards and rigorous control and compliance procedures aimed at preventing and detecting unlawful conduct, given the breadth and scope of our international operations, we may not be able to detect all potential improper or unlawful conduct by our employees and international partners.

We may be unable to anticipate changes in consumer preferences or to respond to consumer behavior influenced by economic downturns.

Our tobacco business is subject to changes in consumer preferences, which may be influenced by local economic conditions. To be successful, we must:


•	promote brand equity successfully;


•	anticipate and respond to new consumer trends;


•	develop new products and markets and broaden brand portfolios;

- 65-

Table of Contents


•	improve productivity; and


•	be able to protect or enhance margins through price increases.

In periods of economic uncertainty, consumers may tend to purchase lower-price brands, and the volume of our premium-price and mid-price brands and our profitability could suffer accordingly. Such down-trading trends may be reinforced by regulation that limits branding, communication and product differentiation.

We lose revenues as a result of counterfeiting, contraband, cross-border purchases and non-tax-paid volume produced by local manufacturers.

Large quantities of counterfeit cigarettes are sold in the international market. We believe that Marlboro is the most heavily counterfeited international cigarette brand, although we cannot quantify the revenues we lose as a result of this activity. In addition, our revenues are reduced by contraband, legal cross-border purchases and non-tax-paid volume produced by local manufacturers.

From time to time, we are subject to governmental investigations on a range of matters.

Investigations include allegations of contraband shipments of cigarettes, allegations of unlawful pricing activities within certain markets, allegations of underpayment of customs duties and/or excise taxes, allegations of false and misleading usage of descriptors and allegations of unlawful advertising. We cannot predict the outcome of those investigations or whether additional investigations may be commenced, and it is possible that our business could be materially affected by an unfavorable outcome of pending or future investigations. See “Management's Discussion and Analysis of Financial Condition and Results of Operations-Operating Results by Business Segment-Business Environment-Governmental Investigations” for a description of certain governmental investigations to which we are subject.

We may be unsuccessful in our attempts to introduce Reduced-Risk Products, and regulators may not permit reduced exposure or risk claims or the commercialization of these products.

We continue to seek ways to develop commercially viable new product technologies with the potential to reduce exposure to harmful constituents in smoke and individual risk and population harm, all in comparison to smoking cigarettes. Our goal is to develop and commercialize products whose potential to reduce exposure to harmful and potentially harmful constituents, individual risk and population harm can be substantiated by rigorous scientific studies and that provide adult smokers the taste, sensory experience, nicotine delivery profile and ritual characteristics that are similar to those currently provided by cigarettes. We may not succeed in these efforts. If we do not succeed, but others do, we may be at a competitive disadvantage. Furthermore, we cannot predict whether regulators will permit the marketing of tobacco products or other nicotine-containing products with claims of reduced exposure or risk as compared with smoking cigarettes. A prohibition on any such claims could significantly undermine the commercial viability of these products.

Our reported results could be adversely affected by unfavorable currency exchange rates, and currency devaluations could impair our competitiveness.

We conduct our business primarily in local currency and, for purposes of financial reporting, the local currency results are translated into U.S. dollars based on average exchange rates prevailing during a reporting period. During times of a strengthening U.S. dollar, our reported net revenues and operating income will be reduced because the local currency translates into fewer U.S. dollars. During periods of local economic crises, foreign currencies may be devalued significantly against the U.S. dollar, reducing our margins. Actions to recover margins may result in lower volume and a weaker competitive position.

The repatriation of our foreign earnings, changes in the earnings mix, and changes in U.S. tax laws may increase our effective tax rate. Our ability to receive payments from foreign subsidiaries or to repatriate royalties and dividends could be restricted by local country currency exchange controls.

Because we are a U.S. holding company, our most significant source of funds is distributions from our non-U.S. subsidiaries. Under current U.S. tax law, in general we do not pay U.S. taxes on our foreign earnings until they are repatriated to the U.S. as distributions from our non-U.S. subsidiaries. These distributions may result in a residual U.S. tax cost. It may be advantageous to us in certain circumstances to significantly increase the amount of such distributions, which could result in a material increase in our overall effective tax rate. Additionally, the Obama Administration has indicated that it favors changes in U.S. tax law that would fundamentally change how our earnings are taxed in the U.S. If enacted and depending upon its precise terms, such legislation could increase our overall effective tax rate. Certain countries in which we operate have adopted or could institute currency exchange controls that limit or prohibit our local subsidiaries' ability to convert local currency into U.S. dollars or to make payments outside the country. This could subject us to the risks of local currency devaluation and business disruption.

- 66-

Table of Contents

Our ability to grow profitability may be limited by our inability to introduce new products, enter new markets or improve our margins through higher pricing and improvements in our brand and geographic mix.

Our profit growth may suffer if we are unable to introduce new products or enter new markets successfully, to raise prices or to improve the proportion of our sales of higher margin products and in higher margin geographies.

We may be unable to expand our brand portfolio through successful acquisitions or the development of strategic business relationships.

One element of our growth strategy is to strengthen our brand portfolio and market positions through selective acquisitions and the development of strategic business relationships. Acquisition and strategic business development opportunities are limited and present risks of failing to achieve efficient and effective integration, strategic objectives and anticipated revenue improvements and cost savings. There is no assurance that we will be able to acquire attractive businesses on favorable terms, or that future acquisitions or strategic business developments will be accretive to earnings.

Government mandated prices, production control programs, shifts in crops driven by economic conditions and the impact of climate change may increase the cost or reduce the quality of the tobacco and other agricultural products used to manufacture our products.

As with other agricultural commodities, the price of tobacco leaf and cloves can be influenced by imbalances in supply and demand, and crop quality can be influenced by variations in weather patterns, including those caused by climate change. Tobacco production in certain countries is subject to a variety of controls, including government mandated prices and production control programs. Changes in the patterns of demand for agricultural products could cause farmers to plant less tobacco. Any significant change in tobacco leaf and clove prices, quality and quantity could affect our profitability and our business.

Our ability to implement our strategy of attracting and retaining the best global talent may be impaired by the decreasing social acceptance of cigarette smoking.

The tobacco industry competes for talent with consumer products and other companies that enjoy greater societal acceptance. As a result, we may be unable to attract and retain the best global talent.

The failure of our information systems to function as intended or their penetration by outside parties with the intent to corrupt them could result in business disruption, litigation and regulatory action, and loss of revenue, assets or personal or other sensitive data.

We use information systems to help manage business processes, collect and interpret business data and communicate internally and externally with employees, suppliers, customers and others. Some of these information systems are managed by third-party service providers. We have backup systems and business continuity plans in place, and we take care to protect our systems and data from unauthorized access. Nevertheless, failure of our systems to function as intended, or penetration of our systems by outside parties intent on extracting or corrupting information or otherwise disrupting business processes, could result in loss of revenue, assets or personal or other sensitive data, litigation and regulatory action, cause damage to our reputation and that of our brands and result in significant remediation and other costs to us.

We may be required to replace third-party contract manufacturers or service providers with our own resources.

In certain instances, we contract with third parties to manufacture some of our products or product parts or to provide other services. We may be unable to renew these agreements on satisfactory terms for numerous reasons, including government regulations. Accordingly, our costs may increase significantly if we must replace such third parties with our own resources.

- 67-

Table of Contents

Item 4. Controls and Procedures.

PMI carried out an evaluation, with the participation of PMI’s management, including PMI’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of PMI’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, PMI’s Chief Executive Officer and Chief Financial Officer concluded that PMI’s disclosure controls and procedures are effective. There have been no changes in PMI’s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, PMI’s internal control over financial reporting.

- 68-

Table of Contents

Part II - OTHER INFORMATION


Item 1.	Legal Proceedings.

See Note 9. Contingencies of the Notes to the Condensed Consolidated Financial Statements included in Part I – Item 1 of this report for a discussion of legal proceedings pending against Philip Morris International Inc. and its subsidiaries.


Item 1A.	Risk Factors.

Information regarding Risk Factors appears in “MD&A – Cautionary Factors That May Affect Future Results,” in Part I – Item 2 of this Form 10-Q and in Part I – Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2015. There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K.

- 69-

Table of Contents


Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.

Our share repurchase activity for each of the three months in the quarter ended March 31, 2016 was as follows:



Period	Total Number of Shares Repurchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
January 1, 2016 – January 31, 2016 (1)	—	$	—	—	$	—
February 1, 2016 – February 29, 2016 (1)	—	$	—	—	$	—
March 1, 2016 – March 31, 2016 (1)	—	$	—	—	$	—
Pursuant to Publicly Announced Plans or Programs	—	$	—
January 1, 2016 – January 31, 2016 (3)	807	$	87.64
February 1, 2016 – February 29, 2016 (3)	231,729	$	90.98
March 1, 2016 – March 31, 2016 (3)	3,286	$	92.84
For the Quarter Ended March 31, 2016	235,822	$	90.99


(1)	Our authorized three-year share repurchase program of $18 billion expired in August 2015. During this reporting period, we did not have an authorized share repurchase program.


(2)	Aggregate number of shares repurchased under the above-mentioned share repurchase program as of the end of the period presented.


(3)	Shares repurchased represent shares tendered to us by employees who vested in deferred stock awards and used shares to pay all, or a portion of, the related taxes.

- 70-

Table of Contents


Item 6.	Exhibits.




3.1		Amended and Restated By-Laws of Philip Morris International Inc., effective as of September 16, 2015 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed September 18, 2015).

10.1		Amendment No. 2 to the Credit Agreement, effective February 9, 2016, among Philip Morris International Inc., the lenders named therein and Citibank Europe PLC, UK Branch, as administrative agent (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed January 28, 2016).

10.2		Form of Extension Agreement, effective February 28, 2016, among Philip Morris International Inc., each lender named therein, J.P. Morgan Europe Limited, as facility agent, and JPMorgan Chase Bank, N.A., as swingline agent (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed January 28, 2016).

10.3		Form of Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed February 9, 2016).

10.4		Form of Performance Share Unit Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed February 9, 2016).

12		Statement regarding computation of ratios of earnings to fixed charges.

31.1		Certification of the Registrant's Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of the Registrant's Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of the Registrant's Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of the Registrant's Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document.

101.SCH		XBRL Taxonomy Extension Schema.

101.CAL		XBRL Taxonomy Extension Calculation Linkbase.

101.DEF		XBRL Taxonomy Extension Definition Linkbase.

101.LAB		XBRL Taxonomy Extension Label Linkbase.

101.PRE		XBRL Taxonomy Extension Presentation Linkbase.

- 71-

Table of Contents

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

PHILIP MORRIS INTERNATIONAL INC.

/s/ JACEK OLCZAK

Jacek Olczak

Chief Financial Officer

April 26, 2016

- 72-

EX-12 2 pm-ex12_33116xq1.htm STATEMENT REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES Exhibit

Exhibit 12

PHILIP MORRIS INTERNATIONAL INC. AND SUBSIDIARIES

Computation of Ratios of Earnings to Fixed Charges

(in millions of dollars)



	Three Months Ended March 31, 2016
Earnings before income taxes	$	2,226
Add (deduct):
Dividends from less than 50% owned affiliates	—
Fixed charges	305
Interest capitalized, net of amortization	—
Earnings available for fixed charges	$	2,531
Fixed charges:
Interest incurred	$	281
Portion of rent expense deemed to represent interest factor	24
Fixed charges	$	305
Ratio of earnings to fixed charges	8.3

- 1 -

Exhibit 12

PHILIP MORRIS INTERNATIONAL INC. AND SUBSIDIARIES

Computation of Ratios of Earnings to Fixed Charges

(in millions of dollars)



	For the Years Ended December 31,
	2015			2014		2013		2012		2011
Earnings before income taxes	$	9,615		$	10,650	$	12,542	$	13,004	$	12,542
Add (deduct):
Dividends from less than 50% owned affiliates	127			107		1		—		—
Fixed charges	1,232			1,284		1,216		1,115		1,042
Interest capitalized, net of amortization	(3		)	1		4		2		(2		)
Earnings available for fixed charges	$	10,971		$	12,042	$	13,763	$	14,121	$	13,582
Fixed charges:
Interest incurred	$	1,137		$	1,172	$	1,105	$	1,009	$	940
Portion of rent expense deemed to represent interest factor	95			112		111		106		102
Fixed charges	$	1,232		$	1,284	$	1,216	$	1,115	$	1,042
Ratio of earnings to fixed charges	8.9			9.4		11.3		12.7		13.0

- 2 -

EX-31.1 3 pm-ex311_33116xq1.htm CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)/15D-14(A) Exhibit

Exhibit 31.1

Certifications

I, André Calantzopoulos, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 26, 2016

/s/ ANDRÉ CALANTZOPOULOS

André Calantzopoulos

Chief Executive Officer

-1-

EX-31.2 4 pm-ex312_33116xq1.htm CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)/15D-14(A) Exhibit

Exhibit 31.2

Certifications

I, Jacek Olczak, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 26, 2016

/s/ JACEK OLCZAK

Jacek Olczak

Chief Financial Officer

- 1 -

EX-32.1 5 pm-ex321_33116xq1.htm CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. 1350 Exhibit

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, André Calantzopoulos, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ ANDRÉ CALANTZOPOULOS

André Calantzopoulos

Chief Executive Officer

April 26, 2016

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Philip Morris International Inc. and will be retained by Philip Morris International Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

-1-

EX-32.2 6 pm-ex322_33116xq1.htm CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. 1350 Exhibit

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jacek Olczak, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JACEK OLCZAK

Jacek Olczak

Chief Financial Officer

April 26, 2016

-1-

EX-101.INS 7 pm-20160331.xml XBRL INSTANCE DOCUMENT 0001413329 2016-01-01 2016-03-31 0001413329 2016-04-22 0001413329 2016-03-31 0001413329 2015-12-31 0001413329 2015-01-01 2015-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-03-31 0001413329 2015-03-31 0001413329 us-gaap:TreasuryStockMember 2016-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2015-03-31 0001413329 us-gaap:TreasuryStockMember 2014-12-31 0001413329 us-gaap:CommonStockMember 2015-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-03-31 0001413329 us-gaap:RetainedEarningsMember 2015-01-01 2015-03-31 0001413329 us-gaap:RetainedEarningsMember 2016-01-01 2016-03-31 0001413329 us-gaap:TreasuryStockMember 2015-01-01 2015-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2016-03-31 0001413329 us-gaap:RetainedEarningsMember 2016-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2014-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001413329 us-gaap:TreasuryStockMember 2016-01-01 2016-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2015-03-31 0001413329 us-gaap:RetainedEarningsMember 2015-03-31 0001413329 2014-12-31 0001413329 us-gaap:CommonStockMember 2014-12-31 0001413329 us-gaap:RetainedEarningsMember 2014-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2016-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-03-31 0001413329 us-gaap:TreasuryStockMember 2015-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2015-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-03-31 0001413329 us-gaap:TreasuryStockMember 2015-03-31 0001413329 us-gaap:CommonStockMember 2016-03-31 0001413329 us-gaap:RetainedEarningsMember 2015-12-31 0001413329 us-gaap:CommonStockMember 2015-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0001413329 pm:GrantDateFairValueMember us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001413329 us-gaap:PerformanceSharesMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001413329 pm:PerformanceShareUnitsTSRRelativeToCustomerPeerGroupMember 2016-01-01 2016-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0001413329 pm:A2008NonEmployeeDirectorsPlanMember 2016-01-01 2016-03-31 0001413329 pm:A2012PerformanceIncentivePlanMember 2012-05-31 0001413329 us-gaap:PerformanceSharesMember 2016-01-01 2016-03-31 0001413329 pm:A2008NonEmployeeDirectorsPlanMember 2016-03-31 0001413329 us-gaap:PerformanceSharesMember 2016-03-31 0001413329 pm:A2008NonEmployeeDirectorsPlanMember 2008-12-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001413329 pm:FairValueMember us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001413329 us-gaap:PerformanceSharesMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001413329 pm:A2012PerformanceIncentivePlanMember 2016-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2016-03-31 0001413329 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignPensionPlansDefinedBenefitMember 2016-01-01 2016-03-31 0001413329 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-01-01 2015-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember 2016-03-31 0001413329 us-gaap:DistributionRightsMember 2016-03-31 0001413329 us-gaap:TrademarksMember 2016-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2015-12-31 0001413329 us-gaap:AsiaMember 2015-12-31 0001413329 us-gaap:AsiaMember 2016-01-01 2016-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2016-01-01 2016-03-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2016-01-01 2016-03-31 0001413329 us-gaap:AsiaMember 2016-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2016-03-31 0001413329 us-gaap:EuropeanUnionMember 2016-03-31 0001413329 us-gaap:EuropeanUnionMember 2016-01-01 2016-03-31 0001413329 us-gaap:EuropeanUnionMember 2015-12-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2015-12-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2016-03-31 0001413329 us-gaap:TrademarksMember 2016-01-01 2016-03-31 0001413329 us-gaap:TrademarksMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember 2016-01-01 2016-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001413329 us-gaap:DistributionRightsMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001413329 us-gaap:DistributionRightsMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001413329 us-gaap:TrademarksMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001413329 us-gaap:DistributionRightsMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2014-12-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2015-12-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2016-03-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-03-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001413329 us-gaap:ForeignExchangeContractMember 2015-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-03-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-03-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember pm:MarketingAdministrationAndResearchCostsMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember pm:MarketingAdministrationAndResearchCostsMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2015-01-01 2015-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:EuropeanUnionMember 2015-01-01 2015-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:LatinAmericaAndCanadaMember 2015-01-01 2015-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:EuropeanUnionMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:AsiaMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2015-01-01 2015-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:AsiaMember 2015-01-01 2015-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:LatinAmericaAndCanadaMember 2016-01-01 2016-03-31 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:CA 2016-01-01 2016-03-31 0001413329 pm:RothmansBensonHedgesInc.andImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:UnderAdvisementMember country:CA 2015-08-01 2015-08-31 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:PendingLitigationMember country:CA 2015-06-01 2015-06-30 0001413329 pm:AdamsMember us-gaap:PendingLitigationMember country:CA 2009-07-10 2009-07-10 0001413329 pm:TheAttorneyGeneralOfOvoStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2007-05-25 2007-05-25 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CA us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:TheAttorneyGeneralOfKanoStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2007-05-09 2007-05-09 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualLightsCasesMember country:CL us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:PublicCivilActionsMember 2015-04-30 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA 2015-10-01 2015-10-30 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember us-gaap:PendingLitigationMember pm:OtherLitigationMember country:TH 2016-01-18 2016-01-18 0001413329 pm:IndividualLightsCasesMember 2014-05-01 0001413329 pm:PublicCivilActionsMember us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:ImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA 2015-10-01 2015-10-30 0001413329 pm:IndividualLightsCasesMember country:IT us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember pm:AppellateRulingMember country:CA 2015-07-01 2015-07-31 0001413329 pm:HealthCareCostRecoveryActionsMember 2014-05-01 0001413329 pm:HealthCareCostRecoveryActionsMember us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:CasesRemainingOnAppealMember 2016-03-31 0001413329 pm:IndividualSmokingAndHealthCasesMember country:IT us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:TheAttorneyGeneralOfOgunStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-02-26 2008-02-26 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualSmokingAndHealthCasesMember pm:ScotlandMember us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:PublicCivilActionsMember country:AR us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember country:CA 2015-10-01 2015-10-30 0001413329 pm:SmokingAndHealthClassActionsMember country:BR us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:HealthCareCostRecoveryActionsMember 2015-04-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember country:CA 2015-12-01 2015-12-31 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:SmokingAndHealthClassActionsMember 2004-04-30 0001413329 pm:FoundationfortheDefenseofCitizensagainstAbusesoftheStateFACIASMember us-gaap:PendingLitigationMember pm:PublicCivilActionsMember country:RO 2015-11-20 2015-11-20 0001413329 pm:SmokingAndHealthClassActionsMember country:CA us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:IndividualSmokingAndHealthCasesMember us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:IndividualSmokingAndHealthCasesMember 2015-04-30 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:AwardpersmokerperyearMember pm:SmokingAndHealthClassActionsMember 2004-04-01 2004-04-30 0001413329 pm:TheAttorneyGeneralOfLagosStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-03-13 2008-03-13 0001413329 pm:HealthCareCostRecoveryActionsMember country:CA us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CR us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:CeciliaLetourneauMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualLightsCasesMember us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:ImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember country:CA 2015-10-01 2015-10-30 0001413329 pm:IndividualSmokingAndHealthCasesMember 2014-05-01 0001413329 pm:TheAttorneyGeneralOfGombeStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-10-17 2008-10-17 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CL us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:HealthCareCostRecoveryActionsMember country:KR 2014-04-14 2014-04-14 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember country:CA 2015-05-27 2015-05-27 0001413329 pm:CaseDecidedInFavorOfPlaintiffMember 2016-03-31 0001413329 pm:IndividualLightsCasesMember 2015-04-30 0001413329 pm:HealthCareCostRecoveryActionsMember country:NG us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:IndividualSmokingAndHealthCasesMember country:AR us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember country:CA 2015-06-01 2015-06-30 0001413329 pm:PublicCivilActionsMember 2014-05-01 0001413329 pm:IndividualSmokingAndHealthCasesMember country:PH us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:HealthCareCostRecoveryActionsMember country:KR us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:IndividualSmokingAndHealthCasesMember country:BR us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:SuzanneJacklinMember us-gaap:PendingLitigationMember country:CA 2012-06-20 2012-06-20 0001413329 pm:PublicCivilActionsMember country:VE us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:PublicCivilActionsMember country:RO us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:SmokingAndHealthClassActionsMember 2014-05-01 0001413329 pm:SmokingAndHealthClassActionsMember 2015-04-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember pm:AppellateRulingMember country:CA 2015-07-01 2015-07-31 0001413329 pm:SmokingAndHealthClassActionsMember us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:CeciliaLetourneauMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:CA 2016-01-01 2016-03-31 0001413329 pm:LightsClassActionsMember 2015-04-30 0001413329 pm:LightsClassActionsMember us-gaap:SubsequentEventMember 2016-04-22 0001413329 pm:LightsClassActionsMember 2014-05-01 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:BR 2016-01-01 2016-03-31 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:AwardpersmokerperyearMember pm:SmokingAndHealthClassActionsMember country:BR 2004-04-01 2004-04-30 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:SmokingAndHealthClassActionsMember country:BR 2004-04-30 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember pm:SmokingAndHealthClassActionsMember country:CA 2015-06-01 2015-06-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-10-01 2015-10-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:PendingLitigationMember pm:SmokingAndHealthClassActionsMember country:CA 2015-06-01 2015-06-30 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 us-gaap:ScenarioForecastMember 2016-01-01 2016-12-31 0001413329 country:US 2016-01-01 2016-03-31 0001413329 pm:MultiYearRevolvingCreditExpiringFebruaryTwentyEighthTwoThousandTwentyOneMember 2016-03-31 0001413329 pm:MultiYearRevolvingCreditExpiringOctoberFirstTwoThousandTwentyMemberDomain 2016-03-31 0001413329 pm:RevolvingCreditExpiringFebruaryNinthTwoThousandSeventeenMember 2016-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2015-12-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2016-03-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2015-12-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2016-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2016-03-31 0001413329 pm:UsDollarNotesMember 2016-03-31 0001413329 pm:UsDollarNotesMember 2015-12-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2015-12-31 0001413329 pm:MultiYearRevolvingCreditExpiringFebruaryTwentyEighthTwoThousandTwentyOneMember 2016-01-27 0001413329 pm:RevolvingCreditExpiringFebruaryNinthTwoThousandSeventeenMember 2016-01-27 0001413329 pm:OnePointEightSevenFivePercentUSDollarNotesDueFebruary2021Member pm:UsDollarNotesMember 2016-03-31 0001413329 pm:OnePointThreeSevenFivePercentUSDollarNotesDueFebruary2019Member pm:UsDollarNotesMember 2016-01-01 2016-03-31 0001413329 pm:TwoPointSevenFivePercentUSDollarNotesDueFebruary2026Member pm:UsDollarNotesMember 2016-01-01 2016-03-31 0001413329 pm:TwoPointSevenFivePercentUSDollarNotesDueFebruary2026Member pm:UsDollarNotesMember 2016-03-31 0001413329 pm:OnePointEightSevenFivePercentUSDollarNotesDueFebruary2021Member pm:UsDollarNotesMember 2016-01-01 2016-03-31 0001413329 pm:OnePointThreeSevenFivePercentUSDollarNotesDueFebruary2019Member pm:UsDollarNotesMember 2016-03-31 0001413329 pm:UsDollarNotesMember 2016-01-01 2016-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2016-01-01 2016-03-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2016-01-01 2016-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2016-01-01 2016-03-31 0001413329 us-gaap:FairValueInputsLevel2Member 2016-03-31 0001413329 us-gaap:FairValueInputsLevel3Member 2016-03-31 0001413329 us-gaap:FairValueInputsLevel1Member 2016-03-31 0001413329 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-03-31 0001413329 us-gaap:EquityMethodInvestmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2015-03-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:EquityMethodInvestmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2016-03-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:EquityMethodInvestmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2015-03-31 0001413329 us-gaap:EquityMethodInvestmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2016-03-31 0001413329 us-gaap:EquityMethodInvestmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2016-01-01 2016-03-31 0001413329 us-gaap:EquityMethodInvestmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2015-01-01 2015-03-31 0001413329 us-gaap:CorporateJointVentureMember pm:EITAOwnershipPercentageinSocitdesTabacsAlgroEmiratieSTAEMMember 2016-03-31 0001413329 us-gaap:MaximumMember us-gaap:EquityMethodInvestmentsMember 2016-01-01 2016-03-31 0001413329 pm:MegapolisMember 2013-12-31 0001413329 pm:STAEMMember 2016-03-31 0001413329 us-gaap:EquityMethodInvestmentsMember 2016-03-31 0001413329 us-gaap:MinimumMember us-gaap:EquityMethodInvestmentsMember 2016-01-01 2016-03-31 0001413329 us-gaap:CorporateJointVentureMember pm:SocieteNationaledesTabacsetAllumettesSpAOwnershipPercentageinSocitdesTabacsAlgroEmiratieSTAEMMember 2016-03-31 0001413329 pm:EquityMethodInvestmentGoodwillMember 2015-12-31 0001413329 pm:EITAMember 2016-03-31 0001413329 2015-01-01 2015-12-31 0001413329 us-gaap:EquityMethodInvestmentsMember 2015-12-31 0001413329 pm:MegapolisMember 2013-01-01 2013-12-31 0001413329 pm:EquityMethodInvestmentGoodwillMember 2016-03-31 0001413329 pm:GrupoCarsoMember us-gaap:AffiliatedEntityMember country:MX 2013-09-01 2013-09-30 0001413329 pm:PTHMSampoernaTbkMember country:ID 2015-10-26 2015-10-26 0001413329 pm:PTHMSampoernaTbkMember country:ID 2015-09-30 0001413329 pm:GrupoCarsoMember country:MX 2013-09-01 2013-09-30 0001413329 pm:NicocigsLimitedMember country:GB 2014-06-01 2014-06-30 0001413329 pm:GrupoCarsoMember us-gaap:AffiliatedEntityMember country:MX 2015-05-01 2015-05-31 0001413329 pm:PTHMSampoernaTbkMember country:ID 2015-09-30 2015-09-30 0001413329 pm:NicocigsLimitedMember country:GB 2014-06-30 0001413329 pm:GrupoCarsoMember country:MX 2013-09-30 0001413329 pm:PTHMSampoernaTbkMember country:ID 2015-06-01 2015-06-30 0001413329 pm:GrupoCarsoMember us-gaap:AffiliatedEntityMember country:MX 2013-09-30 0001413329 pm:GrupoCarsoMember country:MX 2014-03-01 2014-03-31 iso4217:BRL xbrli:pure iso4217:CAD pm:cigarette pm:import_entry xbrli:shares pm:manufacturer iso4217:USD xbrli:shares iso4217:THB pm:performance_metric pm:litigation_case pm:plaintiff pm:defendant pm:patient pm:year pm:installment iso4217:USD iso4217:IDR xbrli:shares false --12-31 Q1 2016 2016-03-31 10-Q 0001413329 1551264326 Large Accelerated Filer Philip Morris International Inc. 25300000000 3700000000 7200000000 14400000000 590000000 -160000000 -14000000 P3Y 15 2 65 1 2 11 16 2 61 0 2 11 10 1 5 16 2 1 3 31 20 2 8 2 1 1 1 66 0 1 1 1 3 2 9 11 100000000 P3Y P4Y May 27, 2015 May 27, 2015 February 2004 P20Y P3Y 86000000 2327000000 922000000 2640000000 3034000000 100000000 12 3 9 444 200000000 158000000 789000000 1000000000 1000000000 789000000 158000000 200000000 158000000 200000000 P60D P60D 12200000000 15500000000 15500000000 12200000000 2400000000 3100000000 3100000000 2400000000 P60D 0.2 0.2 P60D P60D P60D P60D P60D 46000000 36300000 103000000 131000000 103000000 131000000 71000 90000 90000 71000 36300000 46000000 36000000 46000000 30000 23700 30000 23700 0.01 P20Y P20Y P20Y P20Y P20Y 3484 P20Y P20Y P20Y P20Y P20Y 0.01 918000 99957 5000000000 3900000000 85000000 108000000 37600000 29700000 29700000 37600000 758000000 598000000 178000000 226000000 178000000 226000000 2 2 7 6 272 P3Y 25000 25000 In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.) In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $178 million). A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.) Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending. 1494000000 1496000000 58 1788000000 1525000000 0.5 2012 and onward 866000000 230000000 934000000 927000000 633000000 229000000 778000000 906000000 0 3000000 P2Y 3 0.01349 P3Y 1 0.01 0.01 1 29106000000 300000000 1900000000 108000000 589000000

1289000000

1496000000

2778000000

2989000000

64000000

319000000

970000000

576000000

640000000

536000000

6046000000

6337000000

123000000

121000000

59000000

-10000000

2964000000

3332000000

3287000000

-5247000000

-6129000000

-5617000000

-8090000000

-9402000000

-8914000000

P10Y

P11Y

P21Y

1929000000

1874000000

-559000000

1100000000

58000000

12000000

41000000

58000000

22000000

18000000

33956000000

34621000000

15804000000

15928000000

511000000

77000000

14000000

1682000000

1524000000

3417000000

2944000000

-158000000

-473000000

1.00

1.02

2109316331

531000000

2018000000

14000000

101000000

545000000

2119000000

2229000000

2096000000

750000000

500000000

750000000

31432000000

480000000

31912000000

0.02433

0.01217

0.03612

0.03126

0.01875

0.01375

0.0275

0.03125

0.02

0.06375

0.01750

0.0075

0.01125

2016-02-01

2021-02-28

2019-02-28

2026-02-28

2033

2024

2044

2024

132000000

10000000

488000000

485000000

206000000

91000000

1543000000

1378000000

-46000000

-3000000

-44000000

-1000000

1000000

52000000

83000000

4000000

81000000

3000000

36000000

5000000

31000000

4000000

51000000

5000000

45000000

4000000

51000000

1000000

50000000

1000000

59000000

192000000

175000000

131000000

209000000

574000000

511000000

432000000

273000000

30000000

63000000

181000000

85000000

301000000

7000000

574000000

149000000

63000000

199000000

100000000

511000000

11000000

29000000

26000000

29000000

117000000

172000000

33000000

30000000

228000000

8000000

299000000

11000000

27000000

P021M

-27000000

30000000

7000000

-7000000

30000000

27000000

4000000

14000000

-17000000

5000000

7000000

-7000000

6000000

25000000

313000000

27000000

286000000

25000000

-79000000

-197000000

-62000000

-276000000

172000000

299000000

131000000

209000000

38000000

1555000000

1587000000

1589000000

1591000000

38000000

1.16

0.98

1.16

0.98

-376000000

77000000

0.302

0.283

0.28

903000000

735000000

29000000

198000000

806000000

824000000

127000000

0.20

0.51

0.49

0.25

10736000000

10705000000

P17Y

P4Y

P30Y

P5Y

P40Y

P2Y

513000000

545000000

73000000

1609000000

1650000000

88000000

153000000

1409000000

-8000000

-751000000

91000000

41000000

46000000

7415000000

374000000

2150000000

3581000000

1310000000

7683000000

381000000

2248000000

3705000000

1349000000

268000000

7000000

98000000

124000000

39000000

4387000000

3987000000

2596000000

2226000000

23000000

9000000

785000000

630000000

58000000

44000000

223000000

-535000000

-485000000

-393000000

-49000000

-7000000

-48000000

-54000000

175000000

1527000000

1559000000

3136000000

3209000000

2623000000

201000000

819000000

1087000000

516000000

2664000000

202000000

830000000

1118000000

514000000

-275000000

-247000000

4220000000

4050000000

8473000000

8699000000

1613000000

1615000000

890000000

744000000

942000000

765000000

45432000000

45515000000

33956000000

34621000000

15386000000

14091000000

31432000000

779000000

32211000000

8000000000

2500000000

3500000000

2000000000

2500000000.0

2000000000

25250000000

26683000000

2405000000

2437000000

27655000000

7423000000

1690000000

18091000000

451000000

29120000000

6844000000

1737000000

20079000000

460000000

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36.3 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.2 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion, into a trust within 60 days.

The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.

1000

280

1000

53700000

80800000000

2300000000

8000000

2024-05-31

1768000000

1859000000

70000000

12000000

0.20

525000000

-593000000

68000000

-419000000

-375000000

462000000

1795000000

1530000000

39000000

75000000

100000000

102000000

2871000000

2473000000

1438000000

1387000000

648000000

811000000

1503000000

1539000000

-1343000000

835000000

-267000000

538000000

434000000

-162000000

-1289000000

-1264000000

-25000000

514000000

488000000

26000000

10000000

-56000000

-55000000

3000000

-1000000

12000000

8000000

2000000

-17000000

687000000

761000000

7000000

5000000

-279000000

186000000

48000000

160000000

14000000

1555000000

1585000000

703000000

103000000

760000000

8000000

7000000

203000000

226000000

2566000000

2602000000

9000000

52000000

302000000

1978000000

-25000000

-29000000

113000000

6000000

2237000000

-136000000

13000000

1834000000

39000000

1795000000

1605000000

75000000

1530000000

11767000000

12202000000

5721000000

5865000000

-100000000

399000000

827000000

54000000

42000000

2000000

29842000000

29785000000

896000000

777000000

1500000000

264209711

0.9818

77000

5121000000

4569000000

17352000000

4147000000

2219000000

4764000000

6222000000

3997000000

1959000000

4689000000

6143000000

16788000000

P3Y

1500000

400000

1200000

82.28

104.60

89.02

2100000

196000000

190000000

1000000

30000000

691432

21608980

2.00

0.00

825000000

673000000

37000000

-97000000

134000000

59000000

-56000000

115000000

-13244000000

-12753000000

22369000000

22745000000

-11203000000

-6826000000

710000000

1426000000

29249000000

-35762000000

-12246000000

-8090000000

613000000

1370000000

29489000000

-35628000000

-11476000000

-9402000000

1929000000

1768000000

29842000000

-35613000000

-10894000000

-8914000000

1874000000

1859000000

29785000000

-35498000000

-3000000

-1000000

-2000000

1.00

559972262

558058798

35613000000

35498000000

1548000000

1550000000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.54191033138402%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross Amounts Recognized</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross Amount Offset in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net Amounts Presented in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross Amounts Not Offset in the</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Condensed Consolidated </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance Sheet</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financial Instruments</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash Collateral Received/Pledged</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">At March 31, 2016</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(209</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(273</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(209</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">At December 31, 2015</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(131</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(432</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">172</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">172</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(131</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Sale of Accounts Receivable:</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative trade receivables sold for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, were </font><font style="font-family:inherit;font-size:10pt;">$1.9 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.3 billion</font><font style="font-family:inherit;font-size:10pt;">, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, were </font><font style="font-family:inherit;font-size:10pt;">$589 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$108 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the consolidated statements of earnings. For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, the loss on sale of trade receivables was not material.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's debt issuances in the first three months of 2016 were as follows: </font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.69395711500975%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face Value </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest Rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maturity</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$750</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.875</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2021</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2026</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font><font style="font-family:inherit;font-size:10pt;"> Interest on these notes is payable semi-annually in arrears beginning in August 2016. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(pre-tax, millions)</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statement of Earnings </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classification of Gain/(Loss) </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassified from Other </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings/(Losses) into </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Cash Flow Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Net Investment Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of </font><font style="font-family:inherit;font-size:10pt;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">May 1, 2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.88109161793372%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 22, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of<br clear="none"/>May 1, 2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smoking and Health Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lights Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Lights Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public Civil Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the verdict and significant post-trial developments in the three pending cases where a verdict was returned in favor of the plaintiff:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2004</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil/The Smoker Health Defense Association</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Cecilia Létourneau<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36.3 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.2 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion, into a trust within 60 days. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $178 million). A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Background and Basis of Presentation:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Background</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Throughout these financial statements, the term “PMI” refers to Philip Morris International Inc. and its subsidiaries.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior years' amounts have been reclassified to conform with the current year's presentation, as reflected in Note 8. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">. The changes did not have an impact on PMI's consolidated financial position, results of operations or cash flows in any of the periods presented.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Contingencies:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Tobacco-Related Litigation</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.    </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To date, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of </font><font style="font-family:inherit;font-size:10pt;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">May 1, 2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.88109161793372%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 22, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of<br clear="none"/>May 1, 2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smoking and Health Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lights Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Lights Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public Civil Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since 1995, when the first tobacco-related litigation was filed against a PMI entity, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">444</font><font style="font-family:inherit;font-size:10pt;"> Smoking and Health, Lights, Health Care Cost Recovery, and Public Civil Actions in which we and/or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Twelve</font><font style="font-family:inherit;font-size:10pt;"> cases have had decisions in favor of plaintiffs. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Nine</font><font style="font-family:inherit;font-size:10pt;"> of these cases have subsequently reached final resolution in our favor and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> remain on appeal.</font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the verdict and significant post-trial developments in the three pending cases where a verdict was returned in favor of the plaintiff:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2004</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil/The Smoker Health Defense Association</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Cecilia Létourneau<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36.3 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.2 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion, into a trust within 60 days. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $178 million). A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pending claims related to tobacco products generally fall within the following categories:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Smoking and Health Litigation:</font><font style="font-family:inherit;font-size:10pt;"> These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-24px;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">66</font><font style="font-family:inherit;font-size:10pt;"> cases brought by individual plaintiffs in Argentina (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">31</font><font style="font-family:inherit;font-size:10pt;">), Brazil (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">20</font><font style="font-family:inherit;font-size:10pt;">), Canada (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">), Chile (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">8</font><font style="font-family:inherit;font-size:10pt;">), Costa Rica (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">), Italy (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), the Philippines (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">) and Scotland (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">61</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">65</font><font style="font-family:inherit;font-size:10pt;"> cases on </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">May 1, 2014</font><font style="font-family:inherit;font-size:10pt;">; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">11</font><font style="font-family:inherit;font-size:10pt;"> cases brought on behalf of classes of individual plaintiffs in Brazil (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">) and Canada (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">9</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">11</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">May 1, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first class action pending in Brazil, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of São Paulo, Brazil</font><font style="font-family:inherit;font-size:10pt;">, filed July 25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded “moral damages” of </font><font style="font-family:inherit;font-size:10pt;">R$1,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$280</font><font style="font-family:inherit;font-size:10pt;">) per smoker per full year of smoking plus interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second class action pending in Brazil</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, Public Prosecutor of São Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of São Paulo, Brazil,</font><font style="font-family:inherit;font-size:10pt;"> filed August 6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of São Paulo, is seeking (i) damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii) damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii) reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities, and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of São Paulo only. In December 2008, the Seventh Civil Court of São Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ADESF</font><font style="font-family:inherit;font-size:10pt;"> case discussed above and should be transferred to the Nineteenth Lower Civil Court in São Paulo where the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ADESF</font><font style="font-family:inherit;font-size:10pt;"> case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the São Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of São Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the São Paulo Court of Appeals rejected plaintiff’s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005.  Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other Canadian manufacturers liable and awarded a total of CAD </font><font style="font-family:inherit;font-size:10pt;">131 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$103 million</font><font style="font-family:inherit;font-size:10pt;">) in punitive damages, allocating CAD </font><font style="font-family:inherit;font-size:10pt;">46 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$36 million</font><font style="font-family:inherit;font-size:10pt;">) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at </font><font style="font-family:inherit;font-size:10pt;">918,000</font><font style="font-family:inherit;font-size:10pt;"> members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau </font><font style="font-family:inherit;font-size:10pt;">case and the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">226 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$178 million</font><font style="font-family:inherit;font-size:10pt;">), in the form of cash into a court trust or letters of credit, in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$29.7 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through March 2017. See the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais </font><font style="font-family:inherit;font-size:10pt;">description for further detail concerning the security order. The Court of Appeal has scheduled a hearing for the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;"> after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Ltd.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD </font><font style="font-family:inherit;font-size:10pt;">15.5 billion</font><font style="font-family:inherit;font-size:10pt;">, including pre-judgment interest (approximately </font><font style="font-family:inherit;font-size:10pt;">$12.2 billion</font><font style="font-family:inherit;font-size:10pt;">). The trial court awarded compensatory damages on a joint and several liability basis, allocating </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> to our subsidiary (approximately CAD </font><font style="font-family:inherit;font-size:10pt;">3.1 billion</font><font style="font-family:inherit;font-size:10pt;">, including pre-judgment interest (approximately </font><font style="font-family:inherit;font-size:10pt;">$2.4 billion</font><font style="font-family:inherit;font-size:10pt;">)). In addition, the trial court awarded CAD </font><font style="font-family:inherit;font-size:10pt;">90,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$71,000</font><font style="font-family:inherit;font-size:10pt;">) in punitive damages, allocating CAD </font><font style="font-family:inherit;font-size:10pt;">30,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$23,700</font><font style="font-family:inherit;font-size:10pt;">) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at </font><font style="font-family:inherit;font-size:10pt;">99,957</font><font style="font-family:inherit;font-size:10pt;"> members. The trial court ordered defendants to pay CAD </font><font style="font-family:inherit;font-size:10pt;">1 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$789 million</font><font style="font-family:inherit;font-size:10pt;">) of the compensatory damage award into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">, CAD </font><font style="font-family:inherit;font-size:10pt;">200 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$158 million</font><font style="font-family:inherit;font-size:10pt;">) of which is our subsidiary’s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make an initial payment within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD </font><font style="font-family:inherit;font-size:10pt;">5 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$3.9 billion</font><font style="font-family:inherit;font-size:10pt;">) into trust, to secure the judgments in both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau </font><font style="font-family:inherit;font-size:10pt;">and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">226 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$178 million</font><font style="font-family:inherit;font-size:10pt;">) to cover both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. Such security may take the form of cash into a court trust or letters of credit, in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$29.7 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">758 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$598 million</font><font style="font-family:inherit;font-size:10pt;">) in </font><font style="font-family:inherit;font-size:10pt;">seven</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">108 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$85 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through June 2017. In March 2016, our subsidiary made its second quarterly installment of security for approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$29.7 million</font><font style="font-family:inherit;font-size:10pt;">) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal has scheduled a hearing for the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, below).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams v. Canadian Tobacco Manufacturers' Council, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Queen's Bench, Saskatchewan, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed July 10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of </font><font style="font-family:inherit;font-size:10pt;">25,000</font><font style="font-family:inherit;font-size:10pt;"> cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Semple v. Canadian Tobacco Manufacturers' Council, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Supreme Court (trial court), Nova Scotia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, above).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the sixth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed June 15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, above).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the seventh class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">McDermid v. Imperial Tobacco Canada Limited, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Supreme Court, British Columbia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the eighth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Bourassa v. Imperial Tobacco Canada Limited, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Supreme Court, British Columbia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, the plaintiff filed an amended statement of claim. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the ninth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, </font><font style="font-family:inherit;font-size:10pt;">filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of </font><font style="font-family:inherit;font-size:10pt;">25,000</font><font style="font-family:inherit;font-size:10pt;"> cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Health Care Cost Recovery Litigation:</font><font style="font-family:inherit;font-size:10pt;"> These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10</font><font style="font-family:inherit;font-size:10pt;">), Korea (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">) and Nigeria (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">15</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">May 1, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first health care cost recovery case pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed January 24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.” The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed March 13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed September 29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants are scheduled to file their defenses in April 2016.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed February 8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants are scheduled to file their defenses in May 2016.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in December 2014 and July 2015. Pre-trial discovery is ongoing. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the sixth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in March 2016.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the seventh health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in September 2014. Discovery is scheduled to begin in 2017.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the eighth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the ninth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada</font><font style="font-family:inherit;font-size:10pt;">, filed September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the tenth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in July 2015. Discovery is scheduled to begin in 2017.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed October 17, 2008, we and other members of the industry are defendants</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed May 25, 2007, we and other members of the industry are defendants</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria</font><font style="font-family:inherit;font-size:10pt;">, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the health care cost recovery case in Korea, the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">National Health Insurance Service v. KT&G, et. al.,</font><font style="font-family:inherit;font-size:10pt;"> filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lights</font><font style="font-family:inherit;font-size:10pt;"> cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately </font><font style="font-family:inherit;font-size:10pt;">$53.7 million</font><font style="font-family:inherit;font-size:10pt;"> allegedly incurred in treating </font><font style="font-family:inherit;font-size:10pt;">3,484</font><font style="font-family:inherit;font-size:10pt;"> patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lights Cases:</font><font style="font-family:inherit;font-size:10pt;"> These cases, brought by individual plaintiffs, allege that the use of the term “lights” constitutes fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;"> lights cases brought by individual plaintiffs pending against our subsidiaries or indemnitees in Chile (</font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">) and Italy (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">May 1, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Public Civil Actions:</font><font style="font-family:inherit;font-size:10pt;"> Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;"> public civil actions pending against our subsidiaries in Argentina (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), Romania (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">) and Venezuela (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">May 1, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the public civil action in Argentina, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Asociación Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina,</font><font style="font-family:inherit;font-size:10pt;"> filed February 26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to the Federal Court on Administrative Matters after the Civil Court granted the plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In a newly filed action in Romania, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foundation for the Defense of Citizens against Abuses of the State (FACIAS) v. the State of Romania, Philip Morris România (PMR) and Philip Morris Trading SLR (PMTR), et al., Administrative and Fiscal Litigation Section of the Bucharest Tribunal</font><font style="font-family:inherit;font-size:10pt;">, filed November 20, 2015, our subsidiaries, several other members of the industry, and the State of Romania through various of its institutions are defendants.  The plaintiff, a non-governmental organization, asks the court to compel the government to enact legislation as directed by the 2014 EU Tobacco Product Directive and to establish a fund for the treatment of smoking-related diseases and promotion of tobacco control efforts.  The plaintiff also seeks an order directing that </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> of the excise taxes collected from tobacco manufacturers, “as well as an amount representing </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> of the turnover” of tobacco manufacturers and distributors, be used to finance the fund.  It is unclear whether the “</font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> of turnover” is sought from the tobacco company defendants or the government. Our subsidiaries answered the complaint in December 2015. In January 2016, the Tribunal ruled that it lacked jurisdiction. The case was transferred to the Bucharest Court of Appeals, which has jurisdiction to hear administrative cases involving the central government. In March 2016, the Bucharest Court of Appeal announced its dismissal of plaintiff’s claims as inadmissible. A written ruling is expected in the second quarter 2016. The plaintiff may appeal.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the public civil action in Venezuela, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court</font><font style="font-family:inherit;font-size:10pt;">, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Litigation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Department of Special Investigations of the government of Thailand has been conducting an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">in the</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under declared import prices of cigarettes to avoid full payment of taxes and duties in connection with </font><font style="font-family:inherit;font-size:10pt;">272</font><font style="font-family:inherit;font-size:10pt;"> import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB </font><font style="font-family:inherit;font-size:10pt;">80.8 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$2.30 billion</font><font style="font-family:inherit;font-size:10pt;">). The first hearing, held in April 2016, focused on preliminary procedural matters. The case is now in the pre-trial evidentiary phase. PM Thailand contends that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Accumulated Other Comprehensive Losses:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85.38011695906432%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,617</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension and other benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,287</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,332</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,964</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives accounted for as hedges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,914</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,402</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,090</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications from Other Comprehensive Earnings </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">. For additional information, see Note 4. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Benefit Plans</font><font style="font-family:inherit;font-size:10pt;"> and Note 6. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:inherit;font-size:10pt;"> for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Financial Instruments:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Overview</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. PMI reports its net transaction gains or losses in marketing, administration and research costs on the condensed consolidated statements of earnings.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Russian ruble, Swiss franc and Turkish lira. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, PMI had contracts with aggregate notional amounts of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.3 billion</font><font style="font-family:inherit;font-size:10pt;"> of which </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.7 billion</font><font style="font-family:inherit;font-size:10pt;"> related to cash flow hedges, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$7.2 billion</font><font style="font-family:inherit;font-size:10pt;"> related to hedges of net investments in foreign operations and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$14.4 billion</font><font style="font-family:inherit;font-size:10pt;"> related to other derivatives that primarily offset currency exposures on intercompany financing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts designated as hedging instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts not designated as hedging instruments </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(pre-tax, millions)</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statement of Earnings </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classification of Gain/(Loss) </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassified from Other </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings/(Losses) into </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Cash Flow Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Net Investment Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash Flow Hedges</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI has entered into foreign exchange contracts to hedge foreign currency exchange risk related to certain forecasted transactions. The effective portion of gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, ineffectiveness related to cash flow hedges was not material. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, PMI has hedged forecasted transactions for periods not exceeding the next </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">twenty-one</font><font style="font-family:inherit;font-size:10pt;"> months with the exception of </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> foreign exchange contract that expires in </font><font style="font-family:inherit;font-size:10pt;">May 2024</font><font style="font-family:inherit;font-size:10pt;">. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statement of cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hedges of Net Investments in Foreign Operations</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges of its foreign operations. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, these hedges of net investments resulted in gains (losses), net of income taxes, of </font><font style="font-family:inherit;font-size:10pt;">$(267) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$835 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. These gains/(losses) were reported as a component of accumulated other comprehensive losses within currency translation adjustments. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, ineffectiveness related to net investment hedges was not material. Other investing cash flows on PMI’s condensed consolidated statements of cash flows include the premiums paid for, and settlements of, net investment hedges.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Derivatives</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, the gains (losses) from contracts for which PMI did not apply hedge accounting were </font><font style="font-family:inherit;font-size:10pt;">$91 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$(751) million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The gains/(losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, the net impact of these contracts on the condensed consolidated statements of earnings was not material.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.95711500974659%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain as of January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative gains transferred to earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(loss) as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, PMI expects </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$8 million</font><font style="font-family:inherit;font-size:10pt;"> of derivative losses that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next twelve months. These losses are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Features</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s derivative instruments do not contain contingent features.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Credit Exposure and Credit Risk</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 12. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:inherit;font-size:10pt;"> and Note 14. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet Offsetting</font><font style="font-family:inherit;font-size:10pt;"> for additional discussion of derivative financial instruments.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Stock Plans:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2012, PMI’s shareholders approved the Philip Morris International Inc. 2012 Performance Incentive Plan (the “2012 Plan”). Under the 2012 Plan, PMI may grant to eligible employees restricted stock, restricted stock units and deferred stock units (collectively referred to as restricted share units), performance-based cash incentive awards and performance-based equity awards. Up to </font><font style="font-family:inherit;font-size:10pt;">30 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI’s common stock may be issued under the 2012 Plan. At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, shares available for grant under the 2012 Plan were </font><font style="font-family:inherit;font-size:10pt;">21,608,980</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2008, PMI adopted the Philip Morris International Inc. 2008 Stock Compensation Plan for Non-Employee Directors (the “Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to </font><font style="font-family:inherit;font-size:10pt;">1 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI common stock may be awarded under the Non-Employee Directors Plan. At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, shares available for grant under the plan were </font><font style="font-family:inherit;font-size:10pt;">691,432</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted share unit (RSU) awards</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, PMI granted </font><font style="font-family:inherit;font-size:10pt;">1.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares of RSU awards to eligible employees at a weighted-average grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$89.02</font><font style="font-family:inherit;font-size:10pt;"> per share. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, PMI granted </font><font style="font-family:inherit;font-size:10pt;">1.5 million</font><font style="font-family:inherit;font-size:10pt;"> shares of RSU awards to eligible employees at a grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$82.28</font><font style="font-family:inherit;font-size:10pt;"> per share. PMI recorded compensation expense related to RSU awards of </font><font style="font-family:inherit;font-size:10pt;">$41 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$58 million</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, PMI had </font><font style="font-family:inherit;font-size:10pt;">$198 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> or more years after the date of the award, subject to earlier vesting on death, disability or normal retirement, or separation from employment by mutual agreement after reaching age </font><font style="font-family:inherit;font-size:10pt;">58</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2.1 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI RSU awards vested. The grant date fair value of all the vested shares was approximately </font><font style="font-family:inherit;font-size:10pt;">$190 million</font><font style="font-family:inherit;font-size:10pt;">. The total fair value of RSU awards that vested during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> was approximately </font><font style="font-family:inherit;font-size:10pt;">$196 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance share unit (PSU) awards</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group, PMI’s currency neutral compound annual adjusted operating companies income growth rate, excluding acquisitions, and PMI’s performance against specific measures of PMI’s innovation. The aggregate of the weighted performance factors for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> metrics determines the percentage of PSUs that will vest at the end of the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance cycle. Each vested PSU entitles the participant to </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> share of common stock. An aggregate weighted PSU performance factor of </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> will result in the targeted number of PSUs being vested. The minimum percentage of PSUs that can vest is </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">, with a maximum percentage of </font><font style="font-family:inherit;font-size:10pt;">200</font><font style="font-family:inherit;font-size:10pt;">. Participants are entitled to dividend equivalents for any vested PSUs, at the end of the performance cycle. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, PMI granted </font><font style="font-family:inherit;font-size:10pt;">0.4 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PSU awards to eligible employees. The grant date fair value of the PSU market based awards subject to the TSR performance factor is </font><font style="font-family:inherit;font-size:10pt;">$104.60</font><font style="font-family:inherit;font-size:10pt;"> per share, which was determined by using the Monte Carlo simulation model. The grant date fair value of the PSU awards subject to the other performance factors is </font><font style="font-family:inherit;font-size:10pt;">$89.02</font><font style="font-family:inherit;font-size:10pt;"> per share, which was determined by using the average of the high and low market price of PMI’s stock at the date of grant. PMI recorded compensation expense related to PSU awards of </font><font style="font-family:inherit;font-size:10pt;">$12 million</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, PMI had </font><font style="font-family:inherit;font-size:10pt;">$29 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the original restriction period of the awards, which is typically </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years after the date of the award, or upon death, disability or reaching the age of </font><font style="font-family:inherit;font-size:10pt;">58</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Earnings Per Share:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share (“EPS”) were calculated using the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to PMI</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less distributed and undistributed earnings attributable to share-based payment awards</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings for basic and diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,525</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,788</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for basic and diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,548</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> computations, there were no antidilutive stock awards.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s earnings activity from unconsolidated subsidiaries was as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">777</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">896</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Receivables</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notes receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair values of PMI’s derivative financial instruments and debt as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.76218323586744%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value<br clear="none"/>at<br clear="none"/>March 31,<br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets/Liabilities<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,912</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,211</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,432</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">779</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Fair Value Measurements:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:20px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 1 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted prices in active markets for identical assets or liabilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 2 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 3 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. PMI’s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 6. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:inherit;font-size:10pt;"> for an additional discussion of derivative financial instruments.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI’s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI’s debt, excluding short-term borrowings and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$14 million</font><font style="font-family:inherit;font-size:10pt;"> of capital lease obligations, was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$29,106 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The fair value of PMI’s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, has been classified within Level 1 and Level 2 in the table shown below.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair values of PMI’s derivative financial instruments and debt as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.76218323586744%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value<br clear="none"/>at<br clear="none"/>March 31,<br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets/Liabilities<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,912</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,211</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,432</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">779</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Goodwill and Other Intangible Assets, net:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill and other intangible assets, net, by segment were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Intangible Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">514</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,150</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">830</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">819</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,683</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,415</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,664</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,623</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill primarily reflects PMI’s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European<br clear="none"/>Union</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern<br clear="none"/>Europe,<br clear="none"/>Middle East<br clear="none"/>&<br clear="none"/>Africa</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin<br clear="none"/>America &<br clear="none"/>Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,415</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,349</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,248</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,683</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional details of other intangible assets were as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,527</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,650</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,609</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,209</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,136</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(dollars in millions) </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Initial Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average<br clear="none"/>Remaining Useful Life</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 - 40 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 30 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (including farmer<br clear="none"/>  contracts and intellectual property rights)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,650</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-tax amortization expense for intangible assets during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$18 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Amortization expense for each of the next </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> years is estimated to be </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$73 million</font><font style="font-family:inherit;font-size:10pt;"> or less, assuming no additional transactions occur that require the amortization of intangible assets.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The increase in the gross carrying amount of other intangible assets from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, was due to currency movements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, PMI completed its annual review of goodwill for potential impairment using the market valuation approach. No impairment charge was required as a result of this review.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Income Taxes:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s effective tax rates for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">28.3%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">30.2%</font><font style="font-family:inherit;font-size:10pt;">, respectively. PMI estimates that its full-year </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> effective tax rate will be approximately </font><font style="font-family:inherit;font-size:10pt;">28%</font><font style="font-family:inherit;font-size:10pt;">. The effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, was unfavorably impacted by changes to repatriation assertions on certain foreign subsidiary historical earnings (</font><font style="font-family:inherit;font-size:10pt;">$58 million</font><font style="font-family:inherit;font-size:10pt;">). Excluding the effect of the 2015 repatriation assertion changes, the change in the effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, as compared to the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effective tax rates are based on PMI’s full-year earnings mix projections by taxing jurisdiction and cash repatriation plans. Changes in earnings mix by taxing jurisdiction or in cash repatriation plans could have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012 and onward</font><font style="font-family:inherit;font-size:10pt;">. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is reasonably possible that within the next twelve months certain tax examinations will close, which could result in a change in unrecognized tax benefits, along with related interest and penalties. An estimate of any possible change cannot be made at this time.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">New Accounting Standards:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 5, 2016, the FASB issued Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01 will require equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changes certain disclosure requirements and other aspects of current U.S. GAAP. ASU 2016-01 is effective for interim and annual reporting periods beginning on or after January 1, 2018. PMI is currently assessing the impact that the adoption of ASU 2016-01 will have on its financial position or results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 20, 2015, the FASB issued Accounting Standard Update ASU 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”). ASU 2015-17 requires that all deferred tax assets and liabilities, along with any related valuation allowance, be classified as noncurrent on the balance sheet. ASU 2015-17 is effective for interim and annual reporting periods beginning on or after January 1, 2017 with early adoption permitted. Entities can apply the final standard either prospectively, for all deferred tax assets and liabilities, or retrospectively with disclosures providing qualitative information about the effects of the accounting change on prior periods. The adoption of ASU 2015-17 will not have a material impact on PMI’s consolidated results of operations, financial position or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 28, 2014, the FASB issued Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Entities can apply the final standard using one of the following two methods:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">retrospectively to each prior period presented; or </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2014-09 is effective for interim and annual reporting periods beginning on or after January 1, 2017. In July 2015, the FASB approved a proposal which allows for a deferral of the implementation until January 1, 2018, and permits early application, but not before the original effective date of January 1, 2017. PMI is currently assessing the impact that the adoption of ASU 2014-09 will have on its financial position or results of operations.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85.38011695906432%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,617</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension and other benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,287</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,332</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,964</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives accounted for as hedges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,914</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,402</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,090</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, PMI’s long-term debt consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.46588693957115%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.612%), due through 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,079</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency obligations:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro notes, 1.750% to 3.125% (average interest rate 2.433%), due through 2033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,844</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swiss franc notes, 0.750% to 2.000% (average interest rate 1.217%), due through 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,737</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,690</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (average interest rate 3.126%), due through 2024</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">460</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,655</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion of long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,437</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,405</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,683</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,250</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.95711500974659%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain as of January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative gains transferred to earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(loss) as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share (“EPS”) were calculated using the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to PMI</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less distributed and undistributed earnings attributable to share-based payment awards</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings for basic and diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,525</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,788</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for basic and diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,548</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(dollars in millions) </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Initial Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average<br clear="none"/>Remaining Useful Life</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 - 40 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 30 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (including farmer<br clear="none"/>  contracts and intellectual property rights)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,650</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts designated as hedging instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts not designated as hedging instruments </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The movements in goodwill from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European<br clear="none"/>Union</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern<br clear="none"/>Europe,<br clear="none"/>Middle East<br clear="none"/>&<br clear="none"/>Africa</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin<br clear="none"/>America &<br clear="none"/>Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,415</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,349</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,248</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,683</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional details of other intangible assets were as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,527</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,650</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,609</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,209</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,136</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill and other intangible assets, net, by segment were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Intangible Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,349</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">514</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,248</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,150</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">830</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">819</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,683</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,415</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,664</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,623</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, PMI's total committed credit facilities were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in billions)</font></div><div style="line-height:120%;padding-left:6px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:84.21052631578947%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Committed</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Credit</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Facilities</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364-day revolving credit, expiring February 7, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring February 28, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring October 1, 2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total facilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The movement in exit cost liabilities for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability balance, January 1, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash spent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency/other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability balance, March 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment data were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,222</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,689</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,219</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,788</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,352</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating companies income:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">906</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">866</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">934</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity (income)/loss in unconsolidated subsidiaries, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,871</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(275</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,226</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,596</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Segment Reporting:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Reportable segments for PMI are organized and managed by geographic region. PMI’s reportable segments are European Union; Eastern Europe, Middle East & Africa; Asia; and Latin America & Canada. PMI records net revenues and operating companies income to its segments based upon the geographic area in which the customer resides.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s management evaluates segment performance and allocates resources based on operating companies income, which PMI defines as operating income, excluding general corporate expenses and amortization of intangibles, plus equity (income)/loss in unconsolidated subsidiaries, net. Interest expense, net, and provision for income taxes are centrally managed and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by management.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2015, to further align with the Member State composition of the European Union, PMI transferred the management of its operations in Bulgaria, Croatia, Romania and Slovenia from its Eastern Europe, Middle East & Africa segment to its European Union segment, resulting in the reclassification of prior year amounts between the two segments.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment data were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,222</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,689</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,219</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,788</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,352</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating companies income:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">906</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">927</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">866</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">934</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity (income)/loss in unconsolidated subsidiaries, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,871</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(275</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,226</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,596</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

EX-101.SCH 8 pm-20160331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2115100 - Disclosure - Accumulated Other Comprehensive Losses link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Accumulated Other Comprehensive Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Acquisitions and Other Business Arrangements link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Acquisitions and Other Business Arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Asset Impairment and Exit Costs link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Asset Impairment and Exit Costs (Movement In The Exit Cost Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Asset Impairment and Exit Costs (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Asset Impairment and Exit Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Background and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Balance Sheet Offsetting link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Balance Sheet Offsetting (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Balance Sheet Offsetting (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Benefit Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003001 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Earnings (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2411406 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411407 - Disclosure - Contingencies (Lights Cases) (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) link:presentationLink link:calculationLink link:definitionLink 2411408 - Disclosure - Contingencies (Public Civil Actions and Other Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Contingencies (Smoking And Health Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Contingencies (Tobacco-Related Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Contingencies (Verdicts and Post-Trial Developments) (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Financial Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Goodwill and Other Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2406406 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Goodwill and Other Intangible Assets, net (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Indebtedness link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - Indebtedness (Credit Facilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Indebtedness (Debt Issuances During Current Period) (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Indebtedness (Long-Term Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Indebtedness (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Indebtedness (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Investments in Unconsolidated Subsidiaries link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Investments in Unconsolidated Subsidiaries (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Investments in Unconsolidated Subsidiaries (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2220201 - Disclosure - New Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Sale of Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 2419401 - Disclosure - Sale of Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Stock Plans link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - Stock Plans (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 pm-20160331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 pm-20160331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 pm-20160331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Italy [Member] ITALY Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case [Domain] Case Decided In Favor Of Plaintiff [Member] Case Decided In Favor Of Plaintiff [Member] Case Decided in Favor of Plaintiff Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Cases Remaining On Appeal [Member] Cases Remaining On Appeal [Member] Cases Remaining on Appeal Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of cases decided in favor of PM Loss Contingency Claims Resolved in Favor of the Company Loss Contingency Claims Resolved in Favor of the Company Number of cases decided in favor of plaintiff Loss Contingency Claims Resolved in Favor of Plaintiffs Loss Contingency Claims Resolved in Favor of Plaintiffs Number of cases that reached final resolution in favor of PM Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company Statement of Cash Flows [Abstract] CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments to reconcile net earnings to operating cash flows: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Deferred income tax provision Deferred Income Tax Expense (Benefit) Asset impairment and exit costs, net of cash paid Asset Impairment And Exit Costs, Net Of Cash Paid Adjustment to remove provision for asset impairment and exit costs, net of the related cash payments. Cash effects of changes: Increase (Decrease) in Operating Capital [Abstract] Receivables, net Increase (Decrease) in Receivables Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Income taxes Increase (Decrease) in Income Taxes Payable Accrued liabilities and other current assets Increase Decrease In Accrued Liabilities And Other Current Assets The net change during the reporting period in the aggregate amount of expenses incurred but not yet paid, as well as the net change during the reporting period in the aggregate value of other current assets, associated with transactions that are classified as operating activities Pension plan contributions Pension Contributions Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Investments in unconsolidated subsidiaries Payments to Acquire Interest in Subsidiaries and Affiliates Other Payments for (Proceeds from) Other Investing Activities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] Short-term borrowing activity by original maturity: Proceeds from (Repayments of) Debt [Abstract] Net (repayments) issuances - maturities of 90 days or less Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Issuances - maturities longer than 90 days Proceeds from Short-term Debt, Maturing in More than Three Months Long-term debt proceeds Proceeds from Issuance of Long-term Debt Long-term debt repaid Repayments of Long-term Debt Repurchases of common stock Payments for Repurchase of Common Stock Dividends paid Payments of Dividends Sale (purchase) of subsidiary shares to (from) noncontrolling interests Proceeds from (Payments to) Noncontrolling Interests Other Proceeds from (Payments for) Other Financing Activities Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Cash and cash equivalents: Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] Decrease Cash and Cash Equivalents, Period Increase (Decrease) Balance at beginning of period Cash and Cash Equivalents, at Carrying Value Balance at end of period Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill and Intangible Assets, Net, by Segment or Major Class Schedule of Intangible Assets and Goodwill [Table Text Block] Movements in Goodwill Schedule of Goodwill [Table Text Block] Gross Carrying Amount, Range of Useful Lives and Weighted-Average Remaining Useful Life of Amortizable Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Sale of Accounts Receivable [Abstract] Sale of Accounts Receivable [Abstract] Sale of Accounts Receivable Sale of Trade Accounts Receivable Disclosure [Text Block] Sale of Trade Accounts Receivable Disclosure [Text Block] Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Non-amortizable intangible assets, gross carrying amount Indefinite-Lived Intangible Assets (Excluding Goodwill) Amortizable intangible assets, gross carrying amount Finite-Lived Intangible Assets, Gross Total other intangible assets, gross carrying amount Intangible Assets, Gross (Excluding Goodwill) Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Debt Disclosure [Abstract] Line of Credit Facility [Table] Line of Credit Facility [Table] Lender Name [Axis] Lender Name [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Revolving Credit Expiring February 9, 2017 [Member] Revolving Credit Expiring February Ninth Two Thousand Seventeen [Member] Revolving Credit Expiring February Ninth Two Thousand Seventeen [Member] Multi-year revolving credit, expiring February 28, 2021 [Member] Multi Year Revolving Credit Expiring February Twenty Eighth Two Thousand Twenty One [Member] Multi Year Revolving Credit Expiring February Twenty Eighth Two Thousand Twenty One [Member] Multi-year revolving credit, expiring October 1, 2020 [Member] Multi Year Revolving Credit Expiring October First Two Thousand Twenty [Member] [Domain] Multi Year Revolving Credit Expiring October First Two Thousand Twenty [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Committed credit facilities Line of Credit Facility, Maximum Borrowing Capacity Indebtedness Debt Disclosure [Text Block] Trade receivables sold and derecognized from the Consolidated Balance Sheets Trade Receivable Sold and Derecognized from the Consolidated Balance Sheets Trade receivables sold without recourse to unaffiliated financial institutions and derecognized from the consolidated balance sheets. Trade receivables sold and derecognized that remain uncollected Trade Receivables Sold and Derecognized that Remained Uncollected Trade accounts receivable sold and derecognized from the consolidated balance sheets that remain uncollected by unaffiliated financial institutions. Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Cash and cash equivalents Receivables (less allowances of $58 in 2016 and $58 in 2015) Accounts Receivable, Net, Current Inventories: Inventory, Net [Abstract] Leaf tobacco Inventory Leaf Tobacco Carrying amount as of the balance sheet date of leaf tobacco inventory to be consumed in the manufacturing and production process. Other raw materials Inventory, Raw Materials, Gross Finished product Inventory, Finished Goods, Gross Total inventory, net Inventory, Net Deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Current Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment, at cost Property, Plant and Equipment, Gross Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property, plant and equipment, net Property, Plant and Equipment, Net Goodwill (Note 5) Goodwill Other intangible assets, net (Note 5) Intangible Assets, Net (Excluding Goodwill) Investments in unconsolidated subsidiaries (Note 15) Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Other assets Other Assets, Noncurrent TOTAL ASSETS Assets LIABILITIES Liabilities [Abstract] Short-term borrowings (Note 11) Short-term Debt Current portion of long-term debt (Note 11) Long-term Debt and Capital Lease Obligations, Current Accounts payable Accounts Payable, Current Accrued liabilities: Accrued Liabilities, Current [Abstract] Marketing and selling Accrued Marketing Costs, Current Taxes, except income taxes Sales and Excise Tax Payable, Current Employment costs Employee-related Liabilities, Current Dividends payable Dividends Payable, Current Other Other Accrued Liabilities, Current Income taxes Accrued Income Taxes, Current Deferred income taxes Deferred Tax Liabilities, Net, Current Total current liabilities Liabilities, Current Long-term debt (Note 11) Long-term Debt and Capital Lease Obligations Deferred income taxes Deferred Tax Liabilities, Net, Noncurrent Employment costs Pension and Other Postretirement and Postemployment Benefit Plans, Liabilities, Noncurrent Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Contingencies (Note 9) Commitments and Contingencies STOCKHOLDERS’ (DEFICIT) EQUITY Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Common stock, no par value (2,109,316,331 shares issued in 2016 and 2015) Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Earnings reinvested in the business Retained Earnings (Accumulated Deficit) Accumulated other comprehensive losses Accumulated Other Comprehensive Income (Loss), Net of Tax Total stockholders' equity before treasury stock Stockholders' Equity before Treasury Stock Less: cost of repurchased stock (558,058,798 and 559,972,262 shares in 2016 and 2015, respectively) Treasury Stock, Value Total PMI stockholders’ deficit Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders’ deficit Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Liabilities and Equity Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash Flow Hedges [Member] Cash Flow Hedging [Member] Net Investment Hedges [Member] Net Investment Hedging [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Net Revenue [Member] Sales [Member] Cost of Sales [Member] Cost of Sales [Member] Marketing Administration And Research Costs [Member] Marketing Administration And Research Costs [Member] Marketing, administration and research costs Interest Expense [Member] Interest Expense [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative [Table] Derivative [Table] Derivative Instrument [Axis] Cash Flow Hedging [Member] Net Investment Hedging [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Derivative [Line Items] Derivative [Line Items] Notional amount Derivative, Notional Amount Maximum length of time hedged in a Cash Flow Hedge Derivative, Higher Remaining Maturity Range Maturity of Foreign Currency Derivatives - Cash Flow Hedges Maturity of Foreign Currency Derivatives Unrealized gain (loss) on hedges of net investments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Gain (Loss) on derivatives not designated as hedging instruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Derivative Instruments, gains to be reclassified to earnings. Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Equity Method Investments and Joint Ventures [Abstract] Earnings and Balance Sheet Activities with Unconsolidated Subsidiaries Equity Method Investments [Table Text Block] Restructuring and Related Activities [Abstract] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Liability beginning balance Restructuring Reserve Charges, net Restructuring Charges Cash spent Payments for Restructuring Currency/other Restructuring Reserve, Translation and Other Adjustment Liability ending balance Schedule of Tobacco Related Cases Pending Against Company Schedule Of Tobacco Related Cases Pending Against Company [Table Text Block] Schedule of tobacco related cases pending against company and/or subsidiaries or indemnities Schedule Of Verdicts And Post Trial Developments Where a Verdict was Returned In Favor of the Plaintiff(s) Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] Earnings Per Share [Abstract] Calculation of Basic and Diluted EPS Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Business Combinations [Abstract] Acquisitions and Other Business Arrangements Business Combination Disclosure [Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] European Union [Member] European Union [Member] Eastern Europe, Middle East & Africa [Member] Eastern Europe Middle East And Africa [Member] Eastern Europe, Middle East and Africa Asia [Member] Asia [Member] Latin America & Canada [Member] Latin America And Canada [Member] Latin America and Canada Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Balances, December 31, 2015 Changes due to: Goodwill, Translation and Purchase Accounting Adjustments [Abstract] Currency Goodwill, Translation and Purchase Accounting Adjustments Balances, March 31, 2016 Document And Entity Information [Abstract] Document And Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus EX-101.PRE 12 pm-20160331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2016	Apr. 22, 2016
Document And Entity Information [Abstract]
Entity Registrant Name	Philip Morris International Inc.
Entity Central Index Key	0001413329
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		1,551,264,326

XML 14 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
ASSETS
Cash and cash equivalents	$ 2,944	$ 3,417
Receivables (less allowances of $58 in 2016 and $58 in 2015)	2,989	2,778
Inventories:
Leaf tobacco	3,034	2,640
Other raw materials	1,615	1,613
Finished product	4,050	4,220
Total inventory, net	8,699	8,473
Deferred income taxes	485	488
Other current assets	811	648
Total current assets	15,928	15,804
Property, plant and equipment, at cost	12,202	11,767
Less: accumulated depreciation	6,337	6,046
Total property, plant and equipment, net	5,865	5,721
Goodwill (Note 5)	7,683	7,415
Other intangible assets, net (Note 5)	2,664	2,623
Investments in unconsolidated subsidiaries (Note 15)	942	890
Other assets	1,539	1,503
TOTAL ASSETS	34,621	33,956
LIABILITIES
Short-term borrowings (Note 11)	673	825
Current portion of long-term debt (Note 11)	2,437	2,405
Accounts payable	1,496	1,289
Accrued liabilities:
Marketing and selling	536	640
Taxes, except income taxes	4,569	5,121
Employment costs	735	903
Dividends payable	1,591	1,589
Other	1,387	1,438
Income taxes	576	970
Deferred income taxes	91	206
Total current liabilities	14,091	15,386
Long-term debt (Note 11)	26,683	25,250
Deferred income taxes	1,378	1,543
Employment costs	2,602	2,566
Other liabilities	761	687
Total liabilities	$ 45,515	$ 45,432
Contingencies (Note 9)
STOCKHOLDERS’ (DEFICIT) EQUITY
Common stock, no par value (2,109,316,331 shares issued in 2016 and 2015)	$ 0	$ 0
Additional paid-in capital	1,874	1,929
Earnings reinvested in the business	29,785	29,842
Accumulated other comprehensive losses	(8,914)	(9,402)
Total stockholders' equity before treasury stock	22,745	22,369
Less: cost of repurchased stock (558,058,798 and 559,972,262 shares in 2016 and 2015, respectively)	35,498	35,613
Total PMI stockholders’ deficit	(12,753)	(13,244)
Noncontrolling interests	1,859	1,768
Total stockholders’ deficit	(10,894)	(11,476)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY	$ 34,621	$ 33,956

XML 15 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Receivables, allowances	$ 58	$ 58
Common stock, no par value (in dollars per share)
Common stock, shares issued (in shares)	2,109,316,331	2,109,316,331
Repurchased stock, shares (in shares)	558,058,798	559,972,262

XML 16 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Net revenues	$ 16,788	$ 17,352
Cost of sales	2,096	2,229
Excise taxes on products	10,705	10,736
Gross profit	3,987	4,387
Marketing, administration and research costs	1,496	1,494
Amortization of intangibles	18	22
Operating income	2,473	2,871
Interest expense, net	247	275
Earnings before income taxes	2,226	2,596
Provision for income taxes	630	785
Equity (income)/loss in unconsolidated subsidiaries, net	(9)	(23)
Net earnings	1,605	1,834
Net earnings attributable to noncontrolling interests	75	39
Net earnings attributable to PMI	$ 1,530	$ 1,795
Per share data (Note 7):
Basic earnings per share (in dollars per share)	$ 0.98	$ 1.16
Diluted earnings per share (in dollars per share)	0.98	1.16
Dividends declared (in dollars per share)	$ 1.02	$ 1

XML 17 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Abstract]
Net earnings	$ 1,605	$ 1,834
Change in currency translation adjustments:
Unrealized gains (losses), net of income taxes of $162 in 2016 and ($434) in 2015	538	(1,343)
Change in net loss and prior service cost:
Net losses and prior service costs, net of income taxes of $3 in 2016 and $- in 2015	(10)	0
Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($8) in 2016 and ($12) in 2015	55	56
Change in fair value of derivatives accounted for as hedges:
Gains (losses) recognized, net of income taxes of $17 in 2016 and ($2) in 2015	(62)	25
(Gains) losses transferred to earnings, net of income taxes of ($1) in 2016 and $3 in 2015	(7)	(27)
Total other comprehensive earnings (losses)	514	(1,289)
Total comprehensive earnings	2,119	545
Less comprehensive earnings attributable to:
Noncontrolling interests	101	14
Comprehensive earnings attributable to PMI	$ 2,018	$ 531

XML 18 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Abstract]
Income taxes on Currency translation adjustments	$ 162	$ (434)
Income taxes on Net Losses and Prior Service Costs	3	0
Income taxes on Amortization of net losses, prior service costs and net transition costs	(8)	(12)
Income taxes on (loss)/gain recognized from fair value of derivatives accounted for as hedges	17	(2)
Income taxes on loss/(gain) transferred to earnings from fair value of derivatives accounted for as hedges	$ (1)	$ 3

XML 19 R7.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Earnings Reinvested in the Business [Member]	Accumulated Other Comprehensive Losses [Member]	Cost of Repurchased Stock [Member]	Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2014	$ (11,203)	$ 0	$ 710	$ 29,249	$ (6,826)	$ (35,762)	$ 1,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	1,834			1,795			39
Other comprehensive earnings (losses), net of income taxes	(1,289)				(1,264)		(25)
Issuance of stock awards	37		(97)			134
Dividends declared ($1.00 and $1.02 per share for the three months ended March 31, 2015 and 2016, respectively)	(1,555)			(1,555)
Payments to noncontrolling interests	(70)						(70)
Ending balance at Mar. 31, 2015	(12,246)	0	613	29,489	(8,090)	(35,628)	1,370
Beginning balance at Dec. 31, 2015	(11,476)	0	1,929	29,842	(9,402)	(35,613)	1,768
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	1,605			1,530			75
Other comprehensive earnings (losses), net of income taxes	514				488		26
Issuance of stock awards	59		(56)			115
Dividends declared ($1.00 and $1.02 per share for the three months ended March 31, 2015 and 2016, respectively)	(1,587)			(1,587)
Payments to noncontrolling interests	(12)						(12)
Other	3		1				2
Ending balance at Mar. 31, 2016	$ (10,894)	$ 0	$ 1,874	$ 29,785	$ (8,914)	$ (35,498)	$ 1,859

XML 20 R8.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 1.02	$ 1

XML 21 R9.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
Net earnings	$ 1,605	$ 1,834
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	175	192
Deferred income tax provision	10	132
Asset impairment and exit costs, net of cash paid	(14)	(160)
Cash effects of changes:
Receivables, net	(175)	54
Inventories	49	393
Accounts payable	223	44
Income taxes	(485)	(535)
Accrued liabilities and other current assets	(922)	(2,327)
Pension plan contributions	(52)	(9)
Other	48	7
Net cash provided by (used in) operating activities	462	(375)
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
Capital expenditures	(226)	(203)
Investments in unconsolidated subsidiaries	(7)	(8)
Other	(186)	279
Net cash provided by (used in) investing activities	(419)	68
Short-term borrowing activity by original maturity:
Net (repayments) issuances - maturities of 90 days or less	(136)	2,237
Issuances - maturities longer than 90 days	0	13
Long-term debt proceeds	1,978	302
Long-term debt repaid	(827)	(399)
Repurchases of common stock	0	(48)
Dividends paid	(1,585)	(1,555)
Sale (purchase) of subsidiary shares to (from) noncontrolling interests	6	0
Other	(29)	(25)
Net cash provided by (used in) financing activities	(593)	525
Effect of exchange rate changes on cash and cash equivalents	77	(376)
Cash and cash equivalents:
Decrease	(473)	(158)
Balance at beginning of period	3,417	1,682
Balance at end of period	$ 2,944	$ 1,524

XML 22 R10.htm IDEA: XBRL DOCUMENT

Background and Basis of Presentation	3 Months Ended
Background and Basis of Presentation	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation: Background Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Throughout these financial statements, the term “PMI” refers to Philip Morris International Inc. and its subsidiaries. Basis of Presentation The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year. Certain prior years' amounts have been reclassified to conform with the current year's presentation, as reflected in Note 8. Segment Reporting. The changes did not have an impact on PMI's consolidated financial position, results of operations or cash flows in any of the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2015.

XML 23 R11.htm IDEA: XBRL DOCUMENT

Asset Impairment and Exit Costs

3 Months Ended

Mar. 31, 2016

Restructuring and Related Activities [Abstract]

Asset Impairment and Exit Costs

Asset Impairment and Exit Costs:

During the three months ended March 31, 2016 and 2015, PMI did not incur asset impairment and exit costs.

Movement in Exit Cost Liabilities

The movement in exit cost liabilities for the three months ended March 31, 2016 was as follows:



(in millions)
Liability balance, January 1, 2016	$	54
Charges, net	—
Cash spent	(14		)
Currency/other	2
Liability balance, March 31, 2016	$	42

XML 24 R12.htm IDEA: XBRL DOCUMENT

Stock Plans	3 Months Ended
Stock Plans	Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Plans	Stock Plans: In May 2012, PMI’s shareholders approved the Philip Morris International Inc. 2012 Performance Incentive Plan (the “2012 Plan”). Under the 2012 Plan, PMI may grant to eligible employees restricted stock, restricted stock units and deferred stock units (collectively referred to as restricted share units), performance-based cash incentive awards and performance-based equity awards. Up to 30 million shares of PMI’s common stock may be issued under the 2012 Plan. At March 31, 2016, shares available for grant under the 2012 Plan were 21,608,980. In 2008, PMI adopted the Philip Morris International Inc. 2008 Stock Compensation Plan for Non-Employee Directors (the “Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the Non-Employee Directors Plan. At March 31, 2016, shares available for grant under the plan were 691,432. Restricted share unit (RSU) awards During the three months ended March 31, 2016, PMI granted 1.2 million shares of RSU awards to eligible employees at a weighted-average grant date fair value of $89.02 per share. During the three months ended March 31, 2015, PMI granted 1.5 million shares of RSU awards to eligible employees at a grant date fair value of $82.28 per share. PMI recorded compensation expense related to RSU awards of $41 million and $58 million during the three months ended March 31, 2016 and 2015, respectively. As of March 31, 2016, PMI had $198 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three or more years after the date of the award, subject to earlier vesting on death, disability or normal retirement, or separation from employment by mutual agreement after reaching age 58. During the three months ended March 31, 2016, 2.1 million shares of PMI RSU awards vested. The grant date fair value of all the vested shares was approximately $190 million. The total fair value of RSU awards that vested during the three months ended March 31, 2016 was approximately $196 million. Performance share unit (PSU) awards During the three months ended March 31, 2016, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a three-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group, PMI’s currency neutral compound annual adjusted operating companies income growth rate, excluding acquisitions, and PMI’s performance against specific measures of PMI’s innovation. The aggregate of the weighted performance factors for the three metrics determines the percentage of PSUs that will vest at the end of the three-year performance cycle. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. The minimum percentage of PSUs that can vest is zero, with a maximum percentage of 200. Participants are entitled to dividend equivalents for any vested PSUs, at the end of the performance cycle. During the three months ended March 31, 2016, PMI granted 0.4 million shares of PSU awards to eligible employees. The grant date fair value of the PSU market based awards subject to the TSR performance factor is $104.60 per share, which was determined by using the Monte Carlo simulation model. The grant date fair value of the PSU awards subject to the other performance factors is $89.02 per share, which was determined by using the average of the high and low market price of PMI’s stock at the date of grant. PMI recorded compensation expense related to PSU awards of $12 million during the three months ended March 31, 2016. As of March 31, 2016, PMI had $29 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

XML 25 R13.htm IDEA: XBRL DOCUMENT

Benefit Plans

3 Months Ended

Mar. 31, 2016

Compensation and Retirement Disclosure [Abstract]

Benefit Plans

Benefit Plans:

Pension Plans

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:



	U.S. Plans						Non-U.S. Plans
	For the Three Months Ended March 31,						For the Three Months Ended March 31,
(in millions)	2016			2015			2016			2015
Service cost	$	1		$	1		$	50		$	51
Interest cost	4			5			31			36
Expected return on plan assets	(3		)	(4		)	(81		)	(83		)
Amortization:
Net loss	1			3			44			46
Prior service cost	1			—			1			1
Net periodic pension cost	$	4		$	5		$	45		$	51

Employer Contributions

XML 26 R14.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangible Assets, net

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets, net

Goodwill and Other Intangible Assets, net:

Goodwill and other intangible assets, net, by segment were as follows:



	Goodwill				Other Intangible Assets, net
(in millions)	March 31, 2016		December 31, 2015		March 31, 2016		December 31, 2015
European Union	$	1,349	$	1,310	$	514	$	516
Eastern Europe, Middle East & Africa	381		374		202		201
Asia	3,705		3,581		1,118		1,087
Latin America & Canada	2,248		2,150		830		819
Total	$	7,683	$	7,415	$	2,664	$	2,623



(in millions)	European Union		Eastern Europe, Middle East & Africa		Asia		Latin America & Canada		Total
Balances, December 31, 2015	$	1,310	$	374	$	3,581	$	2,150	$	7,415
Changes due to:
Currency	39		7		124		98		268
Balances, March 31, 2016	$	1,349	$	381	$	3,705	$	2,248	$	7,683

Additional details of other intangible assets were as follows:



	March 31, 2016				December 31, 2015
(in millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Non-amortizable intangible assets	$	1,559			$	1,527
Amortizable intangible assets	1,650		$	545	1,609		$	513
Total other intangible assets	$	3,209	$	545	$	3,136	$	513



(dollars in millions)	Gross Carrying Amount		Initial Estimated Useful Lives	Weighted-Average Remaining Useful Life
Trademarks	$	1,409	2 - 40 years	21 years
Distribution networks	153		5 - 30 years	11 years
Other (including farmer contracts and intellectual property rights)	88		4 - 17 years	10 years
	$	1,650

The increase in the gross carrying amount of other intangible assets from December 31, 2015, was due to currency movements.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 27 R15.htm IDEA: XBRL DOCUMENT

Financial Instruments

3 Months Ended

Mar. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments

Financial Instruments:

Overview

The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2016 and December 31, 2015, were as follows:



	Asset Derivatives					Liability Derivatives
		Fair Value					Fair Value
(in millions)	Balance Sheet Classification	At March 31, 2016		At December 31, 2015		Balance Sheet Classification	At March 31, 2016		At December 31, 2015
Foreign exchange contracts designated as hedging instruments	Other current assets	$	199	$	301	Other accrued liabilities	$	33	$	26
	Other assets	149		181		Other liabilities	228		117
Foreign exchange contracts not designated as hedging instruments	Other current assets	100		7		Other accrued liabilities	30		29
	Other assets	63		85		Other liabilities	8		—
Total derivatives		$	511	$	574		$	299	$	172



(pre-tax, millions)	For the Three Months Ended March 31,
	Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives					Statement of Earnings Classification of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings
	2016			2015			2016			2015
Derivatives in Cash Flow Hedging Relationship
Foreign exchange contracts	$	(79	)	$	27
						Net revenues	$	5		$	30
						Cost of sales	14			—
						Marketing, administration and research costs	4			7
						Interest expense, net	(17		)	(7		)
Derivatives in Net Investment Hedging Relationship
Foreign exchange contracts	(197		)	286
Total	$	(276	)	$	313		$	6		$	30

Cash Flow Hedges

Hedges of Net Investments in Foreign Operations

Other Derivatives

For the three months ended March 31, 2016 and 2015, the net impact of these contracts on the condensed consolidated statements of earnings was not material.

Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses



(in millions)	For the Three Months Ended March 31,
	2016			2015
Gain as of January 1,	$	59		$	123
Derivative gains transferred to earnings	(7		)	(27		)
Change in fair value	(62		)	25
Gain/(loss) as of March 31,	$	(10	)	$	121

Contingent Features

PMI’s derivative instruments do not contain contingent features.

Credit Exposure and Credit Risk

PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.

Fair Value

See Note 12. Fair Value Measurements and Note 14. Balance Sheet Offsetting for additional discussion of derivative financial instruments.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

XML 28 R16.htm IDEA: XBRL DOCUMENT

Earnings Per Share

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share:

Basic and diluted earnings per share (“EPS”) were calculated using the following:



(in millions)	For the Three Months Ended March 31,
	2016		2015
Net earnings attributable to PMI	$	1,530	$	1,795
Less distributed and undistributed earnings attributable to share-based payment awards	5		7
Net earnings for basic and diluted EPS	$	1,525	$	1,788
Weighted-average shares for basic and diluted EPS	1,550		1,548

For the 2016 and 2015 computations, there were no antidilutive stock awards.

XML 29 R17.htm IDEA: XBRL DOCUMENT

Segment Reporting

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment Reporting

Segment Reporting:

Segment data were as follows:



(in millions)	For the Three Months Ended March 31,
	2016			2015
Net revenues:
European Union	$	6,143		$	6,222
Eastern Europe, Middle East & Africa	3,997			4,147
Asia	4,689			4,764
Latin America & Canada	1,959			2,219
Net revenues	$	16,788		$	17,352
Earnings before income taxes:
Operating companies income:
European Union	$	906		$	927
Eastern Europe, Middle East & Africa	633			866
Asia	778			934
Latin America & Canada	229			230
Amortization of intangibles	(18		)	(22		)
General corporate expenses	(46		)	(41		)
Less:
Equity (income)/loss in unconsolidated subsidiaries, net	(9		)	(23		)
Operating income	2,473			2,871
Interest expense, net	(247		)	(275		)
Earnings before income taxes	$	2,226		$	2,596

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

XML 30 R18.htm IDEA: XBRL DOCUMENT

Contingencies

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Contingencies:

Tobacco-Related Litigation

To date, no tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.

The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 22, 2016, April 30, 2015 and May 1, 2014:



Type of Case	Number of Cases Pending as of April 22, 2016	Number of Cases Pending as of April 30, 2015	Number of Cases Pending as of May 1, 2014
Individual Smoking and Health Cases	66	61	65
Smoking and Health Class Actions	11	11	11
Health Care Cost Recovery Actions	16	16	15
Lights Class Actions	—	—	1
Individual Lights Cases	3	2	2
Public Civil Actions	3	2	2

The table below lists the verdict and significant post-trial developments in the three pending cases where a verdict was returned in favor of the plaintiff:



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
February 2004	Brazil/The Smoker Health Defense Association	Class Action	The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.	Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Cecilia Létourneau	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36.3 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.2 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion, into a trust within 60 days.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $178 million). A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)

Pending claims related to tobacco products generally fall within the following categories:

As of April 22, 2016, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:


•	66 cases brought by individual plaintiffs in Argentina (31), Brazil (20), Canada (2), Chile (8), Costa Rica (2), Italy (1), the Philippines (1) and Scotland (1), compared with 61 such cases on April 30, 2015, and 65 cases on May 1, 2014; and


•	11 cases brought on behalf of classes of individual plaintiffs in Brazil (2) and Canada (9), compared with 11 such cases on April 30, 2015 and 11 such cases on May 1, 2014.

In the first class action pending in Canada, Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million), in the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.7 million) beginning in December 2015 through March 2017. See the Blais description for further detail concerning the security order. The Court of Appeal has scheduled a hearing for the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than three years after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the second class action pending in Canada, Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion, including pre-judgment interest (approximately $12.2 billion). The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion, including pre-judgment interest (approximately $2.4 billion)). In addition, the trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at 99,957 members. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award into a trust within 60 days, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make an initial payment within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD 5 billion (approximately $3.9 billion) into trust, to secure the judgments in both the Létourneau and Blais cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. Such security may take the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.7 million) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $598 million) in seven equal consecutive quarterly installments of approximately CAD 108 million (approximately $85 million) beginning in December 2015 through June 2017. In March 2016, our subsidiary made its second quarterly installment of security for approximately CAD 37.6 million (approximately $29.7 million) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal has scheduled a hearing for the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the fourth health care cost recovery case filed in Canada, Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada, filed February 8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants are scheduled to file their defenses in May 2016.

Other Litigation

XML 31 R19.htm IDEA: XBRL DOCUMENT

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes: Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets. PMI’s effective tax rates for the three months ended March 31, 2016 and 2015 were 28.3% and 30.2%, respectively. PMI estimates that its full-year 2016 effective tax rate will be approximately 28%. The effective tax rate for the three months ended March 31, 2015, was unfavorably impacted by changes to repatriation assertions on certain foreign subsidiary historical earnings ($58 million). Excluding the effect of the 2015 repatriation assertion changes, the change in the effective tax rate for the three months ended March 31, 2016, as compared to the three months ended March 31, 2015, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences. The effective tax rates are based on PMI’s full-year earnings mix projections by taxing jurisdiction and cash repatriation plans. Changes in earnings mix by taxing jurisdiction or in cash repatriation plans could have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions. PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2012 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years. It is reasonably possible that within the next twelve months certain tax examinations will close, which could result in a change in unrecognized tax benefits, along with related interest and penalties. An estimate of any possible change cannot be made at this time.

XML 32 R20.htm IDEA: XBRL DOCUMENT

Indebtedness

3 Months Ended

Mar. 31, 2016

Debt Disclosure [Abstract]

Indebtedness

Indebtedness:

Short-term Borrowings:

Long-term Debt:

At March 31, 2016 and December 31, 2015, PMI’s long-term debt consisted of the following:



(in millions)	March 31, 2016		December 31, 2015
U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.612%), due through 2044	$	20,079	$	18,091
Foreign currency obligations:
Euro notes, 1.750% to 3.125% (average interest rate 2.433%), due through 2033	6,844		7,423
Swiss franc notes, 0.750% to 2.000% (average interest rate 1.217%), due through 2024	1,737		1,690
Other (average interest rate 3.126%), due through 2024	460		451
	29,120		27,655
Less current portion of long-term debt	2,437		2,405
	$	26,683	$	25,250

Other foreign currency debt above includes mortgage debt in Switzerland, capital lease obligations and a bank loan in the Philippines.

PMI's debt issuances in the first three months of 2016 were as follows:



(in millions)
Type		Face Value	Interest Rate		Issuance	Maturity

U.S. dollar notes	^(a)	$500	1.375	%	February 2016	February 2019
U.S. dollar notes	^(a)	$750	1.875	%	February 2016	February 2021
U.S. dollar notes	^(a)	$750	2.750	%	February 2016	February 2026

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2016.

The net proceeds from the sale of the securities listed in the table above will be used for general corporate purposes.

Credit Facilities:

At March 31, 2016, PMI's total committed credit facilities were as follows:

(in billions)



Type	Committed Credit Facilities
364-day revolving credit, expiring February 7, 2017	$	2.0
Multi-year revolving credit, expiring February 28, 2021	2.5
Multi-year revolving credit, expiring October 1, 2020	3.5
Total facilities	$	8.0

At March 31, 2016, there were no borrowings under these committed credit facilities, and the entire committed amounts were available for borrowing.

XML 33 R21.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements:


Level 1 -	Quoted prices in active markets for identical assets or liabilities;


Level 2 -	Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and


Level 3 -	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period.

Derivative Financial Instruments

Debt

The aggregate fair values of PMI’s derivative financial instruments and debt as of March 31, 2016, were as follows:



(in millions)	Fair Value at March 31, 2016		Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Foreign exchange contracts	$	511	$	—	$	511	$	—
Total assets	$	511	$	—	$	511	$	—
Liabilities:
Debt	$	31,912	$	31,432	$	480	$	—
Foreign exchange contracts	299		—		299		—
Total liabilities	$	32,211	$	31,432	$	779	$	—

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 34 R22.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Losses

3 Months Ended

Mar. 31, 2016

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Losses

Accumulated Other Comprehensive Losses:

PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:



(in millions)	At March 31, 2016			At December 31, 2015			At March 31, 2015
Currency translation adjustments	$	(5,617	)	$	(6,129	)	$	(5,247	)
Pension and other benefits	(3,287		)	(3,332		)	(2,964		)
Derivatives accounted for as hedges	(10		)	59			121
Total accumulated other comprehensive losses	$	(8,914	)	$	(9,402	)	$	(8,090	)

Reclassifications from Other Comprehensive Earnings

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

XML 35 R23.htm IDEA: XBRL DOCUMENT

Balance Sheet Offsetting

3 Months Ended

Mar. 31, 2016

Offsetting [Abstract]

Balance Sheet Offsetting

Balance Sheet Offsetting:

Derivative Financial Instruments

The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:



(in millions)	Gross Amounts Recognized		Gross Amount Offset in the Condensed Consolidated Balance Sheet		Net Amounts Presented in the Condensed Consolidated Balance Sheet		Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet
							Financial Instruments			Cash Collateral Received/Pledged
													Net Amount

At March 31, 2016
Assets
Foreign exchange contracts	$	511	$	—	$	511	$	(209	)	$	(273	)	$	29
Liabilities
Foreign exchange contracts	$	299	$	—	$	299	$	(209	)	$	(63	)	$	27
At December 31, 2015
Assets
Foreign exchange contracts	$	574	$	—	$	574	$	(131	)	$	(432	)	$	11
Liabilities
Foreign exchange contracts	$	172	$	—	$	172	$	(131	)	$	(30	)	$	11

XML 36 R24.htm IDEA: XBRL DOCUMENT

Investments in Unconsolidated Subsidiaries

3 Months Ended

Mar. 31, 2016

Equity Method Investments and Joint Ventures [Abstract]

Investments in Unconsolidated Subsidiaries

Investments in Unconsolidated Subsidiaries:

PMI’s earnings activity from unconsolidated subsidiaries was as follows:



	For the Three Months Ended March 31,
(in millions)	2016		2015
Net revenues	$	777	$	896

PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:



(in millions)	At March 31, 2016		At December 31, 2015

Receivables	$	319	$	64
Notes receivable	$	102	$	100
Other liabilities	$	100	$	100

XML 37 R25.htm IDEA: XBRL DOCUMENT

Acquisitions and Other Business Arrangements	3 Months Ended
Acquisitions and Other Business Arrangements	Mar. 31, 2016
Business Combinations [Abstract]
Acquisitions and Other Business Arrangements	Acquisitions and Other Business Arrangements: As announced in June 2015, PMI’s subsidiary PT HM Sampoerna Tbk. (“Sampoerna”), of which PMI held a 98.18% interest, was required to comply with the January 30, 2014, Indonesian Stock Exchange (“IDX”) regulation requiring all listed public companies to have at least a 7.5% public shareholding by January 30, 2016. In order to comply with this requirement, Sampoerna conducted a rights issue (the “Rights Issue”). The exercise price for the rights was set at Rp. 77,000 per share, a 1.349% premium to the closing price on the IDX as of September 30, 2015. In connection with the Rights Issue, PT Philip Morris Indonesia (“PMID”), a fully consolidated subsidiary of PMI, sold 264,209,711 of the rights to third-party investors. Delivery of the rights sold took place on October 26, 2015. The total net proceeds from the Rights Issue were $1.5 billion at prevailing exchange rates on the closing date. The sale of the rights resulted in an increase to PMI's additional paid-in capital of $1.1 billion during the fourth quarter of 2015. In June 2014, PMI acquired 100% of Nicocigs Limited, a leading U.K.-based e-vapor company, for the final purchase price of $103 million, net of cash acquired, with additional contingent payments of up to $77 million, primarily relating to performance targets over a three-year period. As of March 31, 2016, PMI does not anticipate that the performance targets will be met. In September 2013, Grupo Carso, S.A.B. de C.V. ("Grupo Carso") sold to PMI its remaining 20% interest in PMI's Mexican tobacco business for $703 million. As a result, PMI now owns 100% of its Mexican tobacco business. A former director of PMI, whose term expired at the Annual Meeting of Shareholders in May 2015, had an affiliation with Grupo Carso. The final purchase price was subject to an adjustment based on the actual performance of the Mexican tobacco business over the three-year period ending two fiscal years after the closing of the purchase. In May 2015, PMI received a payment of $113 million from Grupo Carso as the final purchase price adjustment. This resulted in a total net purchase price of $590 million. In addition, PMI agreed to pay a dividend of approximately $38 million to Grupo Carso related to the earnings of the Mexican tobacco business for the nine months ended September 30, 2013. In March 2014, the dividend was declared and paid. The purchase of the remaining 20% interest resulted in a net decrease to PMI's additional paid-in capital of $559 million. The effects of these acquisitions were not material to PMI's condensed consolidated financial position, results of operations or operating cash flows in any of the periods presented.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

XML 38 R26.htm IDEA: XBRL DOCUMENT

Sale of Accounts Receivable	3 Months Ended
Sale of Accounts Receivable	Mar. 31, 2016
Sale of Accounts Receivable [Abstract]
Sale of Accounts Receivable	Sale of Accounts Receivable: To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of March 31, 2016 and March 31, 2015. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions. Cumulative trade receivables sold for the three months ended March 31, 2016 and March 31, 2015, were $1.9 billion and $0.3 billion, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2016 and March 31, 2015, were $589 million, and $108 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the consolidated statements of earnings. For the three months ended March 31, 2016 and 2015, the loss on sale of trade receivables was not material.

XML 39 R27.htm IDEA: XBRL DOCUMENT

New Accounting Standards

3 Months Ended

Mar. 31, 2016

Accounting Changes and Error Corrections [Abstract]

New Accounting Standards

New Accounting Standards:

Entities can apply the final standard using one of the following two methods:


1.	retrospectively to each prior period presented; or


2.	retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6510796

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

+ Details

XML 40 R28.htm IDEA: XBRL DOCUMENT

New Accounting Standards (Policies)

3 Months Ended

Mar. 31, 2016

Accounting Changes and Error Corrections [Abstract]

New Accounting Standards

New Accounting Standards:

Entities can apply the final standard using one of the following two methods:


1.	retrospectively to each prior period presented; or


2.	retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.

XML 41 R29.htm IDEA: XBRL DOCUMENT

Asset Impairment and Exit Costs (Tables)

3 Months Ended

Mar. 31, 2016

Restructuring and Related Activities [Abstract]

Movement in the Exit Cost Liabilities

The movement in exit cost liabilities for the three months ended March 31, 2016 was as follows:



(in millions)
Liability balance, January 1, 2016	$	54
Charges, net	—
Cash spent	(14		)
Currency/other	2
Liability balance, March 31, 2016	$	42

XML 42 R30.htm IDEA: XBRL DOCUMENT

Benefit Plans (Tables)

3 Months Ended

Mar. 31, 2016

Compensation and Retirement Disclosure [Abstract]

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:



	U.S. Plans						Non-U.S. Plans
	For the Three Months Ended March 31,						For the Three Months Ended March 31,
(in millions)	2016			2015			2016			2015
Service cost	$	1		$	1		$	50		$	51
Interest cost	4			5			31			36
Expected return on plan assets	(3		)	(4		)	(81		)	(83		)
Amortization:
Net loss	1			3			44			46
Prior service cost	1			—			1			1
Net periodic pension cost	$	4		$	5		$	45		$	51

XML 43 R31.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangible Assets, net (Tables)

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill and Intangible Assets, Net, by Segment or Major Class

Additional details of other intangible assets were as follows:



	March 31, 2016				December 31, 2015
(in millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Non-amortizable intangible assets	$	1,559			$	1,527
Amortizable intangible assets	1,650		$	545	1,609		$	513
Total other intangible assets	$	3,209	$	545	$	3,136	$	513

Goodwill and other intangible assets, net, by segment were as follows:



	Goodwill				Other Intangible Assets, net
(in millions)	March 31, 2016		December 31, 2015		March 31, 2016		December 31, 2015
European Union	$	1,349	$	1,310	$	514	$	516
Eastern Europe, Middle East & Africa	381		374		202		201
Asia	3,705		3,581		1,118		1,087
Latin America & Canada	2,248		2,150		830		819
Total	$	7,683	$	7,415	$	2,664	$	2,623

Movements in Goodwill

The movements in goodwill from December 31, 2015, were as follows:



(in millions)	European Union		Eastern Europe, Middle East & Africa		Asia		Latin America & Canada		Total
Balances, December 31, 2015	$	1,310	$	374	$	3,581	$	2,150	$	7,415
Changes due to:
Currency	39		7		124		98		268
Balances, March 31, 2016	$	1,349	$	381	$	3,705	$	2,248	$	7,683

Gross Carrying Amount, Range of Useful Lives and Weighted-Average Remaining Useful Life of Amortizable Intangible Assets

The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2016, were as follows:



(dollars in millions)	Gross Carrying Amount		Initial Estimated Useful Lives	Weighted-Average Remaining Useful Life
Trademarks	$	1,409	2 - 40 years	21 years
Distribution networks	153		5 - 30 years	11 years
Other (including farmer contracts and intellectual property rights)	88		4 - 17 years	10 years
	$	1,650

XML 44 R32.htm IDEA: XBRL DOCUMENT

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value of Foreign Exchange Contracts

The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2016 and December 31, 2015, were as follows:



	Asset Derivatives					Liability Derivatives
		Fair Value					Fair Value
(in millions)	Balance Sheet Classification	At March 31, 2016		At December 31, 2015		Balance Sheet Classification	At March 31, 2016		At December 31, 2015
Foreign exchange contracts designated as hedging instruments	Other current assets	$	199	$	301	Other accrued liabilities	$	33	$	26
	Other assets	149		181		Other liabilities	228		117
Foreign exchange contracts not designated as hedging instruments	Other current assets	100		7		Other accrued liabilities	30		29
	Other assets	63		85		Other liabilities	8		—
Total derivatives		$	511	$	574		$	299	$	172

Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings



(pre-tax, millions)	For the Three Months Ended March 31,
	Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives					Statement of Earnings Classification of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings
	2016			2015			2016			2015
Derivatives in Cash Flow Hedging Relationship
Foreign exchange contracts	$	(79	)	$	27
						Net revenues	$	5		$	30
						Cost of sales	14			—
						Marketing, administration and research costs	4			7
						Interest expense, net	(17		)	(7		)
Derivatives in Net Investment Hedging Relationship
Foreign exchange contracts	(197		)	286
Total	$	(276	)	$	313		$	6		$	30

Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses), Net of Income Taxes

Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:



(in millions)	For the Three Months Ended March 31,
	2016			2015
Gain as of January 1,	$	59		$	123
Derivative gains transferred to earnings	(7		)	(27		)
Change in fair value	(62		)	25
Gain/(loss) as of March 31,	$	(10	)	$	121

XML 45 R33.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Calculation of Basic and Diluted EPS

Basic and diluted earnings per share (“EPS”) were calculated using the following:



(in millions)	For the Three Months Ended March 31,
	2016		2015
Net earnings attributable to PMI	$	1,530	$	1,795
Less distributed and undistributed earnings attributable to share-based payment awards	5		7
Net earnings for basic and diluted EPS	$	1,525	$	1,788
Weighted-average shares for basic and diluted EPS	1,550		1,548

XML 46 R34.htm IDEA: XBRL DOCUMENT

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment Data

Segment data were as follows:



(in millions)	For the Three Months Ended March 31,
	2016			2015
Net revenues:
European Union	$	6,143		$	6,222
Eastern Europe, Middle East & Africa	3,997			4,147
Asia	4,689			4,764
Latin America & Canada	1,959			2,219
Net revenues	$	16,788		$	17,352
Earnings before income taxes:
Operating companies income:
European Union	$	906		$	927
Eastern Europe, Middle East & Africa	633			866
Asia	778			934
Latin America & Canada	229			230
Amortization of intangibles	(18		)	(22		)
General corporate expenses	(46		)	(41		)
Less:
Equity (income)/loss in unconsolidated subsidiaries, net	(9		)	(23		)
Operating income	2,473			2,871
Interest expense, net	(247		)	(275		)
Earnings before income taxes	$	2,226		$	2,596

XML 47 R35.htm IDEA: XBRL DOCUMENT

Contingencies (Tables)

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Schedule of Tobacco Related Cases Pending Against Company

The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 22, 2016, April 30, 2015 and May 1, 2014:



Type of Case	Number of Cases Pending as of April 22, 2016	Number of Cases Pending as of April 30, 2015	Number of Cases Pending as of May 1, 2014
Individual Smoking and Health Cases	66	61	65
Smoking and Health Class Actions	11	11	11
Health Care Cost Recovery Actions	16	16	15
Lights Class Actions	—	—	1
Individual Lights Cases	3	2	2
Public Civil Actions	3	2	2

Schedule Of Verdicts And Post Trial Developments Where a Verdict was Returned In Favor of the Plaintiff(s)

The table below lists the verdict and significant post-trial developments in the three pending cases where a verdict was returned in favor of the plaintiff:



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
February 2004	Brazil/The Smoker Health Defense Association	Class Action	The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.	Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Cecilia Létourneau	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36.3 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.2 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion, into a trust within 60 days.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $178 million). A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)

XML 48 R36.htm IDEA: XBRL DOCUMENT

Indebtedness (Tables)

3 Months Ended

Mar. 31, 2016

Debt Disclosure [Abstract]

Long-Term Debt

At March 31, 2016 and December 31, 2015, PMI’s long-term debt consisted of the following:



(in millions)	March 31, 2016		December 31, 2015
U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.612%), due through 2044	$	20,079	$	18,091
Foreign currency obligations:
Euro notes, 1.750% to 3.125% (average interest rate 2.433%), due through 2033	6,844		7,423
Swiss franc notes, 0.750% to 2.000% (average interest rate 1.217%), due through 2024	1,737		1,690
Other (average interest rate 3.126%), due through 2024	460		451
	29,120		27,655
Less current portion of long-term debt	2,437		2,405
	$	26,683	$	25,250

Debt Issuances During Current Period

PMI's debt issuances in the first three months of 2016 were as follows:



(in millions)
Type		Face Value	Interest Rate		Issuance	Maturity

U.S. dollar notes	^(a)	$500	1.375	%	February 2016	February 2019
U.S. dollar notes	^(a)	$750	1.875	%	February 2016	February 2021
U.S. dollar notes	^(a)	$750	2.750	%	February 2016	February 2026

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2016.

Schedule of Committed Credit Facilities

At March 31, 2016, PMI's total committed credit facilities were as follows:

(in billions)



Type	Committed Credit Facilities
364-day revolving credit, expiring February 7, 2017	$	2.0
Multi-year revolving credit, expiring February 28, 2021	2.5
Multi-year revolving credit, expiring October 1, 2020	3.5
Total facilities	$	8.0

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

XML 49 R37.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Aggregate Fair Values of Derivative Financial Instruments and Debt

The aggregate fair values of PMI’s derivative financial instruments and debt as of March 31, 2016, were as follows:



(in millions)	Fair Value at March 31, 2016		Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Foreign exchange contracts	$	511	$	—	$	511	$	—
Total assets	$	511	$	—	$	511	$	—
Liabilities:
Debt	$	31,912	$	31,432	$	480	$	—
Foreign exchange contracts	299		—		299		—
Total liabilities	$	32,211	$	31,432	$	779	$	—

XML 50 R38.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Losses (Tables)

3 Months Ended

Mar. 31, 2016

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Components of Accumulated Other Comprehensive Earnings (Losses), Net of Taxes

PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:



(in millions)	At March 31, 2016			At December 31, 2015			At March 31, 2015
Currency translation adjustments	$	(5,617	)	$	(6,129	)	$	(5,247	)
Pension and other benefits	(3,287		)	(3,332		)	(2,964		)
Derivatives accounted for as hedges	(10		)	59			121
Total accumulated other comprehensive losses	$	(8,914	)	$	(9,402	)	$	(8,090	)

XML 51 R39.htm IDEA: XBRL DOCUMENT

Balance Sheet Offsetting (Tables)

3 Months Ended

Mar. 31, 2016

Offsetting [Abstract]

Offsetting Assets and Liabilities

The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:



(in millions)	Gross Amounts Recognized		Gross Amount Offset in the Condensed Consolidated Balance Sheet		Net Amounts Presented in the Condensed Consolidated Balance Sheet		Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet
							Financial Instruments			Cash Collateral Received/Pledged
													Net Amount

At March 31, 2016
Assets
Foreign exchange contracts	$	511	$	—	$	511	$	(209	)	$	(273	)	$	29
Liabilities
Foreign exchange contracts	$	299	$	—	$	299	$	(209	)	$	(63	)	$	27
At December 31, 2015
Assets
Foreign exchange contracts	$	574	$	—	$	574	$	(131	)	$	(432	)	$	11
Liabilities
Foreign exchange contracts	$	172	$	—	$	172	$	(131	)	$	(30	)	$	11

XML 52 R40.htm IDEA: XBRL DOCUMENT

Investments in Unconsolidated Subsidiaries (Tables)

3 Months Ended

Mar. 31, 2016

Equity Method Investments and Joint Ventures [Abstract]

Earnings and Balance Sheet Activities with Unconsolidated Subsidiaries

PMI’s earnings activity from unconsolidated subsidiaries was as follows:



	For the Three Months Ended March 31,
(in millions)	2016		2015
Net revenues	$	777	$	896

PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:



(in millions)	At March 31, 2016		At December 31, 2015

Receivables	$	319	$	64
Notes receivable	$	102	$	100
Other liabilities	$	100	$	100

XML 53 R41.htm IDEA: XBRL DOCUMENT

Asset Impairment and Exit Costs (Movement In The Exit Cost Liabilities) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Restructuring Reserve [Roll Forward]
Liability beginning balance	$ 54
Charges, net	0
Cash spent	(14)	$ (160)
Currency/other	2
Liability ending balance	$ 42

XML 54 R42.htm IDEA: XBRL DOCUMENT

Asset Impairment and Exit Costs (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Restructuring and Related Activities [Abstract]
Cash payments related to exit costs	$ 14	$ 160
Restructuring Reserve	$ 42		$ 54

XML 55 R43.htm IDEA: XBRL DOCUMENT

Stock Plans (Details) $ / shares in Units, $ in Millions	3 Months Ended
Stock Plans (Details) $ / shares in Units, $ in Millions	Mar. 31, 2016 USD ($) performance_metric year $ / shares shares	Mar. 31, 2015 USD ($) $ / shares shares	May. 31, 2012 shares	Dec. 31, 2008 shares
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Minimum Retirement Age \| year	58
Restricted Stock Units (RSUs) [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Number of shares of stock awards granted during period (in shares)	1,200,000	1,500,000
Weighted average grant date fair value of stock awards, per share (in dollars per share) \| $ / shares	$ 89.02	$ 82.28
Compensation expense for stock awards \| $	$ 41	$ 58
Unrecognized compensation cost related to non-vested stock awards \| $	$ 198
Stock awards vested during period (in shares)	2,100,000
Restricted Stock Units (RSUs) [Member] \| Grant Date Fair Value [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Fair value of vested stock awards \| $	$ 190
Restricted Stock Units (RSUs) [Member] \| Total Fair Value [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Fair value of vested stock awards \| $	$ 196
Restricted Stock Units (RSUs) [Member] \| Minimum [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Award requisite service period	3 years
Performance Shares [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Number of shares of stock awards granted during period (in shares)	400,000
Weighted average grant date fair value of stock awards, per share (in dollars per share) \| $ / shares	$ 89.02
Compensation expense for stock awards \| $	$ 12
Unrecognized compensation cost related to non-vested stock awards \| $	$ 29
Award requisite service period	3 years
Performance period	3 years
Number of performance metrics used to determine the percentage of PSU's that will vest \| performance_metric	3
The number of shares of common stock issue for each vested PSU	1
Aggregate weighted performance factor that determines if the target number of PSUs will vest	100.00%
Performance Shares [Member] \| Minimum [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	0.00%
Performance Shares [Member] \| Maximum [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	200.00%
Performance Share Units, TSR Relative To Customer Peer Group [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Weighted average grant date fair value of stock awards, per share (in dollars per share) \| $ / shares	$ 104.60
2012 Performance Incentive Plan [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)			30,000,000
Shares available for grant under the plan (in shares)	21,608,980
Non Employee Directors Plan [Member]
Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items]
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)				1,000,000
Shares available for grant under the plan (in shares)	691,432
Percentage of voting shares that PMI may own, used in determining non-employee director status	50.00%

XML 56 R44.htm IDEA: XBRL DOCUMENT

Benefit Plans (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
U.S. Plans - Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1	$ 1
Interest cost	4	5
Expected return on plan assets	(3)	(4)
Amortization:
Net loss	1	3
Prior service cost	1	0
Net periodic pension cost	4	5
Non-U.S. Plans - Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	50	51
Interest cost	31	36
Expected return on plan assets	(81)	(83)
Amortization:
Net loss	44	46
Prior service cost	1	1
Net periodic pension cost	$ 45	$ 51

XML 57 R45.htm IDEA: XBRL DOCUMENT

Benefit Plans (Narrative) (Details) $ in Millions	3 Months Ended
Benefit Plans (Narrative) (Details) $ in Millions	Mar. 31, 2016 USD ($)
Compensation and Retirement Disclosure [Abstract]
Employer Contributions	$ 52
Anticipated additional employer contributions during the remainder of the current fiscal year	$ 59

XML 58 R46.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	$ 7,683	$ 7,415
Other Intangible Assets, net	2,664	2,623
European Union [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	1,349	1,310
Other Intangible Assets, net	514	516
Eastern Europe, Middle East & Africa [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	381	374
Other Intangible Assets, net	202	201
Asia [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	3,705	3,581
Other Intangible Assets, net	1,118	1,087
Latin America & Canada [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	2,248	2,150
Other Intangible Assets, net	$ 830	$ 819

XML 59 R47.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2016 USD ($)
Goodwill [Roll Forward]
Balances, December 31, 2015	$ 7,415
Changes due to:
Currency	268
Balances, March 31, 2016	7,683
European Union [Member]
Goodwill [Roll Forward]
Balances, December 31, 2015	1,310
Changes due to:
Currency	39
Balances, March 31, 2016	1,349
Eastern Europe, Middle East & Africa [Member]
Goodwill [Roll Forward]
Balances, December 31, 2015	374
Changes due to:
Currency	7
Balances, March 31, 2016	381
Asia [Member]
Goodwill [Roll Forward]
Balances, December 31, 2015	3,581
Changes due to:
Currency	124
Balances, March 31, 2016	3,705
Latin America & Canada [Member]
Goodwill [Roll Forward]
Balances, December 31, 2015	2,150
Changes due to:
Currency	98
Balances, March 31, 2016	$ 2,248

XML 60 R48.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Non-amortizable intangible assets, gross carrying amount	$ 1,559	$ 1,527
Amortizable intangible assets, gross carrying amount	1,650	1,609
Total other intangible assets, gross carrying amount	3,209	3,136
Accumulated Amortization	$ 545	$ 513

XML 61 R49.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,650	$ 1,609
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,409
Weighted-Average Remaining Useful Life	21 years
Trademarks [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	2 years
Trademarks [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	40 years
Distribution Networks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 153
Weighted-Average Remaining Useful Life	11 years
Distribution Networks [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	5 years
Distribution Networks [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	30 years
Other (Including Farmer Contracts and Intellectual Property Rights) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 88
Weighted-Average Remaining Useful Life	10 years
Other (Including Farmer Contracts and Intellectual Property Rights) [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	4 years
Other (Including Farmer Contracts and Intellectual Property Rights) [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	17 years

XML 62 R50.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangible Assets, net (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, pre-tax amortization expense	$ 18,000,000	$ 22,000,000
Estimated Amortization Expense, Year One, assuming no additional transactions occur that require the amortization of intangible assets	73,000,000
Estimated Amortization Expense, Year Two, assuming no additional transactions occur that require the amortization of intangible assets	73,000,000
Estimated Amortization Expense, Year Three, assuming no additional transactions occur that require the amortization of intangible assets	73,000,000
Estimated Amortization Expense, Year Four, assuming no additional transactions occur that require the amortization of intangible assets	73,000,000
Estimated Amortization Expense, Year Five, assuming no additional transactions occur that require the amortization of intangible assets	$ 73,000,000
Goodwill impairment		$ 0

XML 63 R51.htm IDEA: XBRL DOCUMENT

Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Derivative [Line Items]
Maturity of Foreign Currency Derivatives - Cash Flow Hedges	May 31, 2024
Unrealized gain (loss) on hedges of net investments	$ 538	$ (1,343)
Foreign Exchange Contract [Member]
Derivative [Line Items]
Notional amount	$ 25,300
Maximum length of time hedged in a Cash Flow Hedge	21 months
Derivative Instruments, gains to be reclassified to earnings.	$ (8)
Foreign Exchange Contract [Member] \| Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional amount	14,400
Gain (Loss) on derivatives not designated as hedging instruments	91	(751)
Foreign Exchange Contract [Member] \| Cash Flow Hedging [Member]
Derivative [Line Items]
Notional amount	3,700
Foreign Exchange Contract [Member] \| Net Investment Hedging [Member]
Derivative [Line Items]
Notional amount	7,200
Unrealized gain (loss) on hedges of net investments	$ (267)	$ 835

XML 64 R52.htm IDEA: XBRL DOCUMENT

Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) - Foreign Exchange Contract [Member] - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Derivative asset fair value	$ 511	$ 574
Derivative liability fair value	299	172
Designated as Hedging Instrument [Member] \| Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	199	301
Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	149	181
Designated as Hedging Instrument [Member] \| Other Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	33	26
Designated as Hedging Instrument [Member] \| Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	228	117
Not Designated as Hedging Instrument [Member] \| Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	100	7
Not Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	63	85
Not Designated as Hedging Instrument [Member] \| Other Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	30	29
Not Designated as Hedging Instrument [Member] \| Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	$ 8	$ 0

XML 65 R53.htm IDEA: XBRL DOCUMENT

Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives	$ (62)	$ 25
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	(7)	(27)
Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives	(276)	313
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	6	30
Foreign Exchange Contract [Member] \| Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives	(79)	27
Foreign Exchange Contract [Member] \| Cash Flow Hedges [Member] \| Net Revenue [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	5	30
Foreign Exchange Contract [Member] \| Cash Flow Hedges [Member] \| Cost of Sales [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	14	0
Foreign Exchange Contract [Member] \| Cash Flow Hedges [Member] \| Marketing Administration And Research Costs [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	4	7
Foreign Exchange Contract [Member] \| Cash Flow Hedges [Member] \| Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	(17)	(7)
Foreign Exchange Contract [Member] \| Net Investment Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives	$ (197)	$ 286

XML 66 R54.htm IDEA: XBRL DOCUMENT

Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]
Gain as of January 1,	$ 59
Derivative gains transferred to earnings	7	$ 27
Change in fair value	(62)	25
Gain/(loss) as of March 31,	(10)	121
Foreign Exchange Contract [Member]
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]
Derivative gains transferred to earnings	(6)	(30)
Change in fair value	(276)	313
Other Comprehensive Income (Loss) [Member] \| Foreign Exchange Contract [Member]
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]
Gain as of January 1,	59	123
Derivative gains transferred to earnings	(7)	(27)
Change in fair value	(62)	25
Gain/(loss) as of March 31,	$ (10)	$ 121

XML 67 R55.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Net earnings attributable to PMI	$ 1,530	$ 1,795
Less distributed and undistributed earnings attributable to share-based payment awards	5	7
Net earnings for basic and diluted EPS	$ 1,525	$ 1,788
Weighted-average shares for basic and diluted EPS (in shares)	1,550,000,000	1,548,000,000
Antidilutive stock awards	0	0

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 68 R56.htm IDEA: XBRL DOCUMENT

Segment Reporting (Details) - USD ($) $ in Millions	3 Months Ended
Segment Reporting (Details) - USD ($) $ in Millions	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Net revenues	$ 16,788	$ 17,352
Amortization of intangibles	(18)	(22)
General corporate expenses	(46)	(41)
Equity (income)/loss in unconsolidated subsidiaries, net	(9)	(23)
Operating income	2,473	2,871
Interest expense, net	(247)	(275)
Earnings before income taxes	2,226	2,596
Operating Segments [Member] \| European Union [Member]
Segment Reporting Information [Line Items]
Net revenues	6,143	6,222
Operating companies income:	906	927
Operating Segments [Member] \| Eastern Europe, Middle East & Africa [Member]
Segment Reporting Information [Line Items]
Net revenues	3,997	4,147
Operating companies income:	633	866
Operating Segments [Member] \| Asia [Member]
Segment Reporting Information [Line Items]
Net revenues	4,689	4,764
Operating companies income:	778	934
Operating Segments [Member] \| Latin America & Canada [Member]
Segment Reporting Information [Line Items]
Net revenues	1,959	2,219
Operating companies income:	$ 229	$ 230

XML 69 R57.htm IDEA: XBRL DOCUMENT

Contingencies (Tobacco-Related Litigation) (Details)	Mar. 31, 2016 litigation_case
Loss Contingencies [Line Items]
Number of cases decided in favor of PM	444
Number of cases decided in favor of plaintiff	12
Cases Remaining On Appeal [Member]
Loss Contingencies [Line Items]
Number of cases decided in favor of plaintiff	3
Case Decided In Favor Of Plaintiff [Member]
Loss Contingencies [Line Items]
Number of cases that reached final resolution in favor of PM	9

XML 70 R58.htm IDEA: XBRL DOCUMENT

Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) - litigation_case	Apr. 22, 2016	Apr. 30, 2015	May. 01, 2014
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM		61	65
Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		11	11
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		16	15
Lights Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		0	1
Individual Lights Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM		2	2
Public Civil Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		2	2
Subsequent Event [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM	66
Subsequent Event [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	11
Subsequent Event [Member] \| Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	16
Subsequent Event [Member] \| Lights Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	0
Subsequent Event [Member] \| Individual Lights Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM	3
Subsequent Event [Member] \| Public Civil Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	3

XML 71 R59.htm IDEA: XBRL DOCUMENT

Contingencies (Verdicts and Post-Trial Developments) (Details)			1 Months Ended							3 Months Ended
	May. 27, 2015 CAD	May. 27, 2015 USD ($)	Oct. 30, 2015 CAD	Oct. 30, 2015 USD ($)	Jul. 31, 2015	Jun. 30, 2015 CAD	Jun. 30, 2015 USD ($)	Apr. 30, 2004 BRL	Apr. 30, 2004 USD ($)	Mar. 31, 2016
Smoking And Health Class Actions [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate (percentage per month)								1.00%	1.00%
Smoking And Health Class Actions [Member] \| Award per smoker per year [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Damages awarded								BRL 1,000	$ 280
Brazil [Member] \| Smoking And Health Class Actions [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate (percentage per month)								1.00%	1.00%
Brazil [Member] \| Smoking And Health Class Actions [Member] \| Award per smoker per year [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Damages awarded								BRL 1,000	$ 280
Brazil [Member] \| Smoking And Health Class Actions [Member] \| Cases With Verdicts And Post Trial Developments [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Date										February 2004
Verdict										The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $280) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.
Post-Trial Developments										Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 131,000,000	$ 103,000,000
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 46,000,000	$ 36,000,000
Payment period for awarded punitive damages to be deposited into trust	60 days	60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust					60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust						60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust	60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 90,000	$ 71,000
Compensatory damages awarded	15,500,000,000	12,200,000,000
Awarded compensatory damages that are to be deposited into trust	1,000,000,000	789,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	30,000	23,700
Compensatory damages awarded	CAD 3,100,000,000	$ 2,400,000,000
Damages allocated to subsidiary (percent)	20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust	CAD 200,000,000	$ 158,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust					60 days
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished			CAD 226,000,000	$ 178,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cases With Verdicts And Post Trial Developments [Member] \| Cecilia Letourneau [Member]
Loss Contingencies [Line Items]
Date										May 27, 2015
Verdict										On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36.3 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
Post-Trial Developments										In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $178 million) to cover both the Létourneau and Blais cases. A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cases With Verdicts And Post Trial Developments [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]
Loss Contingencies [Line Items]
Date										May 27, 2015
Verdict										On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.2 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $71,000) in punitive damages, allocating CAD 30,000 (approximately $23,700) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $789 million) of the compensatory damage award, CAD 200 million (approximately $158 million) of which is our subsidiary’s portion, into a trust within 60 days.
Post-Trial Developments										In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $178 million). A hearing for the merits appeal is scheduled in November 2016. (See below for further detail.)
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	131,000,000	103,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 46,000,000	$ 36,300,000
Payment period for awarded punitive damages to be deposited into trust	60 days	60 days
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded						CAD 46,000,000	$ 36,300,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust	60 days	60 days
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 90,000	$ 71,000
Compensatory damages awarded	15,500,000,000	12,200,000,000
Awarded compensatory damages that are to be deposited into trust	1,000,000,000	789,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	30,000	23,700
Compensatory damages awarded	CAD 3,100,000,000	$ 2,400,000,000
Damages allocated to subsidiary (percent)	20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust	CAD 200,000,000	$ 158,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Awarded compensatory damages that are to be deposited into trust						CAD 200,000,000	$ 158,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished			CAD 226,000,000	$ 178,000,000

XML 72 R60.htm IDEA: XBRL DOCUMENT

Contingencies (Smoking And Health Litigation) (Details)					1 Months Ended
Contingencies (Smoking And Health Litigation) (Details)	May. 27, 2015 CAD manufacturer plaintiff	May. 27, 2015 USD ($) manufacturer plaintiff	Jun. 20, 2012 cigarette	Jul. 10, 2009 cigarette	Dec. 31, 2015 CAD	Dec. 31, 2015 USD ($)	Oct. 30, 2015 CAD installment	Oct. 30, 2015 USD ($) installment	Aug. 31, 2015 CAD	Aug. 31, 2015 USD ($)	Jul. 31, 2015	Jun. 30, 2015 CAD	Jun. 30, 2015 USD ($)	Apr. 30, 2004 BRL	Apr. 30, 2004 USD ($)	Apr. 22, 2016 litigation_case	Apr. 30, 2015 litigation_case	May. 01, 2014 litigation_case
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																	61	65
Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																	11	11
The Smoker Health Defense Association (ADESF) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate														1.00%	1.00%
The Smoker Health Defense Association (ADESF) [Member] \| Award per smoker per year [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Damages awarded														BRL 1,000	$ 280
Brazil [Member] \| The Smoker Health Defense Association (ADESF) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate														1.00%	1.00%
Brazil [Member] \| The Smoker Health Defense Association (ADESF) [Member] \| Award per smoker per year [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Damages awarded														BRL 1,000	$ 280
Canada [Member] \| Cecilia Letourneau [Member]
Loss Contingencies [Line Items]
Number of additional manufacturers found liable \| manufacturer	2	2
Estimated number of members in class \| plaintiff	918,000	918,000
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 131,000,000	$ 103,000,000
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	131,000,000	103,000,000
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 46,000,000	$ 36,000,000
Payment period for awarded punitive damages to be deposited into trust	60 days	60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 46,000,000	$ 36,300,000
Payment period for awarded punitive damages to be deposited into trust	60 days	60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust											60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust												60 days	60 days
Period between addiction warning and claim	3 years	3 years
Canada [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded												CAD 46,000,000	$ 36,300,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]
Loss Contingencies [Line Items]
Number of additional manufacturers found liable \| manufacturer	2	2
Estimated number of members in class \| plaintiff	99,957	99,957
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust	60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust	60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 90,000	$ 71,000
Compensatory damages awarded	15,500,000,000	12,200,000,000
Awarded compensatory damages that are to be deposited into trust	1,000,000,000	789,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	90,000	71,000
Compensatory damages awarded	15,500,000,000	12,200,000,000
Awarded compensatory damages that are to be deposited into trust	1,000,000,000	789,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	30,000	23,700
Compensatory damages awarded	CAD 3,100,000,000	$ 2,400,000,000
Damages allocated to subsidiary (percent)	20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust	CAD 200,000,000	$ 158,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	30,000	23,700
Compensatory damages awarded	CAD 3,100,000,000	$ 2,400,000,000
Damages allocated to subsidiary (percent)	20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust	CAD 200,000,000	$ 158,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust											60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust												60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Awarded compensatory damages that are to be deposited into trust												CAD 200,000,000	$ 158,000,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Number of consecutive quarterly installment \| installment							6	6
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Imperial Tobacco Ltd. [Member]
Loss Contingencies [Line Items]
Number of consecutive quarterly installment \| installment							7	7
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished							CAD 226,000,000	$ 178,000,000
Amount of security to be furnished in each consecutive quarterly installment							37,600,000	29,700,000
Amount of security furnished by defendants in quarterly installment					CAD 37,600,000	$ 29,700,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished							226,000,000	178,000,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Imperial Tobacco Ltd. [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished							758,000,000	598,000,000
Amount of security to be furnished in each consecutive quarterly installment							CAD 108,000,000	$ 85,000,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Under Advisement [Member] \| Rothmans, Benson & Hedges Inc. and Imperial Tobacco Ltd. [Member]
Loss Contingencies [Line Items]
Motion to secure judgment, Letters of credit to be placed into trust, option 1									CAD 5,000,000,000	$ 3,900,000,000
Canada [Member] \| Adams [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Plaintiff requirement, Minimum number of cigarettes smoked \| cigarette				25,000
Canada [Member] \| Suzanne Jacklin [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Plaintiff requirement, Minimum number of cigarettes smoked \| cigarette			25,000
Subsequent Event [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																66
Subsequent Event [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																11
Subsequent Event [Member] \| Argentina [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																31
Subsequent Event [Member] \| Brazil [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																20
Subsequent Event [Member] \| Brazil [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																2
Subsequent Event [Member] \| Canada [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																2
Subsequent Event [Member] \| Canada [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																9
Subsequent Event [Member] \| Chile [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																8
Subsequent Event [Member] \| Costa Rica [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																2
Subsequent Event [Member] \| Italy [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																1
Subsequent Event [Member] \| Philippines [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																1
Subsequent Event [Member] \| Scotland [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																1

XML 73 R61.htm IDEA: XBRL DOCUMENT

Contingencies (Health Care Cost Recovery Litigation) (Details) - Health Care Cost Recovery Actions [Member] $ in Millions	Apr. 14, 2014 USD ($) patient	Oct. 17, 2008	Mar. 13, 2008	Feb. 26, 2008	May. 25, 2007	May. 09, 2007	Apr. 22, 2016 litigation_case	Apr. 30, 2015 litigation_case	May. 01, 2014 litigation_case
Loss Contingencies [Line Items]
Cases brought against PM								16	15
Korea [Member]
Loss Contingencies [Line Items]
Damages sought, value \| $	$ 53.7
Damages sought, number of patients \| patient	3,484
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Lagos State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements			20 years
Damages sought, period of future reimbursements			20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Kano State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements						20 years
Damages sought, period of future reimbursements						20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Gombe State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements		20 years
Damages sought, period of future reimbursements		20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Ovo State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements					20 years
Damages sought, period of future reimbursements					20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Ogun State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements				20 years
Damages sought, period of future reimbursements				20 years
Subsequent Event [Member]
Loss Contingencies [Line Items]
Cases brought against PM							16
Subsequent Event [Member] \| Canada [Member]
Loss Contingencies [Line Items]
Cases brought against PM							10
Subsequent Event [Member] \| Korea [Member]
Loss Contingencies [Line Items]
Cases brought against PM							1
Subsequent Event [Member] \| Nigeria [Member]
Loss Contingencies [Line Items]
Cases brought against PM							5

XML 74 R62.htm IDEA: XBRL DOCUMENT

Contingencies (Lights Cases) (Details) - Individual Lights Cases [Member] - litigation_case	Apr. 22, 2016	Apr. 30, 2015	May. 01, 2014
Loss Contingencies [Line Items]
Cases brought against PM		2	2
Subsequent Event [Member]
Loss Contingencies [Line Items]
Cases brought against PM	3
Subsequent Event [Member] \| Chile [Member]
Loss Contingencies [Line Items]
Cases brought against PM	2
Subsequent Event [Member] \| Italy [Member]
Loss Contingencies [Line Items]
Cases brought against PM	1

XML 75 R63.htm IDEA: XBRL DOCUMENT

Contingencies (Public Civil Actions and Other Litigation) (Details) defendant in Millions, $ in Millions, THB in Billions	Jan. 18, 2016 THB import_entry defendant	Jan. 18, 2016 USD ($) import_entry defendant	Nov. 20, 2015	Apr. 22, 2016 litigation_case	Apr. 30, 2015 litigation_case	May. 01, 2014 litigation_case
Public Civil Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM					2	2
Public Civil Actions [Member] \| Romania [Member] \| Foundation for the Defense of Citizens against Abuses of the State (FACIAS) [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Excise taxes collected from tobacco manufacturers, percent			1.00%
Percentage of turnover of tobacco manufacturers and distributors			1.00%
Public Civil Actions [Member] \| Subsequent Event [Member]
Loss Contingencies [Line Items]
Cases brought against PM				3
Public Civil Actions [Member] \| Subsequent Event [Member] \| Argentina [Member]
Loss Contingencies [Line Items]
Cases brought against PM				1
Public Civil Actions [Member] \| Subsequent Event [Member] \| Romania [Member]
Loss Contingencies [Line Items]
Cases brought against PM				1
Public Civil Actions [Member] \| Subsequent Event [Member] \| Venezuela [Member]
Loss Contingencies [Line Items]
Cases brought against PM				1
Other Litigation [Member] \| Thailand [Member] \| The Department of Special Investigations of the Government of Thailand [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of defendants \| defendant	8	8
Number of import entities \| import_entry	272	272
Damages sought, value	THB 80.8	$ 2,300

XML 76 R64.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2016
Income Taxes [Line Items]
Effective tax rate	28.30%	30.20%
Impact on effective tax rate related to changes to repatriation assertions on certain foreign subsidiary historical earnings		$ 58
United States [Member]
Income Taxes [Line Items]
Open Tax Year	2012 and onward
Scenario, Forecast [Member]
Income Taxes [Line Items]
Effective tax rate			28.00%

XML 77 R65.htm IDEA: XBRL DOCUMENT

Indebtedness (Narrative) (Details) - USD ($)	Mar. 31, 2016	Jan. 27, 2016	Dec. 31, 2015
Line of Credit Facility [Line Items]
Short-term borrowings, carrying value	$ 673,000,000		$ 825,000,000
Committed credit facilities	8,000,000,000
Borrowings under committed credit facilities	0
Revolving Credit Expiring February 9, 2017 [Member]
Line of Credit Facility [Line Items]
Committed credit facilities	2,000,000,000	$ 2,000,000,000
Multi-year revolving credit, expiring February 28, 2021 [Member]
Line of Credit Facility [Line Items]
Committed credit facilities	$ 2,500,000,000	$ 2,500,000,000.0

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References + Details

XML 78 R66.htm IDEA: XBRL DOCUMENT

Indebtedness (Long-Term Debt) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Long-term Debt and Capital Lease Obligations, Including Current Maturities	$ 29,120	$ 27,655
Less current portion of long-term debt	2,437	2,405
Long-term Debt	26,683	25,250
U.S. Dollar Notes [Member]
Debt Instrument [Line Items]
Long-term Debt and Capital Lease Obligations, Including Current Maturities	$ 20,079	18,091
Due through	2044
Interest rate, minimum	1.125%
Interest rate, maximum	6.375%
Interest rate, average	3.612%
Euro Notes [Member] \| Foreign Currency Obligations [Member]
Debt Instrument [Line Items]
Long-term Debt and Capital Lease Obligations, Including Current Maturities	$ 6,844	7,423
Due through	2033
Interest rate, minimum	1.75%
Interest rate, maximum	3.125%
Interest rate, average	2.433%
Swiss Franc Notes [Member] \| Foreign Currency Obligations [Member]
Debt Instrument [Line Items]
Long-term Debt and Capital Lease Obligations, Including Current Maturities	$ 1,737	1,690
Due through	2024
Interest rate, minimum	0.75%
Interest rate, maximum	2.00%
Interest rate, average	1.217%
Other [Member] \| Foreign Currency Obligations [Member]
Debt Instrument [Line Items]
Long-term Debt and Capital Lease Obligations, Including Current Maturities	$ 460	$ 451
Due through	2024
Interest rate, average	3.126%

XML 79 R67.htm IDEA: XBRL DOCUMENT

Indebtedness (Debt Issuances During Current Period) (Details) - US Dollar Notes [Member]	3 Months Ended
	Mar. 31, 2016 USD ($)
1.375% US Dollar Notes Due February 2019 [Member]
Debt Instrument [Line Items]
Face Value	$ 500,000,000
Interest Rate	1.375%
Issuance	Feb. 01, 2016
Maturity	Feb. 28, 2019
1.875% US Dollar Notes Due February 2021 [Member]
Debt Instrument [Line Items]
Face Value	$ 750,000,000
Interest Rate	1.875%
Issuance	Feb. 01, 2016
Maturity	Feb. 28, 2021
2.750% US Dollar Notes Due February 2026 [Member]
Debt Instrument [Line Items]
Face Value	$ 750,000,000
Interest Rate	2.75%
Issuance	Feb. 01, 2016
Maturity	Feb. 28, 2026

XML 80 R68.htm IDEA: XBRL DOCUMENT

Indebtedness (Credit Facilities) (Details) - USD ($)	Mar. 31, 2016	Jan. 27, 2016
Line of Credit Facility [Line Items]
Committed credit facilities	$ 8,000,000,000
Revolving Credit Expiring February 9, 2017 [Member]
Line of Credit Facility [Line Items]
Committed credit facilities	2,000,000,000	$ 2,000,000,000
Multi-year revolving credit, expiring February 28, 2021 [Member]
Line of Credit Facility [Line Items]
Committed credit facilities	2,500,000,000	$ 2,500,000,000.0
Multi-year revolving credit, expiring October 1, 2020 [Member]
Line of Credit Facility [Line Items]
Committed credit facilities	$ 3,500,000,000

XML 81 R69.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Narrative) (Details) $ in Millions	Mar. 31, 2016 USD ($)
Fair Value Disclosures [Abstract]
Capital lease obligations, carrying value	$ 14
Debt excluding short-term borrowings and capital lease obligations, carrying value	$ 29,106

XML 82 R70.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) $ in Millions	Mar. 31, 2016 USD ($)
Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) [Member]
Assets:
Foreign exchange contracts	$ 0
Total assets	0
Liabilities:
Debt	31,432
Foreign exchange contracts	0
Total liabilities	31,432
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Foreign exchange contracts	511
Total assets	511
Liabilities:
Debt	480
Foreign exchange contracts	299
Total liabilities	779
Significant Unobservable Inputs (Level 3) [Member]
Assets:
Foreign exchange contracts	0
Total assets	0
Liabilities:
Debt	0
Foreign exchange contracts	0
Total liabilities	0
Fair Value [Member]
Assets:
Foreign exchange contracts	511
Total assets	511
Liabilities:
Debt	31,912
Foreign exchange contracts	299
Total liabilities	$ 32,211

XML 83 R71.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Currency translation adjustments	$ (5,617)	$ (6,129)	$ (5,247)
Pension and other benefits	(3,287)	(3,332)	(2,964)
Derivatives accounted for as hedges	(10)	59	121
Total accumulated other comprehensive losses	$ (8,914)	$ (9,402)	$ (8,090)

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

XML 84 R72.htm IDEA: XBRL DOCUMENT

Balance Sheet Offsetting (Details) - Foreign Exchange Contract [Member] - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Assets
Gross Amounts Recognized	$ 511	$ 574
Gross Amount Offset in the Condensed Consolidated Balance Sheet	0	0
Net Amounts Presented in the Condensed Consolidated Balance Sheet	511	574
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments	(209)	(131)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged	(273)	(432)
Net Amount	29	11
Liabilities
Gross Amounts Recognized	299	172
Gross Amount Offset in the Condensed Consolidated Balance Sheet	0	0
Net Amounts Presented in the Condensed Consolidated Balance Sheet	299	172
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments	(209)	(131)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged	(63)	(30)
Net Amount	$ 27	$ 11

XML 85 R73.htm IDEA: XBRL DOCUMENT

Investments in Unconsolidated Subsidiaries (Narrative) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated subsidiaries	$ 942,000,000	$ 890,000,000
Dividends from unconsolidated subsidiaries	0	127,000,000
Equity Method Investments [Member]
Schedule of Equity Method Investments [Line Items]
Difference between equity method investment carrying value and book value	$ 824,000,000	806,000,000
Equity Method Investments [Member] \| Minimum [Member]
Schedule of Equity Method Investments [Line Items]
Difference between equity method investment carrying value and book value, amortization period	3 years
Equity Method Investments [Member] \| Maximum [Member]
Schedule of Equity Method Investments [Line Items]
Difference between equity method investment carrying value and book value, amortization period	20 years
Equity Method Investment Goodwill [Member]
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated subsidiaries	$ 765,000,000	$ 744,000,000
EITA [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage	49.00%
STAEM [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage	25.00%
EITA Ownership Percentage in Société des Tabacs Algéro-Emiratie (“STAEM”) [Member] \| Joint Venture [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage	51.00%
Societe Nationale des Tabacs et Allumettes SpA [Member] \| Joint Venture [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage	49.00%
Megapolis [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage			20.00%
Purchase Price of Equity Method Investments			$ 760,000,000
Additional contingent consideration (up to $100 million)			$ 100,000,000
Additional contingent consideration measurement period			4 years
Notes receivable to unconsolidated subsidiaries			$ 100,000,000
Discounted liability			$ 86,000,000

XML 86 R74.htm IDEA: XBRL DOCUMENT

Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) - Equity Method Investments [Member] - Eastern Europe Middle East And Africa [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Schedule of Equity Method Investments [Line Items]
Net revenues	$ 777	$ 896
Receivables	319	64
Notes receivable	102	100
Other Liabilities [Member]
Schedule of Equity Method Investments [Line Items]
Other liabilities	$ 100	$ 100

XML 87 R75.htm IDEA: XBRL DOCUMENT

Acquisitions and Other Business Arrangements (Details) $ in Millions			1 Months Ended					3 Months Ended
	Oct. 26, 2015 USD ($) shares	Sep. 30, 2015 IDR / shares	Jun. 30, 2015	May. 31, 2015 USD ($)	Jun. 30, 2014 USD ($)	Mar. 31, 2014 USD ($)	Sep. 30, 2013 USD ($)	Mar. 31, 2016 USD ($)	Mar. 31, 2015 USD ($)
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Sale (purchase) of subsidiary shares to (from) noncontrolling interests								$ 6	$ 0
Nicocigs Limited [Member] \| United Kingdom [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Business acquisition, percentage of interest acquired					100.00%
Payment to acquire business					$ 103
Additional contingent payment, maximum					$ 77
Period of consideration for performance targets related to acquisition					3 years
Grupo Carso [Member] \| Mexican tobacco business [Member] \| Affiliated Entity [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Ownership percentage by noncontrolling owners							20.00%
PT HM Sampoerna Tbk [Member] \| INDONESIA
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Ownership percentage before transaction			98.18%
Share price (in Rp. per share) \| IDR / shares		IDR 77,000
Premium on share price (percent)		1.349%
Shares issued in transaction \| shares	264,209,711
Consideration received from transaction	$ 1,500
Increase (decrease) in additional paid in capital	$ 1,100
Grupo Carso [Member] \| Mexican tobacco business [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Increase (decrease) in additional paid in capital							$ (559)
Ownership percentage by parent							100.00%
Estimated dividend payment to noncontrolling interest							$ 38
Dividends declared and paid						$ 38
Grupo Carso [Member] \| Mexican tobacco business [Member] \| Affiliated Entity [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Payments to acquire additional interest in subsidiaries							$ 703
Purchase price adjustment period							3 years
Purchase price adjustment period, after close of purchase							2 years
Sale (purchase) of subsidiary shares to (from) noncontrolling interests				$ 113
Additional interest in subsidiaries, adjusted purchase price				$ 590

XML 88 R76.htm IDEA: XBRL DOCUMENT

Sale of Accounts Receivable (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Sale of Accounts Receivable [Abstract]
Trade receivables sold and derecognized from the Consolidated Balance Sheets	$ 1,900	$ 300
Trade receivables sold and derecognized that remain uncollected	$ 589	$ 108

EXCEL 89 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 90 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 91 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 93 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 277 308 1 false 121 0 false 18 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.pmi.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Earnings (Unaudited) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfEarningsUnaudited Condensed Consolidated Statements of Earnings (Unaudited) Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) Statements 5 false false R6.htm 1003001 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnauditedParenthetical Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfStockholdersDeficitEquityUnaudited Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Statements 7 false false R8.htm 1004501 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfStockholdersDeficitEquityUnauditedParenthetical Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) (Parenthetical) Statements 8 false false R9.htm 1005000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 9 false false R10.htm 2102100 - Disclosure - Background and Basis of Presentation Sheet http://www.pmi.com/role/BackgroundAndBasisOfPresentation Background and Basis of Presentation Notes 10 false false R11.htm 2103100 - Disclosure - Asset Impairment and Exit Costs Sheet http://www.pmi.com/role/AssetImpairmentAndExitCosts Asset Impairment and Exit Costs Notes 11 false false R12.htm 2104100 - Disclosure - Stock Plans Sheet http://www.pmi.com/role/StockPlans Stock Plans Notes 12 false false R13.htm 2105100 - Disclosure - Benefit Plans Sheet http://www.pmi.com/role/BenefitPlans Benefit Plans Notes 13 false false R14.htm 2106100 - Disclosure - Goodwill and Other Intangible Assets, net Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNet Goodwill and Other Intangible Assets, net Notes 14 false false R15.htm 2107100 - Disclosure - Financial Instruments Sheet http://www.pmi.com/role/FinancialInstruments Financial Instruments Notes 15 false false R16.htm 2108100 - Disclosure - Earnings Per Share Sheet http://www.pmi.com/role/EarningsPerShare Earnings Per Share Notes 16 false false R17.htm 2110100 - Disclosure - Segment Reporting Sheet http://www.pmi.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 2111100 - Disclosure - Contingencies Sheet http://www.pmi.com/role/Contingencies Contingencies Notes 18 false false R19.htm 2112100 - Disclosure - Income Taxes Sheet http://www.pmi.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 2113100 - Disclosure - Indebtedness Sheet http://www.pmi.com/role/Indebtedness Indebtedness Notes 20 false false R21.htm 2114100 - Disclosure - Fair Value Measurements Sheet http://www.pmi.com/role/FairValueMeasurements Fair Value Measurements Notes 21 false false R22.htm 2115100 - Disclosure - Accumulated Other Comprehensive Losses Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses Accumulated Other Comprehensive Losses Notes 22 false false R23.htm 2116100 - Disclosure - Balance Sheet Offsetting Sheet http://www.pmi.com/role/BalanceSheetOffsetting Balance Sheet Offsetting Notes 23 false false R24.htm 2117100 - Disclosure - Investments in Unconsolidated Subsidiaries Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiaries Investments in Unconsolidated Subsidiaries Notes 24 false false R25.htm 2118100 - Disclosure - Acquisitions and Other Business Arrangements Sheet http://www.pmi.com/role/AcquisitionsAndOtherBusinessArrangements Acquisitions and Other Business Arrangements Notes 25 false false R26.htm 2119100 - Disclosure - Sale of Accounts Receivable Sheet http://www.pmi.com/role/SaleOfAccountsReceivable Sale of Accounts Receivable Notes 26 false false R27.htm 2120100 - Disclosure - New Accounting Standards Sheet http://www.pmi.com/role/NewAccountingStandards New Accounting Standards Notes 27 false false R28.htm 2220201 - Disclosure - New Accounting Standards (Policies) Sheet http://www.pmi.com/role/NewAccountingStandardsPolicies New Accounting Standards (Policies) Policies http://www.pmi.com/role/NewAccountingStandards 28 false false R29.htm 2303301 - Disclosure - Asset Impairment and Exit Costs (Tables) Sheet http://www.pmi.com/role/AssetImpairmentAndExitCostsTables Asset Impairment and Exit Costs (Tables) Tables http://www.pmi.com/role/AssetImpairmentAndExitCosts 29 false false R30.htm 2305301 - Disclosure - Benefit Plans (Tables) Sheet http://www.pmi.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.pmi.com/role/BenefitPlans 30 false false R31.htm 2306301 - Disclosure - Goodwill and Other Intangible Assets, net (Tables) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables Goodwill and Other Intangible Assets, net (Tables) Tables http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNet 31 false false R32.htm 2307301 - Disclosure - Financial Instruments (Tables) Sheet http://www.pmi.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.pmi.com/role/FinancialInstruments 32 false false R33.htm 2308301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.pmi.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.pmi.com/role/EarningsPerShare 33 false false R34.htm 2310301 - Disclosure - Segment Reporting (Tables) Sheet http://www.pmi.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.pmi.com/role/SegmentReporting 34 false false R35.htm 2311301 - Disclosure - Contingencies (Tables) Sheet http://www.pmi.com/role/ContingenciesTables Contingencies (Tables) Tables http://www.pmi.com/role/Contingencies 35 false false R36.htm 2313301 - Disclosure - Indebtedness (Tables) Sheet http://www.pmi.com/role/IndebtednessTables Indebtedness (Tables) Tables http://www.pmi.com/role/Indebtedness 36 false false R37.htm 2314301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pmi.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pmi.com/role/FairValueMeasurements 37 false false R38.htm 2315301 - Disclosure - Accumulated Other Comprehensive Losses (Tables) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables Accumulated Other Comprehensive Losses (Tables) Tables http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses 38 false false R39.htm 2316301 - Disclosure - Balance Sheet Offsetting (Tables) Sheet http://www.pmi.com/role/BalanceSheetOffsettingTables Balance Sheet Offsetting (Tables) Tables http://www.pmi.com/role/BalanceSheetOffsetting 39 false false R40.htm 2317301 - Disclosure - Investments in Unconsolidated Subsidiaries (Tables) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables Investments in Unconsolidated Subsidiaries (Tables) Tables http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiaries 40 false false R41.htm 2403402 - Disclosure - Asset Impairment and Exit Costs (Movement In The Exit Cost Liabilities) (Details) Sheet http://www.pmi.com/role/AssetImpairmentAndExitCostsMovementInExitCostLiabilitiesDetails Asset Impairment and Exit Costs (Movement In The Exit Cost Liabilities) (Details) Details http://www.pmi.com/role/AssetImpairmentAndExitCostsTables 41 false false R42.htm 2403403 - Disclosure - Asset Impairment and Exit Costs (Narrative) (Details) Sheet http://www.pmi.com/role/AssetImpairmentAndExitCostsNarrativeDetails Asset Impairment and Exit Costs (Narrative) (Details) Details http://www.pmi.com/role/AssetImpairmentAndExitCostsTables 42 false false R43.htm 2404401 - Disclosure - Stock Plans (Details) Sheet http://www.pmi.com/role/StockPlansDetails Stock Plans (Details) Details http://www.pmi.com/role/StockPlans 43 false false R44.htm 2405402 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details) Sheet http://www.pmi.com/role/BenefitPlansComponentsOfNetPeriodicBenefitCostDetails Benefit Plans (Components of Net Periodic Benefit Cost) (Details) Details http://www.pmi.com/role/BenefitPlansTables 44 false false R45.htm 2405403 - Disclosure - Benefit Plans (Narrative) (Details) Sheet http://www.pmi.com/role/BenefitPlansNarrativeDetails Benefit Plans (Narrative) (Details) Details http://www.pmi.com/role/BenefitPlansTables 45 false false R46.htm 2406402 - Disclosure - Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetGoodwillAndOtherIntangibleAssetsBySegmentDetails Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 46 false false R47.htm 2406403 - Disclosure - Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetMovementInGoodwillDetails Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 47 false false R48.htm 2406404 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 48 false false R49.htm 2406405 - Disclosure - Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetRangeOfUsefulLivesAndWeightedAverageRemainingUsefulLivesOfAmortizableIntangibleAssetsDetails Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 49 false false R50.htm 2406406 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetNarrativeDetails Goodwill and Other Intangible Assets, net (Narrative) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 50 false false R51.htm 2407402 - Disclosure - Financial Instruments (Narrative) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails Financial Instruments (Narrative) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 51 false false R52.htm 2407403 - Disclosure - Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsFairValueOfForeignExchangeContractsDetails Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 52 false false R53.htm 2407404 - Disclosure - Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsCashFlowAndNetInvestmentHedgingActivitiesEffectOnCondensedConsolidatedStatementsOfEarningsAndOtherComprehensiveEarningsDetails Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 53 false false R54.htm 2407405 - Disclosure - Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedInAccumulatedOtherComprehensiveEarningsLossesNetOfIncomeTaxesDetails Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 54 false false R55.htm 2408402 - Disclosure - Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) Sheet http://www.pmi.com/role/EarningsPerShareCalculationOfBasicAndDilutedEpsDetails Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) Details http://www.pmi.com/role/EarningsPerShareTables 55 false false R56.htm 2410402 - Disclosure - Segment Reporting (Details) Sheet http://www.pmi.com/role/SegmentReportingDetails Segment Reporting (Details) Details http://www.pmi.com/role/SegmentReportingTables 56 false false R57.htm 2411402 - Disclosure - Contingencies (Tobacco-Related Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails Contingencies (Tobacco-Related Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 57 false false R58.htm 2411403 - Disclosure - Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Sheet http://www.pmi.com/role/ContingenciesNumberOfTobaccoRelatedCasesPendingAgainstUsAndOrOurSubsidiariesOrIndemniteesDetails Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Details http://www.pmi.com/role/ContingenciesTables 58 false false R59.htm 2411404 - Disclosure - Contingencies (Verdicts and Post-Trial Developments) (Details) Sheet http://www.pmi.com/role/ContingenciesVerdictsAndPostTrialDevelopmentsDetails Contingencies (Verdicts and Post-Trial Developments) (Details) Details http://www.pmi.com/role/ContingenciesTables 59 false false R60.htm 2411405 - Disclosure - Contingencies (Smoking And Health Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesSmokingAndHealthLitigationDetails Contingencies (Smoking And Health Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 60 false false R61.htm 2411406 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails Contingencies (Health Care Cost Recovery Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 61 false false R62.htm 2411407 - Disclosure - Contingencies (Lights Cases) (Details) Sheet http://www.pmi.com/role/ContingenciesLightsCasesDetails Contingencies (Lights Cases) (Details) Details http://www.pmi.com/role/ContingenciesTables 62 false false R63.htm 2411408 - Disclosure - Contingencies (Public Civil Actions and Other Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesPublicCivilActionsAndOtherLitigationDetails Contingencies (Public Civil Actions and Other Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 63 false false R64.htm 2412401 - Disclosure - Income Taxes (Details) Sheet http://www.pmi.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.pmi.com/role/IncomeTaxes 64 false false R65.htm 2413402 - Disclosure - Indebtedness (Narrative) (Details) Sheet http://www.pmi.com/role/IndebtednessNarrativeDetails Indebtedness (Narrative) (Details) Details http://www.pmi.com/role/IndebtednessTables 65 false false R66.htm 2413403 - Disclosure - Indebtedness (Long-Term Debt) (Details) Sheet http://www.pmi.com/role/IndebtednessLongTermDebtDetails Indebtedness (Long-Term Debt) (Details) Details http://www.pmi.com/role/IndebtednessTables 66 false false R67.htm 2413404 - Disclosure - Indebtedness (Debt Issuances During Current Period) (Details) Sheet http://www.pmi.com/role/IndebtednessDebtIssuancesDuringCurrentPeriodDetails Indebtedness (Debt Issuances During Current Period) (Details) Details http://www.pmi.com/role/IndebtednessTables 67 false false R68.htm 2413405 - Disclosure - Indebtedness (Credit Facilities) (Details) Sheet http://www.pmi.com/role/IndebtednessCreditFacilitiesDetails Indebtedness (Credit Facilities) (Details) Details http://www.pmi.com/role/IndebtednessTables 68 false false R69.htm 2414402 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.pmi.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.pmi.com/role/FairValueMeasurementsTables 69 false false R70.htm 2414403 - Disclosure - Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) Sheet http://www.pmi.com/role/FairValueMeasurementsAggregateFairValueOfDerivativeFinancialInstrumentsDebtAndContingentConsiderationDetails Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) Details http://www.pmi.com/role/FairValueMeasurementsTables 70 false false R71.htm 2415402 - Disclosure - Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsOfAccumulatedOtherComprehensiveEarningsLossesNetOfTaxDetails Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Details http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables 71 false false R72.htm 2416402 - Disclosure - Balance Sheet Offsetting (Details) Sheet http://www.pmi.com/role/BalanceSheetOffsettingDetails Balance Sheet Offsetting (Details) Details http://www.pmi.com/role/BalanceSheetOffsettingTables 72 false false R73.htm 2417402 - Disclosure - Investments in Unconsolidated Subsidiaries (Narrative) (Details) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesNarrativeDetails Investments in Unconsolidated Subsidiaries (Narrative) (Details) Details http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables 73 false false R74.htm 2417403 - Disclosure - Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesBalanceSheetAndEarningsActivityDetails Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) Details http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables 74 false false R75.htm 2418401 - Disclosure - Acquisitions and Other Business Arrangements (Details) Sheet http://www.pmi.com/role/AcquisitionsAndOtherBusinessArrangementsDetails Acquisitions and Other Business Arrangements (Details) Details http://www.pmi.com/role/AcquisitionsAndOtherBusinessArrangements 75 false false R76.htm 2419401 - Disclosure - Sale of Accounts Receivable (Details) Sheet http://www.pmi.com/role/SaleOfAccountsReceivableDetails Sale of Accounts Receivable (Details) Details http://www.pmi.com/role/SaleOfAccountsReceivable 76 false false All Reports Book All Reports pm-20160331.xml pm-20160331.xsd pm-20160331_cal.xml pm-20160331_def.xml pm-20160331_lab.xml pm-20160331_pre.xml true true ZIP 95 0001413329-16-000082-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001413329-16-000082-xbrl.zip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end